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Eukaryotic Elongation Factor 1A (eEF1A) plays a key role in protein synthesis by 
delivering aminoacylated tRNAs to the A site of the ribosome. In higher vertebrates, 
two isoforms of eEF1A exist called eEF1A1 and eEF1A2, with eEF1A2 being 
expressed in adult brain, heart and skeletal muscle. Since 2012, several different de 
novo heterozygous missense mutations in EEF1A2 have been identified in humans 
and these cause epilepsy, intellectual disability and autism. Before considering 
treatment options, it is vital to determine whether these mutations cause loss or gain 
of protein function. 
 
I performed a battery of behavioural tests using two mouse lines with heterozygous 
loss of function mutations in eEF1A2. The aim was to determine whether there were 
any behavioural phenotypes consistent with intellectual disability and/or autism. 
Using heterozygous wasted mice (Eef1a2+/wst), I analysed the effects of aging on 
behaviour and found that Eef1a2+/wst mice showed reduced marble burying activity 
and reduced movement in the open field test with age. In a test of social behaviour, 
Eef1a2+/wst mice showed a significantly reduced preference for social novelty at all 
ages tested.  
 
The second heterozygous null line, Del22.ex3, was generated on a pure C57BL/6J 
genetic background. This new line was made in order to reduce the level of variation 
observed in data from the wasted line, which was on a mixed genetic background. 
The genetic background was shown to have an influence on behaviour as the results 
differed between this line and the wasted line. Del22.ex3 Eef1a2+/- mice showed 
significantly reduced engagement in repetitive behaviours compared with wild-type 
littermates and normal preference for social novelty. 
 
Using CRISPR/Cas9, a mouse line with the D252H missense mutation was generated 
and I repeated my behavioural testing on heterozygotes from this line. I found no 
behavioural abnormalities in this line suggesting a mouse-human difference in the 
ability to tolerate eEF1A2 missense mutations. Previous attempts to make a line with 
	 xvii 
the G70S missense mutation were unsuccessful but as a product of this experiment, it 
was found that mice expressing G70S eEF1A2 had a comparable phenotype to and 
died at the same age as complete knockouts. This suggested that the G70S protein is 
non-functional and cannot compensate for loss of wild-type eEF1A2. 
 
These experiments have improved our understanding of the phenotypic effects of 
Eef1a2 mutations in mice and have shown, for the first time, that mutations in 




























Cells have a constant need to make new proteins. These are molecules which carry 
out all of the tasks needed for the cell to function, grow and survive. All of the cells 
in the body contain a protein called eEF1A which is responsible for making new 
proteins. There are two different forms of eEF1A called eEF1A1 and eEF1A2 and 
these work to make new proteins in different cells from each other. I worked on 
eEF1A2 for my PhD project and this form is present inside cells of the brain, muscle 
and heart. Every cell in these tissues has two copies of eEF1A2. 
 
eEF1A2 is essential for survival in mice. Mice that do not have any eEF1A2 develop 
severe degeneration of their nervous system and muscle and die by four weeks of 
age. Humans who have mutations in one copy of EEF1A2 present with epilepsy, 
intellectual disability and autism. It is important that we find out how these mutations 
lead to disease so that we can consider treatment options. 
 
In my PhD project, I used mice with different mutations in Eef1a2 to look for 
changes that might explain what is happening in humans. The main aim of my 
project was to study mouse behaviour to check if this was abnormal in the mutant 
mice and whether we could link any abnormalities to the intellectual disability and 
autism we see in humans. I found that these mice have abnormal social behaviour 
which seems to fit with the clinical features identified in patients. The mice I used for 
this part of my project had one normal copy and one mutated copy of eEF1A2 (in a 
50:50 ratio). 
 
I also managed to show that these mutant eEF1A2 proteins are unable to function 
properly in mice. Mice that have two mutated copies of eEF1A2 (no normal copies) 
die at the same age as the mice that have no eEF1A2 described above. Therefore, 
having mutated eEF1A2 is just as detrimental as having no eEF1A2 at all. These 
mutant eEF1A2 proteins can be identified in cells using certain analysis techniques 
post-mortem but at much lower levels than we find the normal protein suggesting 
	 xix 
that the cell is degrading these mutant proteins. Therefore, the cell is able to 
recognise these proteins as “the wrong thing” and discard them. 
 
Our team also found that mice that don’t have any eEF1A2 at all experience seizures 
in response to sound. This shows that losing the correct balance of eEF1A2 in both 
humans and mice can result in seizures. 
 
All in all, my research shows that mice with Eef1a2 mutations develop some of the 
clinical features we see in humans and therefore these mice provide a valuable tool 
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Chapter 1: Introduction 
	
1 
Chapter 1: Introduction 
 
1.1. Protein synthesis 
1.1.1. Overview 
Each and every cell needs to carry out de novo protein synthesis in order to survive. 
The process of translating mRNA into protein is divided into three main stages: 
initiation, elongation and termination. Initiation is controlled by proteins called 
initiation factors (IFs) which form a complex with the ribosomal subunits and mRNA 
to begin the translation process. Elongation is controlled by elongation factors (EFs) 
and is the process by which amino acids are added to the growing peptide chain. This 
occurs through recognition of complementary codon and anticodon sequences on the 
mRNA and tRNA, respectively. Termination is controlled by release factors (RFs) 
and signifies the end of protein synthesis. The presence of a stop codon: UAA, UGA 
or UAG allows the mRNA to be released from the ribosome which allows recycling 
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1.1.2. Eukaryotic elongation factor 1A (eEF1A) 
eEF1A participates in the elongation stage of protein synthesis by bringing 
aminoacylated-tRNAs to the A site of the ribosome. This is a GTP-dependent 
process mediated by the GTP exchange eEF1B. After each amino acid is added to 
the growing protein chain, GTP is hydrolysed to GDP and eEF1A is released to bring 




Figure 1.1. The role of eEF1A in protein synthesis. eEF1B, which exists as three subunits 
(eEF1B in orange, eEF1G in green and eEF1D in purple), binds to eEF1A (blue) and 
converts GDP to GTP. The eEF1B complex is then released and eEF1A collects an 
aminoacyl tRNA and brings it to the A site of the ribosome. Once the amino acid bound to 
the tRNA is added to the protein chain, GTP is hydrolysed to GDP and eEF1A is released 
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1.2. eEF1A isoforms in higher vertebrates 
1.2.1. The two isoforms 
eEF1A exists as two isoforms in higher vertebrates which are encoded on different 
chromosomes. In humans, EEF1A1 maps to chromosome 6q14 and EEF1A2 to 
20q13.3 whereas in mouse Eef1a1 maps to chromosome 9 and Eef1a2 to 
chromosome 2 (Lund et al., 1996).  
 
There is little difference in amino acid composition between the two isoforms, 
specifically these are 92% identical and 98% similar. Soares et al (2009) compared 
the amino acid differences between the isoforms and found that most of the 
differences lie in two clusters on one side of the molecule away from the binding 
sites that are important for protein synthesis (Figure 1.2A). This suggests that the 
ability of each isoform to participate in protein synthesis is probably similar and that 
any differences are more likely to relate to differences in the non-canonical functions 
of eEF1A alluded to later in this section. Interestingly, some of the amino acid 
residues that vary between the isoforms lead to differences in the potential of each 
isoform to be phosphorylated (Soares et al., 2009) and differences in post-
translational modifications (Soares and Abbott, 2013). It is important to note that the 
amino acid substitutions don’t appear to affect overall protein structure (Soares et al., 
2009) (Figure 1.2B). 
 
Differences in the molecular dynamics i.e. flexibility and mobility of the isoforms 
have also been observed, leading to differences in conformation between the two 
isoforms and differences in binding affinities for calmodulin (Kanibolotsky et al., 
2008). eEF1A1 is also more hydrophobic and is more likely to bind to itself than 
eEF1A2 is (Timchenko et al., 2013). The two isoforms also have different affinities 
for GTP with eEF1A1 having a higher affinity than eEF1A2. This means that 
eEF1A1 binds GTP more strongly than GDP but eEF1A2 binds GDP more strongly 
than GTP. However, this difference in GTP affinity does not appear to have any 
effect on translation as measured using an in vitro assay. GTPase activity is also 
identical between the isoforms (Kahns et al., 2008). 
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The non-canonical roles of eEF1A include a role in the heat shock response (eEF1A1 
only) (Vera et al., 2014), the ability to bind and bundle actin (Liu et al., 1996, 
Vlasenko et al., 2015), a role in the export of proteins from the nucleus (Khacho et 
al., 2008), a role in protein degradation through interactions with the proteasome 
(Chuang et al., 2005), a role in apoptosis (eEF1A1 pro-apoptotic, eEF1A2 anti-
apoptotic) (Duttaroy et al., 1998, Ruest et al., 2002, Lamberti et al., 2004) and a role 
in oncogenesis (eEF1A2 only) (Anand et al., 2002, Tomlinson et al., 2005, Li et al., 
2006, Schlaeger et al., 2008, Cao et al., 2009). The reason for differences in the 
structure and function of the two isoforms described above may be related to these 









Figure 1.2. Structural differences between eEF1A1 and eEF1A2. A. 3D models of each 
side of the human eEF1A1 molecule with the amino acid residues that differ between this 
isoform and the eEF1A2 isoform mapped in green. These differences appear in two distinct 
clusters labelled “cluster 1” and “cluster 2”. B. Diagrams showing the overall structure of 
each side of the eEF1A1 (blue) and eEF1A2 (red) molecules. Each isoform contains the 
same three domains, called domain I, II and III, the overall structure of which remain 
identical despite the differences in amino acid residues. The side chains that differ between 
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1.2.2. eEF1A undergoes a developmental expression switch 
eEF1A1 and eEF1A2 are differentially expressed. In several studies of adult human, 
mouse, rat and more recently pig eEF1A, eEF1A2 has been shown to be highly 
expressed in brain, spinal cord, heart and skeletal muscle whereas eEF1A1 is 
expressed in all other tissues tested (placenta, lung, liver, kidney, pancreas, spleen, 
testis, bladder, stomach and thymus).  
 
eEF1A1 is expressed ubiquitously throughout development but is down-regulated 
postnatally in neurons, heart and skeletal muscle and is replaced by eEF1A2 (Lee et 
al 1992, Knudsen et al., 1993, Chambers, Peters and Abbott, 1998, Khalyfa et al., 
2001, Newbery et al., 2007, Svobodová et al., 2015). eEF1A2 has also been 
identified postnatally in islet cells in the pancreas and enteroendocrine cells in the 
gut. In adult brain, eEF1A1 continues to be expressed but only in glial cells and 
some small neurons. eEF1A1 is also expressed in glial cells and white matter in the 
spinal cord (Khalyfa et al., 2001, Newbery et al., 2007). 
 
In mouse skeletal muscle at P21, eEF1A1 is undetectable at both the RNA level 
(Chambers, Peters and Abbott, 1998) and at the protein level (Khalyfa et al., 2001) 
having been completely replaced by eEF1A2. In mouse brain at P20, Khalyfa et al 
(2001) showed, using double immunofluorescence labelling, that eEF1A1 co-
localised with a glial-specific marker and eEF1A2 with a neuronal-specific marker, 
suggesting that the expression switch was complete by this time point. Notably, weak 
eEF1A1 staining was also detectable in a few unspecified neuronal cells. Pan et al 
(2004) confirmed the timing of this switch in the brain but analysed the expression 
changes in more detail by looking at changes at specific time points using double-
label immunofluorescence in neurons. It was found that at P14, eEF1A1 was 
expressed at very low levels whilst eEF1A2 had just become detectable. eEF1A2 
then showed a gradual increase in expression until P26, where a plateau was reached. 
Importantly, at P20, eEF1A1 was undetectable in neurons, as found by Khalyfa et al 
(2001). No eEF1A2 expression was detected in glial cells. The developmental 
expression profile in neurons is summarised in table 1.1. 
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Table 1.1. Summary of developmental expression switch in neurons. 
 E16 P1 P14 P20 P26 
eEF1A1 High High Low Undetectable Undetectable 
eEF1A2 Undetectable Undetectable Moderate 
(rising) 
High (rising) High (plateau) 
 
The reason for having two differentially expressed isoforms of eEF1A with slightly 
differing roles is not fully understood. Maybe, following early development, certain 
cell types (neurons, heart, skeletal muscle) switch to eEF1A2 as some of the 
functions performed by eEF1A1 are no longer needed or are potentially detrimental. 
The cells that express eEF1A2 are robust, established and long-living, being 
terminally differentiated. 
 
1.3. eEF1A in disease 
1.3.1. The wasted mouse model and neurodegeneration 
In 1972, a spontaneous deletion in the Eef1a2 gene arose in a mouse line housed in 
the Jackson laboratory. This deletion results in complete loss of eEF1A2 expression 
(Shultz et al., 1982). This Eef1a2 knockout (KO) line has a 15.8 kilobase deletion 
that spans the promoter and first non-coding exon of the gene (Chambers, Peters and 
Abbott, 1998). 
 
This mouse line has been well characterised over the years and is referred to as 
“wasted” due to a severe degenerative phenotype starting at around 21 days postnatal 
(P21). Homozygous wasted mice develop tremors, ataxia and weight loss which, 
over the course of a few days, leads to paralysis and early death at around P28 
(Shultz et al., 1982). Heterozygous mice are phenotypically normal (Griffiths et al., 
2012).  
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In 1984, the gene responsible for the wasted phenotype was mapped to the distal end 
of chromosome 2, 1 centiMorgan from the Ragged (Ra) gene (Sweet, 1984). The 
ragged mutation also arose spontaneously, however, it is semi-dominant meaning 
that homozygotes and heterozygotes manifest with different phenotypes from one 
another. Heterozygotes simply present with ragged coats whereas homozygotes are 
much more severely affected, being almost completely hairless and failing to survive 
post-weaning (Carter and Phillips, 1956). Subsequently, interspecific backcrosses 
were used to map the ragged and wasted genes relative to other genes on the distal 
end of chromosome 2 in order to identify potential candidate genes that may be 
responsible for the phenotypes and to lay the foundation for a positional cloning 
approach. It was found that the gene responsible for the wasted phenotype is 
positioned 3cM distal to Acra-4, the molecular marker closest to the telomere. The 
ragged gene was also successfully mapped relative to the same markers and was 
found to be no further than 2.19cM from Acra-4 and D2Mit74 and further from the 
telomere than the wasted gene (Abbott et al., 1994). No potential candidate genes 
were identified for the wasted phenotype through this mapping approach, therefore, a 
positional cloning approach was necessary to identify the gene responsible. A 
positional cloning/positional candidate approach was used whereby Eef1a2 was 
selected as a candidate gene. Amplification of mouse Eef1a2 by PCR showed a 
difference in product size between wild-type and wasted mice and analysis of 247 
mice showed that Eef1a2 and the wasted gene did not recombine. Subsequent PCR 
amplification across the boundaries of the deletion and sequencing of the product 
revealed that the deletion is 15.8kb and spans the promoter and first non-coding exon 
of the gene (Chambers, Peters and Abbott, 1998). The sequence analysis of the 
deletion is shown in Figure 1.3. 
 
In 2007, work in our laboratory confirmed that Eef1a2 is the only gene responsible 
for the wasted phenotype. Transgenic mice were generated with a bacterial artificial 
chromosome (BAC) containing the Eef1a2 gene and the C20orf149 gene, the mouse 
homologue of a human gene of unknown function. These mice were crossed with 
mice from the wasted line to give rise to wasted homozygotes that carried the 
transgene. These mice showed none of the phenotypes normally seen in wasted mice, 
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were fertile and had a normal lifespan showing that the BAC was able to rescue the 
wasted phenotype. It was therefore reasonable to assume that Eef1a2 and/or 
C20orf149 are responsible for the wasted phenotype. To investigate whether one or 
both genes are involved, a deletion was introduced into the BAC to inactivate 
Eef1a2. When crossed into the wasted line, this BAC failed to correct the phenotype 





Figure 1.3. Sequence analysis of wasted (wst/wst) and wild-type (HRS/J) mice 
revealing position and size of wasted deletion in Eef1a2. Underlined = IAP element, 
non-underlined = intron 1, bold = exon 2. The dotted line represents the 15.8kb deletion in 
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The first signs of neuromuscular pathology can be identified in wasted mice at P17. 
At this early time point, there is retraction of motor nerve terminals from motor end 
plates, leaving both unoccupied and partially occupied endplates which results in 
weak synaptic transmission by P23. At P23, wasted homozygous mice weigh 
significantly less than their heterozygous littermates due to loss of muscle bulk 
(Figure 1.4A). In terms of spinal cord pathology, gliosis and accumulation of 
phosphorylated neurofilaments can be seen inside motor neurons of the anterior horn 
at P19, followed by vacuolation of these motor neurons at P25 (Figure 1.4B) 
(Newbery et al., 2005). Motor impairments and muscle weakness can be assessed 
using the rotarod and grip strength tests respectively. Wasted mice perform 
significantly worse than their littermates in the rotarod test from P21 (Newbery et al., 
2005) and in the grip strength test from P20 (Griffiths et al., 2012). 
 





Figure 1.4. Phenotypic abnormalities in homozygous wasted mice. A. An image 
showing the size difference between a +/+ mouse (left) and its wst/wst littermate (right). B. 
Pathology of wasted mice in the anterior horn of the cervical spinal cord. The top panel 
shows haematoxylin and eosin staining of a +/wst (A) and a wst/wst mouse (B). Arrows show 
areas of vacuolation which can be seen as ‘holes’ in the tissue. The middle panel shows 
staining of phosphorylated neurofilaments by immunohistochemistry. Shown is a section 
from a +/wst mouse (C) and a wst/wst mouse (D). Arrows show accumulation of 
phosphorylated neurofilaments in the cytoplasm of motor neurons. The bottom panel shows 
gliosis measured by immunohistochemistry with an antibody against glial fibrillary acidic 
protein (GFAP) in +/wst (E) and wst/wst (F) sections. The high level of staining in the 
wasted mouse section indicates neuronal damage (brown puncta). Taken from Newbery et 
al., 2005. 
wst/wst +/+ A 
B 




The onset of the wasted phenotype coincides with the loss of eEF1A1 expression in 
muscle (Chambers, Peters and Abbott, 1998). Since there is no eEF1A2 to 
compensate, muscle tissue ends up with no eEF1A which, as evidenced by the 
phenotype, clearly has detrimental effects. This is also around the same time that 
eEF1A1 expression is lost from neurons and again there is no eEF1A2 to compensate 
(Pan et al., 2004). Furthermore, it has been shown that there is no compensatory up-
regulation of eEF1A1 in the absence of eEF1A2 (Khalyfa et al., 2001).  
 
Doig et al (2013) aimed to determine whether the muscle atrophy seen in wasted 
mice is due to loss of eEF1A2 in muscle or whether it is neurogenic in origin. To 
achieve this, they generated transgenic wasted mice expressing eEF1A2 only in 
muscle and compared them with non-transgenic wasted mice by measuring weight, 
survival, grip strength and limb muscle atrophy by post-mortem histology. The levels 
of eEF1A2 expression in the muscle of transgenic wasted mice were confirmed as 
being comparable to wild-type mice. They found that wasted mice carrying the 
transgene were indistinguishable from non-transgenic wasted mice which shows that 
expression of eEF1A2 in muscle is not sufficient to rescue the phenotype. This 
suggests that the muscle atrophy seen in wasted mice is of a neurological origin. The 
authors also attempted to generate transgenic wasted mice expressing eEF1A2 only 
in neurons, but this was unsuccessful as all founAders unexpectedly expressed 
eEF1A2 both in neurons and muscle. 
 
 
1.3.2. Human EEF1A2 mutations cause intellectual disability and 
epilepsy 
Since 2012, 20 different EEF1A2 mutations have been identified over 40 individuals 
which cause intellectual disability, epilepsy or abnormal EEG and in some cases 
autism. It is worth noting that a diagnosis of autism is not always possible as, in 
some cases, the intellectual disability is too severe. Autistic behaviours that have 
been identified in these patients include repetitive hand twisting, finger sucking, 
rocking and self-injury behaviours. All of these mutations are de novo heterozygous 
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missense mutations and were discovered using trio-based exome sequencing of the 
individuals and their unaffected parents. It is important to note that a number of the 
cases are currently unpublished. The mutations are summarised in table 1.2. 
 
In most cases, these mutations are very severe as most of the patients cannot speak at 
all and some can only communicate using signs. If they can speak, they have very 
limited language capabilities. Their motor skills are also severely under-developed. 
Some of the patients are unable to sit, stand or walk at all whilst others are able to do 
some or all of these tasks with assistance. Ataxia has been observed in those that can 
walk independently. 
 
The first case was identified in 2012, a 22-year-old female with a missense mutation 
that changes the amino acid glycine to serine at position 70 on the protein (G70S). 
Her clinical profile stated that she had neonatal hypotonia, seizures from 4 months of 
age, severely delayed motor and language development, autistic features and 
aggressive behaviours. Height, weight, head circumference and facial features were 
normal (de Ligt et al., 2012). A second G70S case was identified in 2013 which 
increased confidence that EEF1A2 was the causative gene as there was now two 
patients with the same mutation sharing similar clinical features. This 10-year-old 
male had clinical features of West syndrome, neonatal hypotonia, seizures starting at 
10 weeks of age, severe developmental delay, gait abnormalities and microcephaly 
with no mention of whether or not there were any autistic features. Language 
development was absent in this individual as he was completely non-verbal 
(Veeramah et al., 2013). 
 
Two more cases were discovered in 2014. These were the first two patients to be 
identified as having characteristic facial features thought to be associated with the 
mutation (Nakajima et al., 2014). Specifically, these features are a broad nasal 
bridge, a tented upper lip, an everted lower lip and downturned corners of the mouth. 
Lam et al (2016) presented seven new cases and reported that six of these seven 
patients showed the facial features described above. Therefore, this may be a helpful 
diagnostic for identifying patients with EEF1A2 mutations in the future. 




It is interesting to note that disease severity varies depending on the mutation. One of 
the most severe cases is a female with a F98L mutation who was 9-years-old at 
diagnosis and has daily seizures that cannot be controlled with medication, cannot 
sit, has no head control, is non-verbal and has severe global developmental delay 
(Lam et al., 2016). By contrast, the mildest case is a female with an E124K mutation 
who was 10-years-old at diagnosis and has seizures that are controlled by 
medication. She can walk independently, speaks in sentences and only has mild 
intellectual disability. She attends a mainstream primary school but will attend a 
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A92T Undefined from 
1 month 
Severe Y     Y Lopes et al., 2016 
D252H GTCS from 8 
years 
Moderate Y Y Cannot walk Non-verbal Y Y Nakajima et al., 2014 
D252H  Severe      Y DDD 
D91N Eye rolling, head 
dropping and 
arm extensions 
from 2 years 
Severe  Y Can walk 
assisted 
Non-verbal Y  Lam et al., 2016 
E122K Infantile seizures 
from undefined 
age 
Severe Y Y Can walk 
unassisted 
but ataxic 
 Y Y Nakajima et al., 2014 
E122K Atypical, 
myoclonic and 
absence from 10 
months 
Severe   Cannot walk Non-verbal Y  Inui et al., 2016 
E122K Myoclonic and 
myoclonic-atonic 
from 8 months 
Severe   Cannot walk Non-verbal Y Y Inui et al., 2016 
E122K Infantile spasms 
from 10 weeks 






Y Y Lam et al., 2016 
E124K Myoclonic 
followed by 
absence from 3 
months 
Mild N N  Verbal N N Lam et al., 2016 
F98C Abnormal EEG 
only 
Moderate Y Y  Non-verbal  N Personal commun-
ication 









GTCS from 4 
months 
Severe Y Y  Non-verbal N  De Ligt et al., 2012 
G70S Infantile spasms, 
tonic, myoclonic 
and GTCS from 
8 months 





Non-verbal  Y Veeramah et al., 
2013 
G70S Myoclonic and 
clonic-tonic 
followed by 
Severe  Y   Y  Lam et al., 2016 





GTCS = Generalised tonic-clonic seizures, DDD = Deciphering Developmental Disorders 
study. Red dot = patient died from respiratory failure. Blank boxes indicate that the 
information was unavailable. Defects on brain scans include microcephaly, generalised 
brain atrophy, atrophy of the cerebrum and ventriculomegaly. Adapted from Davies (2017). 
 
The human missense mutations have been mapped onto a 3D model of the eEF1A2 
protein (Figure 1.5). Most of the mutations are clustered around the sites that are 
important for protein synthesis suggesting that alteration of this process might lead to 
the disease phenotype. For example, the Glu122Lys mutation involves substitution of 
an amino acid residue that is involved in binding the GTP-exchange factor eEF1B 
(Nakajima et al., 2014). Similarly, the Asp252His mutation is in the GDP/GTP 
binding domain (Nakajima et al., 2014) and it has been shown that mutating this 
residue in yeast eEF1A reduces translational fidelity (Sandbaken and Culbertson, 
1988). Interestingly, the patient that has the mildest phenotype (described above) has 
a mutation that is further away from the binding sites important for protein synthesis 
(Lam et al., 2016). 
 
	
G70S Absence, tonic, 
myoclonic and 
GTCS from 18 
months 






Moderate N Y  Non-verbal  N Personal commun-
ication  
 
Helbig et al., 2016 
I71L Undefined 
seizure type and 
age of onset 
















Severe N Y    Y Personal commun-
ication  
R266W Undefined 
seizure type and 
age of onset 
Severe Y    Y  DDD 




Moderate  Y  Non-verbal Y Y Personal commun-
ication  
 
Lam et al., 2016 






























































































A92T Und fin d from 
1 m nth 
v r        Lopes et al., 2016 
D252H T  fr  8 
years 
Moderate Y Y Cannot walk Non-verbal Y Y Nakajima et al., 2014 
D252H  Severe     Y DDD 
D91N Eye rolling, head 
dropping and 
arm extensions 
from 2 years 
Severe  Y Can walk 
assisted 
Non-verbal Y  Lam et al., 2016 
E122K Infantile seizures 
from undefined 
age 
Severe Y Y Can walk 
unassisted 
but ataxic 
 Y Y Nakajima et al., 2014 
E122K Atypical, 
myoclonic and 
absence from 10 
months 
Severe   Cannot walk Non-verbal Y  Inui et al., 2016 
E122K Myoclonic and 
myoclonic-atonic 
from 8 months 
Severe   Cannot walk Non-verbal Y Y Inui et al., 2016 
E122K Infantile spasms 
from 10 weeks 






Y Y Lam et al., 2016 
E124K Myoclonic 
followed by 
absence from 3 
months 
Mild N N  Verbal N N Lam et al., 2016 
F98C Abnormal EEG 
only 
Moderate Y Y  Non-verbal  N Personal commun-
ication 









GTCS from 4 
months 
Severe Y Y  Non-verbal N  De Ligt et al., 2012 
G70S Infantile spasms, 
tonic, myoclonic 
and GTCS from 
8 months 





Non-verbal  Y Veeramah et al., 
2013 
G70S Myoclonic and 
clonic-tonic 
followed by 
Severe  Y   Y  Lam et al., 2016 





Figure 1.5. Human EEF1A2 mutations mapped onto a 3D model of the protein to show 
proximity of mutations to sites crucial for protein synthesis. Both sides of the human 
eEF1A2 protein are shown. Highlighted are the eEF1B binding site (blue), the GDP/GTP 
binding site (yellow), the human mutations (red) and the amino acid residues that vary 
between eEF1A1 and eEF1A2 (green). Residues with side chains that are buried within the 
molecule are labelled in brown. Mutations that are close to or overlap with eEF1B or 
GDP/GTP binding sites are A92T, D252H, D91N, E122K, E124K, F98L, F98C, G70S, I71L, 
M102V, R266W and T432M. 3D modelling by Dinesh Soares. 
 
1.3.3. eEF1A and other nervous system disorders 
Dysregulation of protein synthesis and eEF1A have been implicated in other 
neurological disorders in several studies. The majority of these studies analyse total 
eEF1A levels without distinguishing between the two isoforms. For example, in 
studies investigating protein expression, eEF1A antibodies which are not isoform-
specific are commonly used. However, in some studies, it is possible to decipher 
whether eEF1A1 or eEF1A2 are being studied. For example, expression of eEF1A in 
adult neurons can be assumed to be eEF1A2. However, studies of eEF1A in whole 
tissue will include both isoforms. In the studies described below, specific isoforms 
have been referred to where possible. 
 
Using a combination of western blotting and immunohistochemistry, eEF1A protein 
expression levels have been shown to be down-regulated in Alzheimer’s disease 
(AD), a neurodegenerative disease characterised by memory impairments. In post-
mortem brain samples from patients with the disease, eEF1A2 levels are significantly 
reduced specifically in hippocampal neurons in the CA1 and dentate gyrus. eEF1A 
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levels are also significantly lower in the hippocampus of TG2576 AD model mice 
compared with controls (Beckelman et al., 2015, Beckelman et al., 2016). The 
hippocampus is an important area for memory formation and eEF1A is known to 
contribute to the maintenance of LTP, the physiological process that is hypothesised 
to underlie the formation of new memories (Tsokas et al., 2005). Therefore, perhaps 
it is unsurprising that we find this link between eEF1A and AD. In transgenic AD 
mice, LTP is impaired and it has been found that this can be rescued by up-regulation 
of eEF1A (Beckelman et al., 2016). It has been speculated that eEF1A dysregulation 
might be one of the mechanisms underlying AD pathogenesis and could potentially 
contribute to the memory loss that is a hallmark of the disease. 
 
It has been shown that protein synthesis machinery is altered in human Parkinson’s 
disease (PD) post-mortem brain samples. With regards to eEF1A, there is a reduction 
in protein expression in the frontal cortex that correlates with disease progression, 
shown by western blotting. This means that individuals with more severe disease 
have lower levels of eEF1A (Garcia-Esparcia et al., 2015). Another PD study 
investigated the relationship between the PI3K/Akt/mTOR pathway, which is 
dysregulated in PD, and eEF1A. An MPP+-induced SH-SY5Y cellular model of PD 
was used in which cells were treated with MPP, a compound that is toxic to 
dopaminergic neurons. Using qPCR, both eEF1A isoforms were found to be 
significantly up-regulated at the mRNA level in non-differentiated MPP+ treated 
cells compared with control cells that had not been treated. In differentiated MPP+ 
treated cells, only eEF1A2 was up-regulated. Up-regulation of eEF1A2 was also 
observed in both non-differentiated and differentiated cells at the protein level, 
however, only one sample per group was analysed (Khwanraj et al., 2016). 
 
Altered eEF1A expression has also been observed using mass spectrometry in human 
iPSC-derived forebrain neural progenitor cells from schizophrenia patients. A 
significant 2.4-fold increase in levels of global protein synthesis accompanied by an 
increase in components of the translational machinery was observed. This included a 
significant increase in eEF1A1 and eEF1A2 protein expression compared with 
healthy controls (Topol et al., 2015). 




Changes in eEF1A have been observed in Fragile X syndrome, an X-linked disorder 
which is the most common genetic cause of intellectual disability. Fragile X 
syndrome is caused by mutations in the FMR1 gene which encodes the Fragile X 
Mental Retardation Protein (FMRP) (Verkerk et al., 1991). The normal function of 
FMRP is to suppress translation of specific mRNAs, however, many of the mRNA 
targets remain unidentified (Bagni and Greenough, 2005). Sung et al (2003) sought 
to identify mRNA targets of FMRP and found an interaction with eEF1A. In PC12 
cells transfected with human FMRP, a direct interaction between FMRP and eEF1A 
mRNA was confirmed by immunoprecipitation (IP) and subsequent northern blotting 
of the associated mRNAs. It was shown that PC12 cells expressing lower levels of 
FMRP express higher levels of eEF1A through western blotting. Finally, western 
blotting showed that eEF1A protein expression is increased 2-fold in Fragile X 
lymphocytes compared with control cell lines. A direct interaction between FMRP 
and both eEF1A1 and eEF1A2 mRNA has also been shown using crosslinking IP 
followed by high-throughput sequencing of isolated mRNAs (Darnell et al., 2011). 
These data suggest that FMRP regulates translation of both eEF1A isoforms.  
 
There is an excess of immature dendritic spines in the brains of individuals with 
Fragile X syndrome and Fmr1 knockout mice and subsequent research suggests that 
this is caused by impaired synapse elimination (Pfeiffer et al., 2010). Tsai et al 
(2012) investigated synapse elimination in Fmr1 KO mice using neuronal cultures 
and hippocampal slice cultures. Silencing of eEF1A1 in these cultures using specific 
shRNAs was found to rescue defects in synapse elimination, suggesting that elevated 
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1.4. Autism, intellectual disability and epilepsy: common molecular 
pathways affected 
1.4.1. Co-occurrence of autism, intellectual disability and epilepsy 
Autism, intellectual disability and epilepsy commonly co-occur. Therefore, there is a 
lot of interest in determining which pathways are affected in these disorders and 
where they converge. Individuals with autism have an increased risk of developing 
epilepsy, with 25% of people with autism having a seizure disorder. A striking 70% 
of people with autism also have an intellectual disability (Zoghbi and Bear, 2012). In 
children with autism, IQ is negatively correlated with epilepsy meaning that epilepsy 
is more likely to present itself in those who also have an intellectual disability (Jeste 
and Tuchman, 2015). In cases where these disorders co-occur, it is debated as to 
whether these manifest due to the same common mechanism or whether epilepsy 
disrupts cortical connections which then leads to autism and intellectual disability. 
However, the interplay of both of these mechanisms is likely to be causative. 
 
1.4.2. Genetics 
There have been many identified genetic causes of autism in which individuals also 
present with epilepsy and intellectual disability including well-characterised 
inherited single-gene disorders, such as Fragile X syndrome, Rett syndrome and 
Tuberous Sclerosis Complex (Jeste and Tuchman, 2015, Ronemus et al., 2014). 
Genetic studies have shown that hundreds of different genes are linked to autism 
(Vorstman et al., 2017). Variants in these autism-associated genes are often rare and 
can include both single nucleotide variants (SNVs) and copy number variants 
(CNVs). Additionally, de novo genetic variants i.e. those that are not present in the 
parents are more common in individuals with autism than their unaffected siblings. 
Advances in genetic methods such as whole genome sequencing (WGS) and whole 
exome sequencing (WES) have improved the ability of scientists to identify novel 
causes of autism. Genes with SNVs that have been shown to be associated with ASD 
through sequencing studies include ADNP, ARID1B, SCN2A, DYRK1A, 
SYNGAP1 and GRIN2B. The variants identified in these genes have also been found 
to be associated with ID and epilepsy (Vorstman et al., 2017). 
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Many genes associated with autism, epilepsy and intellectual disability are involved 
in the regulation of synapse structure and function (Jeste and Tuchman, 2015). 
Examples of these are shown in Table 1.3. 
 
Table 1.3. Examples of genes mutated in autism, epilepsy and intellectual disability 
that function at synapses 
Syndrome (if 
applicable) 








Comorbid ID with 
ASD severity linked 








anxiety and ADHD 
 NRXNI Early onset, 
severe, both focal 
and generalised 
epilepsy 
Profound ID, ADHD 








 SHANK3 Generalised, focal, 
absence 
Hypotonia, 









ID = intellectual disability, ASD = autism spectrum disorder, ADHD = attention deficit 
hyperactivity disorder, IQ = intelligence quotient. Adapted from Jeste and Tuchman (2015). 
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All of the genes described in Table 1.3 are involved in regulating protein synthesis at 
excitatory glutamatergic synapses (Zoghbi and Bear, 2012). Therefore, there appears 
to be a link between dysregulation of synaptic protein synthesis and disorders that 
feature autism, epilepsy and intellectual disability. 
 
1.4.3. Extracellular signal-regulated kinase pathway 
Regulation of specific processes within the synapse, including translation, involves 
the activation of the extracellular signal-regulated kinase (ERK1/2) pathway (Figure 
1.6). ERK 1/2 form part of the MAPK signalling cascade that is involved in synaptic 
plasticity and memory formation. Downstream targets of ERK1/2 signalling regulate 
processes including synaptic receptor docking and dendritic spine stabilisation 
(Subramanian et al., 2015). This pathway is commonly affected in disorders that are 
characterised by autism, epilepsy and intellectual disability. Two examples based on 
the mutations in Table 1.3 are described below. 
 
In post-mortem brain tissue from patients with Fragile X syndrome, it has been 
shown that levels of phosphorylated ERK are increased 17.5-fold compared with 
controls (Wang et al., 2012). A similar increase has also been observed in Fmr1 
knockout mice. SL327, a selective inhibitor of ERK activity, can abolish audiogenic 
seizure activity in these mice (Wang et al., 2012). These data suggest that the 
ERK1/2 signalling is altered in Fragile X syndrome and that this contributes to some 
of the phenotypes of the disease. 
 
Osterweil et al (2013) tested whether inhibition of Ras, an upstream component of 
the pathway which acts on ERK1/2, can rescue disease phenotypes in the Fmr1 
knockout mouse. Lovastatin, a drug used to lower cholesterol, happens to be an 
inhibitor of Ras and the team showed that this can rescue the exaggerated levels of 
protein synthesis and prevent epileptiform activity in hippocampal slices from Fmr1 
knockout mice. Strikingly, this drug is also able to significantly reduce audiogenic 
seizure incidence and severity in Fmr1 knockout mice in vivo (Osterweil et al., 
2013). 
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There is evidence to suggest that TSC1/2, the genes mutated in Tuberous Sclerosis, 
interact with the ERK1/2 signalling pathway. In transgenic mouse models of the 
disease, elevated ERK phosphorylation and an increase in ERK signalling have been 
observed in the hippocampus. Furthermore, inhibiting the ERK pathway with the 
antagonist U0126 can rescue disease phenotypes in these mice including restoration 




Figure 1.6. Signalling at the excitatory glutamatergic synapse involves ERK1/2. This 
signalling is necessary for the control of protein synthesis. Autism-related genes are shown 





Chapter 1: Introduction 
	
24 
1.4.4. Mammalian target of rapamycin pathway 
In neurons, the mammalian target of rapamycin (mTOR) signalling pathway is 
involved in the control of protein synthesis, growth and morphogenesis and is 
controlled by metabotropic glutamate receptor 5 (mGluR5) (Subramanian et al., 
2015). Like ERK1/2 signalling, there is much evidence to suggest that the mTOR 
pathway is altered in disorders that are characterised by autism, epilepsy and 
intellectual disability. There is cross-talk between the ERK1/2 pathway and the 
mTOR pathway, as shown in Figure 1.6, so, unsurprisingly, the same mutations have 
been found to affect both pathways. Two examples of mTOR pathway dysfunction in 
disease are given below, based on the mutations in Table 1.3. 
 
The mTOR pathway is overactive in Fmr1 knockout mice. This is evidenced by an 
increase in phosphorylation of mTOR and its downstream targets in the 
hippocampus, shown using western blotting and IP. This is coupled with increased 
protein expression of upstream pathway components PIKE-S and PI3K, the former 
of which is a confirmed target of FMRP (Sharma et al., 2010a). The hypothesised 
action of FMRP on the mTOR pathway, proposed by Sharma et al (2010a), is shown 
in Figure 1.7. Selective knockdown of PI3K mRNA in the prefrontal cortex of FmrI 
knockout mice abolishes specific behavioural deficits and reduces audiogenic seizure 
frequency (Gross et al., 2015). Additionally, this inhibition restores the increase in 
protein synthesis observed in the KO, measured by incorporation of radiolabelled 
amino acids, to wild-type levels. Finally, dendritic spine density is restored to wild-
type levels, shown by golgi staining and subsequent imaging of dendrites. 
 
As can be seen from Figure 1.7, PTEN forms part of the mTOR pathway by 
inhibiting PI3K and mutations in this gene have been found to cause epilepsy, 
intellectual disability and autism (Table 1.3). The mTOR pathway is overactive in 
mice with a conditional knockout of PTEN in the brain and inhibiting mTOR activity 
using rapamycin in these mice alleviates some of the disease phenotypes. These mice 
have macrocephaly but treatment with rapamycin restores brain size to wild-type 
levels. Suppression of mTOR activity with rapamycin also rescues behavioural 
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deficits in tests of anxiety and social behaviour and reduces spontaneous seizure 




Figure 1.7. A schematic of the mTOR pathway showing its proposed interaction with 
FMRP. FMRP is thought to inhibit PIKE-S. This downregulates PI3K and Akt signalling 
resulting in negative regulation of mTOR signalling. Supplying the agonist DHPG to 
activate mGluR5 up-regulates mTOR signalling via complex formation with Homer and 
PIKE-L. An increase in mTOR signalling stimulates translation of synaptic proteins leading 
to mGluR-dependent-LTD. In Fragile X, this LTD is exaggerated due to over-activation of 
the mTOR pathway. The pathway is overactive because FMRP is lost and is therefore unable 
to suppress PIKE-S. The control of protein synthesis is also lost resulting in an imbalance of 
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1.5. eEF1A and aging 
Protein synthesis has been shown to slow down with age in many species, including 
human, rodents and Drosophila (Webster and Webster, 1983, Gonskikh and Polacek, 
2017) and several lines of evidence suggest that elongation is the most rate-limiting 
step. Specifically, the rate of this step has been shown to be reduced by up to 80% by 
measuring translation elongation in vitro using cell-free extracts from aged 
Drosophila, nematode and rodent organs. Similarly, in vivo studies using rat liver 
and brain have shown that the rate of polypeptide chain assembly can be reduced by 
up to 50% with age (Rattan and Clark, 1996). 
 
Several studies have shown a link between eEF1A and aging with convincing 
evidence for an age-related decline in eEF1A activity. One such study in Drosophila 
shows that eEF1A activity declines with aging due to a reduction in eEF1A synthesis 
and that this precedes a drop in global protein synthesis (Webster and Webster, 
1983). It was thought that providing another copy of eEF1A through genetic 
engineering could increase survival age of Drosophila by 41% (Shepherd et al., 
1989) but it was later shown that these genetically engineered flies did not actually 
overexpress eEF1A (Shikama, Ackermann and Brack, 1994). However, it has been 
shown that transgenic fungi containing eEF1A high-fidelity mutations live longer 
which suggests that eEF1A may act to increase lifespan by preventing errors in 
peptide elongation (Silar and Picard, 1994). 
 
Moldave et al (1979) studied protein synthesis in rat brain and liver, and found that 
the rate was 30% less in 30-month-old rats compared with 3-month old rats and that 
this was accompanied by a 30-40% decrease in eEF1A activity. A 35-45% decrease 
in eEF1A protein expression levels and activity has also been observed in cell-free 
extracts from senescent human fibroblasts (Rattan et al., 1996). 
 
eEF1A has also been studied in an attempt to find links with age-related disease. 
Griffiths et al (2012) studied an aging cohort of wasted heterozygous mice to look 
for signs of late-onset neurodegeneration. They used the rotarod and grip strength 
tests to study motor function and muscle function, respectively, and stained spinal 
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cords from 21 month old animals to look for signs of motor neuron degeneration. 
Perhaps surprisingly, they found that the performance of heterozygous mice in the 
rotarod and grip strength tests were comparable with wild-type mice and found no 
signs of neurodegeneration in the spinal cord. This shows that a presumed 50% 
decrease in eEF1A2 expression is compatible with normal function and survival in 
mice. As discussed in Section 1.3.3, eEF1A levels have also been shown to be 
reduced in AD (Beckelman et al., 2015, Beckelman et al., 2016).  
 
 
1.6. Learning and memory 
1.6.1. The basic neuroscience of learning and memory 
Neuroscientists still do not fully understand the molecular processes underlying 
learning and memory, however, recent advances in technology have aided our 
understanding substantially. In the 19th century, many scientists thought that the 
processes involved in learning and memory were carried out by the brain as a whole, 
but lesion studies showed that different parts of the brain controlled different 
memory functions (Queenan et al., 2017). For example, a patient called Henry 
Molaison (“HM”) had his anterior hippocampus, amygdala and surrounding cortex 
removed from both hemispheres to cure his intractable epilepsy. Unfortunately, as a 
product of this, he ended up with a very specific type of memory impairment. This 
memory loss was specific for episodic memories (memories for events) and HM had 
a complete inability to form new memories and a severe impairment in memory 
recall. However, his procedural memory (memory for skills e.g. riding a bike) 
remained intact (Squire, 2009). The different types of memory, including those 










Figure 1.8. The different types of memory. First of all, memory is divided into short-term 
and long-term memory. Short-term memory has limitations in duration and capacity. Short-
term memory can hold a finite number of items temporarily (generally agreed to be around 7 
items in adults). Generally, short-term memory is the memory for the “here and now”. 
Working memory is a type of short-term memory that is used to plan and execute an action. 
Working memory is required to perform mental arithmetic or to cook without introducing the 
same ingredient more than once. Long-term memory is a form of memory whereby memories 
are stored and are able to be recalled later. Long-term memory formation requires new 
protein synthesis. Procedural memory is unconscious memory for skills such as reading, 
writing and riding a bicycle i.e. processes that don’t require thinking about in order to 
perform them. Declarative memory is conscious memory for either events that have 
happened in a person’s life e.g. remembering lunch with a friend last week (episodic) or 
memory for facts e.g. knowing who is the Prime Minister (semantic). Constructed from 
information in Shanks and John, 1994, Cowan, 2008 and Queenan et al., 2017. 
 
Synaptic plasticity is generally accepted to be the cellular mechanism underlying 
learning and memory. This concept was introduced by Donald Hebb in 1949 who 
stated that neurons that “fire together, wire together”. By this, Hebb hypothesised 
that connections between co-activated cells are altered by synaptic activity (Hebb, 
1949, Queenan et al., 2017). This idea was expanded by Bliss and Lomo (1973) who 
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identified that repetitive stimulation of the perforant path fibres to granule cells in the 
hippocampus lead to specific changes. They found that this repeated stimulation 
caused a potentiated response from the granule cells lasting up to 10 hours, 
characterised by a reduction in population spike latency and an increase in 
excitatory-post-synaptic-potential (EPSP) and population spike amplitude. This 
meant that there was an elevation in the efficiency of synaptic transmission. 
 
This strengthening of synaptic connections and therefore increase in the efficacy of 
synaptic transmission is known as long-term potentiation (LTP). When populations 
of cells fire asynchronously, there is a decrease in the efficacy of synaptic 
transmission and a weakening of synaptic connections known as long-term 
depression (LTD). It is thought that these two types of change in synaptic strength 
underlie memory formation, and may confer learning and forgetting, respectively. 
Changes in synaptic strength and connectivity have been observed in specific subsets 
of neurons during memory formation and it is thought that this is required to store 
information. The maintenance of LTP and LTD requires new protein synthesis 
(Martin, Grimwood and Morris, 2000, Queenan et al., 2017). 
 
The specific molecular alterations occurring at the synapse that accompany these 
changes are not fully understood but there are known alterations in neurotransmitter 
receptors, mRNA expression, protein expression, post-translational modifications 
and the structure of the extracellular matrix (Queenan et al., 2017). 
 
1.6.2. The role of eEF1A in learning and memory 
Since the maintenance of LTP and LTD require new protein synthesis, local 
synthesis of proteins at synapses is likely to be important. Much of the recent work 
towards understanding the molecular basis of learning and memory has focussed on 
identifying mRNAs that are expressed at synapses and understanding how translation 
is regulated at these sites. 
 
There is evidence to suggest that eEF1A is translated locally at synapses and plays a 
role in LTP and LTD. In rat hippocampus, eEF1A has been identified as part of a 
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group of mRNAs transported from the soma to the dendrites (Zhong, Zhang and 
Bloch, 2006). In a pull-down experiment using adult rat brain extracts, eEF1A 
protein was identified as a binding partner of the alpha-2 subunit of the glycine 
receptor. This interaction was confirmed in rat spinal cord, specifically for eEF1A2. 
Subsequent immunofluorescence experiments in cultured rat hippocampal and spinal 
cord neurons showed that eEF1A protein co-localised with the alpha-2 subunit at 
inhibitory synapses (Bluem et al., 2007). 
 
It has been found that induction of LTP at rat hippocampal synapses results in both 
an increase in eEF1A protein expression and increased activation of the mTOR 
pathway. This increase in eEF1A can be observed in dendrites that have been 
severed from the cell body, showing that the increase is due to local protein 
synthesis. Both the increase in eEF1A and the maintenance of LTP are blocked by 
rapamycin, an mTOR inhibitor, showing that activation of the mTOR pathway is 
crucial for the maintenance of LTP. It is hypothesised that synaptic stimulation 
activates mTOR signalling which then enhances translation allowing maintenance of 
LTP (Tsokas et al., 2005). This study highlights a role for eEF1A in the maintenance 
of LTP. 
 
Similarly, local translation of eEF1A has been observed at synapses in response to 
LTD. Induction of LTD by metabotropic glutamate receptor (mGluR) activation 
results in an increase in eEF1A protein expression in the dendrites of rat 
hippocampal neurons. Induction of LTD also increases ERK phosphorylation 
suggesting that there is activation of the ERK signalling pathway in response to 
LTD. Interestingly, the same group found that eEF1A mRNA is highly expressed in 
developing dendrites suggesting that eEF1A may play a role in synaptic development 
(Huang, Chotiner and Steward., 2005). This study suggests that eEF1A plays a role 
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1.7. Project aims 
The majority of my PhD project involved behavioural testing of mice with different 
mutations in Eef1a2. I studied two lines with heterozygous null mutations on 
different genetic backgrounds and a third line with the D252H missense mutation 
identified in humans. The aim of this was to determine whether these mice showed 
any phenotypes that were consistent with the intellectual disability and autism 
observed in humans with EEF1A2 mutations. Another part of my project was to 
assist with genotypic and phenotypic characterisation of mice with the Eef1a2/G70S 
missense mutation that were generated using CRISPR/Cas9. 
 
My individual aims according to chapter are as follows: 
• Chapter 3 - To characterise mice with the Eef1a2/G70S missense mutation 
with an aim to better understand the mechanisms underlying the human 
phenotype. 
• Chapter 4 – To determine the effects of age and genetic background on the 
behaviour of heterozygous Eef1a2-null mice. 
• Chapter 5 – To investigate the effects of the Eef1a2/D252H missense 
mutation on mouse behaviour.
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Chapter 2: Materials and Methods 
 
2.1. Materials 
All laboratory chemicals and primers are from Sigma-Aldrich unless otherwise 
stated. Recipes for all buffers and solutions are shown in Table 2.1. 
 
 
Buffer or solution Recipe for working solution 
25% AMPS 0.25g Ammonium Persulphate 
(AMPS) dissolved in 1ml dH2O 
Betaine 7.44g Betaine Monohydrate 
dissolved in 10ml dH2O 
Deoxyribonucleoside triphosphates 
(dNTPs) 
10µl of each 25µM dNTP (dATP, 
dCTP, dGTP, dTTP) (Invitrogen) 
diluted in 60µl dH2O 
Laemmli loading buffer 12ml 0.5M Tris-HCl pH6.8, 0.1g 
bromophenol blue, 10ml 100% 
glycerol, 10ml 20% SDS and 68ml 
dH2O 
Phosphate buffered saline (PBS) 1 Phosphate Buffered Saline tablet 
(PBS) tablet dissolved in 100ml 
dH2O and autoclaved 
Phosphate buffered saline with 
Tween 20 (PBS-T) 
1ml Tween 20 (Thermo Fisher 
Scientific) mixed with 1L PBS 
Primers for Polymerase Chain 
Reaction (PCR) and Reverse-
Transcriptase Polymerase Chain 
Reaction (RT-PCR) 
10µl of forward or reverse 100µM 
primer diluted in 90µl dH2O to make 
10µM aliquots 
Primers for Quantitative RT-PCR 
(qPCR) 
6µl of both forward and reverse 
100µM primer diluted in 88µl dH2O 
to make 6µM aliquots 
Chapter 2: Materials and Methods 
 
33 
Protein extraction buffer 50µl 100mM EDTA, 2.5ml 1M 
Hepes pH7.6, 7.5ml 1M NaCl, 
500µl 1M NaF, 500µl Triton X and 
39ml dH2O 
10% separating gel 8ml 1.5M Tris pH8.8, 10.4ml 30% 
acrylamide/bis (Bio-Rad), 160µl 
20% SDS, 20µl TEMED, 80µl 25% 
AMPS and 13.4ml dH2O 
4.3% stacking gel 5ml 0.5M Tris-HCl pH6.8, 2.9ml 
30% acrylamide/bis (Bio-Rad), 
100µl 20% SDS, 10µl TEMED, 
100µl 25% AMPS and 11.9ml dH2O 
20x TBE buffer stock 216g Tris Base, 110g Boric Acid, 
80ml 0.5M EDTA (pH 8.0) and 
920ml dH2O 
Western running buffer 100ml 10x TGS (Bio-Rad) diluted in 
900ml dH2O 
Western transfer buffer 100ml 10x TGS (Bio-Rad), 200ml 
methanol and 700ml dH2O 
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2.2. General equipment 
All behavioural apparatus was crafted in-house by Richard Wroblewski at the MRC 
Human Genetics Unit workshop. The Macintosh computer with Blackmagic Media 
Express software for mouse behaviour video acquisition was kindly provided by Dr 
Oliver Hardt from the Centre for Cognitive and Neural Systems, George Square. 
Following recording, videos were compressed using Handbrake software. A 30-day 
trial of the Any Maze program was downloaded to analyse the open field test. All 
other videos were scored manually. A small set of the objects used for novel object 
recognition were kindly provided by Dr Tine Pooters from the Centre for Integrative 
Physiology. The digital lux meter LX1010B was used to measure light levels in the 
behavioural apparatus. Animals were weighed using standard scales that gave 
measurements in grams (g) to two decimal places.  
 
2.3. Mouse models 
2.3.1. Husbandry and general practice 
Mice were housed in the Biomedical Research Facility (BRF), University of 
Edinburgh. All maintenance and procedures were carried out in accordance with 
Home Office regulations. Mice were kept on a 12-hour light/dark cycle with ad 
libitum access to standard chow and water. Homozygous wasted mice, homozygous 
Eef1a2/del22.ex2 mice and homozygous Eef1a2/D252H mice were fed with diet gel 
(Clear H2O) from P14. Mice were normally ear notched for genotyping and 
identification purposes at P14 and weaned at P21. When necessary, mice were culled 
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2.3.2. Details of mutations 
The mouse models used in this project are shown in Table 2.2. 
 
















Eef1a2/del22.ex3 22bp deletion in 
exon 3 
C57BL/6J Inbred 
Eef1a2/D252H D252H missense 
mutation identified 
in patients: single 
base change from 
guanine (G) to 
cytosine (C) in 
exon 5 causing 
amino acid 252 to 
change from 
aspartic acid (D) to 
histidine (H) 
C57BL/6J Inbred 
Eef1a2/G70S G70S missense 
mutation identified 
in patients: single 
base change from 
guanine (G) to 
adenine (A) in exon 
3 causing amino 
acid 70 to change 
from glycine (G) to 
serine (S) 
C57BL/6J N/A 
Table 2.2. Details of mouse models used in this project 




2.4. DNA methods 
2.4.1. DNA extraction from ear notches 
Ear notches were boiled for 10 minutes in 300µl 15mM NaOH, vortexed briefly, 
25µl Tris 1M pH8 was added and the samples were shaken by hand to mix. 
 
2.4.2. DNA extraction from tissue 
DNA was extracted from mouse brain using the DNeasy Blood and Tissue Kit 
(Qiagen) following manufacturer’s instructions. 
 
2.4.3. Genotyping of wasted mice 
Two sets of primers were used to genotype the wasted line. One primer pair 
amplified the wild-type allele and the other amplified the wasted allele. The primers 
used in the reaction are shown in Table 2.3. The primers named P2F and P2R 
(Khalyfa et al., 2001) were used to amplify the wild-type allele giving a 452bp 
product. The primers named wstspanF and wstspanR (Newbery et al., 2005) were 
used to amplify the wasted allele giving a 200bp product. 
 
Each PCR reaction contained: 
 
Component       Volume (µl) 
10x PCR buffer (Invitrogen)                             2.5 
MgCl2 (Invitrogen)                                                  1 
Taq DNA polymerase (Invitrogen)                   0.2 
10mM dNTPs (Invitrogen)                                0.5 
10µM primers                                                    1 
Betaine                                                              7.5 
dH2O                                                                  8.3 
Ear notch DNA                                                   1 
Total                                                                   25 




Samples were run in the Bio-rad C1000 Touch Thermal Cycler using the program 
shown in Table 2.4. 
 
Primer name Sequence 5’-3’ 
P2F TAG TGG CTC CTT GGA ACA G 
P2R CTA CTC TCC CTG AAT GCC TT 
wstspanF ATA AGC TCC CCA ATG GTA GAG 
AA 
wstspanR CGC GCC ATT CTT GTA TTG TT 
Table 2.3. Sequences of primers used to genotype the wasted line 
 
Step Temperature Time 
Initial denaturation 95ºC 3 minutes 
30 cycles 95ºC 1 minute 
 62ºC 1 minute 
 72ºC 1 minute 
Final extension 72ºC 5 minutes 
Table 2.4. PCR program for genotyping the wasted line 
 
 
2.4.4. Genotyping of Eef1a2/del22.ex3 mice 
A single set of primers was used to genotype the Eef1a2/del22.ex3 line to give a 
208bp product when amplifying the wild-type allele and an 186bp product when 
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Each PCR reaction contained: 
 
Component                                           Volume (µl) 
10x PCR buffer (Invitrogen)                         2.5 
MgCl2 (Invitrogen)                                              1 
Taq DNA polymerase (Invitrogen)               0.2 
10mM dNTPs (Invitrogen)                            0.5 
10µM primers                                                1 
Betaine                                                           7.5 
dH2O                                                             10.3 
Ear notch DNA                                              1 
Total                                                              25 
 
Samples were run in the Bio-rad C1000 Touch Thermal Cycler using a touchdown 
PCR program optimised in our laboratory by Faith Davies. This is shown in Table 
2.6. 
 
Primer name Sequence 5’-3’ 
CRISPR Eef1a2 null genotyping F TGA GTT GTG CCT CTA CCC TT 
CRISPR Eef1a2 null genotyping R TAC AGG CAC ATC CCA GGT GT 
Table 2.5. Sequences of primers used to genotype the del22.ex3 line 
 
Step Temperature Time 
Initial denaturation 98ºC 5 minutes 
7 cycles 98ºC 10 seconds 
 68ºC, -1ºC/cycle 30 seconds 
 72ºC 45 seconds 
22 cycles 98ºC 10 seconds 
 61ºC 30 seconds 
 72ºC 45 seconds 
Final extension 72ºC 7 minutes 
Table 2.6. PCR program for genotyping Eef1a2/del22.ex3 mice 
 




2.4.5. Genotyping of Eef1a2/D252H mice 
A single set of primers was used to genotype this line to give a 442bp product. The 
primers used in the reaction are shown in Table 2.7. 
 
Each PCR reaction contained: 
 
Component                                                                      Volume (µl) 
5x platinum super-fi buffer (Thermo Fisher Scientific)             4 
Platinum super-fi polymerase (Thermo Fisher Scientific)         0.2 
10mM dNTPs (Invitrogen)                                                         0.4 
10µM primers                                                                              1 
Betaine                                                                                         4 
dH2O                                                                                           9.15 
Ear notch DNA                                                                           0.25 
Total                                                                                             20 
 
Samples were run in the Bio-rad C1000 Touch Thermal Cycler using the PCR 
program shown in Table 2.8. 
 
Following PCR, samples were digested using Hin1II restriction enzyme. A digest of 
the wild-type allele produced two products: one of 330bp and one of 112bp. A digest 
of the allele containing the D252H mutation produced three products: one of 202bp, 
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Each digest contained: 
 
Component                                                                    Volume (µl) 
Fast digest green buffer (Thermo Fisher Scientific)                 2.5 
Hin1II restriction enzyme (Thermo Fisher Scientific)              0.5 
PCR product                                                                              15 
dH2O                                                                                           7 
Total                                                                                           25 
 
Samples were incubated at 37ºC for 5 minutes in the Bio-rad C1000 Touch Thermal 
Cycler. 
 
Primer name Sequence 5’-3’ 
1F primer AGG CTA CCC CTT AGG CAG GT 
1R primer TGA ACA AAT GGT AGG TGG GAG G 
Table 2.7. Sequences of primers used to genotype the Eef1a2/D252H line 
 
Step Temperature Time 
Initial denaturation 98ºC 60 seconds 
30 cycles 98ºC 5 seconds 
 58ºC 10 seconds 
 72ºC 15 seconds 
Final extension 72ºC 10 minutes 
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2.4.6. Genotyping of Eef1a2/G70S mice  
A single set of primers was used to genotype mice from the G70S CRISPR/Cas9 
experiment, giving a 487bp wild-type product. The primers are shown in Table 2.9. 
 
Each PCR reaction contained: 
 
Component                                           Volume (µl) 
10x PCR buffer (Invitrogen)                         2.5 
MgCl2 (Invitrogen)                                               1 
Taq DNA polymerase (Invitrogen)               0.2 
10mM dNTPs (Invitrogen)                            0.5 
10µM primers                                                1 
Betaine                                                           7.5 
 dH2O                                                             10.3 
Ear notch DNA                                               1 
Total                                                               25 
 
Samples were run in the Bio-rad C1000 Touch Thermal Cycler using the touchdown 
PCR program shown in Table 2.10.  
 
PCR products were digested using the restriction enzyme AciI. A digest of the wild-
type allele produced two products: one of 274bp and one of 213bp. A digest of the 
G70S allele produced a full-length 487bp product as the only AciI site had been 
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Each digest contained: 
 
Component                                    Volume (µl) 
Cutsmart buffer (NEB)                           1.5 
Restriction enzyme (NEB)                      0.5 
PCR product                                            5  
dH2O                                                        8 
Total                                                        15 
 
Samples were incubated at 37ºC for 2 hours in the Bio-rad C1000 Touch Thermal 
Cycler. 
 
Primer name Sequence 5’-3’ 
G70S mice long F ATC AAC ACC AGA GAG ATG GGA C 
G70S mice long R TCT TGA GGG ACT CTA TGC CCA AC 
Table 2.9. Sequences of primers used to genotype Eef1a2/G70S mice 
 
 
Step Temperature Time 
Initial denaturation 98ºC 5 minutes 
7 cycles 98ºC 10 seconds 
 68ºC, -1ºC/cycle 30 seconds 
 72ºC 45 seconds 
22 cycles 98ºC 10 seconds 
 61ºC 30 seconds 
 72ºC 45 seconds 
Final extension 72ºC 7 minutes 
Table 2.10. PCR program for genotyping Eef1a2/G70S mice 
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2.5. RNA methods 
2.5.1. RNA extraction from tissue 
RNA was extracted from mouse brain using the RNeasy Mini Kit (Qiagen), 
following manufacturer’s instructions. RNA concentration and quality was measured 
using the Nanodrop 1000 (Thermo Fisher Scientific). 
 
2.5.2. DNase digestion 
The DNase digestion was performed on-column during RNA extraction using the 
RNase-free DNase Set (Qiagen), following manufacturer’s instructions. 
 
2.5.3. RNA clean-up 
To make sure the RNA was pure and free of contaminants, RNA clean-up was 
performed using the RNeasy Mini Kit (Qiagen), following manufacturer’s 
instructions. RNA concentration and quality was measured using the Nanodrop 1000 
(Thermo Fisher Scientific). 
 
2.5.4. cDNA synthesis 
cDNA was synthesised from RNA using the Affinity Script cDNA Synthesis Kit 
(Agilent Genomics), following manufacturer’s instructions. 
A “minus RT” (-RT) control was made in which 1µl of each RNA sample was mixed 
together and run in the reaction without reverse transcriptase to check for genomic 
DNA contamination. A “minus RNA” control was also made in which all 
components were added to the reaction except RNA. 
 
2.5.5. Reverse-transcriptase PCR (RT-PCR) 
All samples were run in triplicate with primers that amplified the Eef1a2 gene and 
primers that amplified the reference gene, actin, in separate reactions. The Eef1a2 
primers amplified a 246 product and the actin primers amplified a 152bp product. 
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Each PCR reaction contained: 
 
Component                                          Volume (µl) 
10x PCR buffer (Invitrogen)                        2.5 
MgCl2 (Invitrogen)                                              1 
Taq DNA polymerase (Invitrogen)              0.2 
10mM dNTPs (Invitrogen)                           0.5 
10µM primers                                                1 
Betaine                                                          7.5 
 dH2O                                                           10.3 
cDNA                                                             1 
Total                                                              25 
 
Samples were run in the Bio-rad C1000 Touch Thermal Cycler on a PCR program 
shown in Table 2.12. For actin, the program was identical except the second cycling 
step was run for 20 cycles instead of 14 cycles (highlighted in bold in Table 2.12). 
 
Primer name Sequence 5’-3’ 
Eef1a2 RT-PCR F GCC ACG ATC AGC ACT GCG 
Eef1a2 RT-PCR R CAA GCG GAC CAT CGA GAA GT 
Actin F TCC ATC ATG AAG TGT GAC GT 
Actin R GAG CAA TGA TCT TGA TCT TCA 
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Step Temperature Time 
Initial denaturation 98ºC 5 minutes 
10 cycles 98ºC 10 seconds 
 69ºC, -1ºC/cycle 30 seconds 
 72ºC 45 seconds 
14 cycles 98ºC 10 seconds 
 61ºC 30 seconds 
 72ºC 45 seconds 
Final extension 72ºC 7 minutes 
Table 2.12. RT-PCR program for G70S mouse brain samples 
 
2.5.6. Restriction enzyme digestion 
RT-PCR products amplified using the protocol shown in Section 2.5.5 were digested 
with two restriction enzymes: AciI and MnlI. Using AciI, a digest of the wild-type 
allele produced four products: 127bp, 90bp, 25bp and 4bp whereas a digest of the 
G70S allele produced three products: 217bp, 25bp and 4bp as one AciI site had been 
destroyed by a PAM site mutation. Using MnlI, a digest of the wild-type allele 
produced four products: 112bp, 73bp, 39bp and 22bp whereas a digest of the G70S 
allele produced three products: 112bp, 112bp and 22bp as one MnlI site was 
destroyed by the G70S point mutation.  
 
AciI and MnlI digests contained: 
 
Component                                    Volume (µl) 
Cutsmart buffer (NEB)                           1.5 
Restriction enzyme (NEB)                      0.5 
PCR product                                            5 
dH2O                                                        8 
Total                                                        15 
 
Samples were incubated at 37ºC for 2 hours in the Bio-rad C1000 Touch Thermal 
Cycler. 




2.5.7. Quantitative RT-PCR (qPCR) 
The following method was used to quantify eEF1A2 mRNA expression. Absolute 
quantification was performed using two reference genes – actin and GAPDH – the 
primer sequences for which are shown in Table 2.13 along with those for the 
eEF1A2 primers. The Brilliant II SYBR Green QPCR Master Mix (Agilent) was 
used to make the reaction mix as follows: 
 
Component                            Volume (µl) 
2x Brilliant II SYBR green           5µl 
6µM primer mix                            0.5µl 
Reference dye                                0.375 (diluted 1:50 in dH2O) 
RNase free water                           0.125 
cDNA                                             4 (diluted 1:10 in dH2O) 
Total                                              10 
 
Samples were run in the Light Cycler HT7900 (Roche) using the program outlined in 
Table 2.14. 
 
Note that cDNA and controls were amplified using the RT-PCR protocol shown in 
Section 2.5.5 and run on a 2% agarose gel before proceeding with the qPCR to 
ensure that there was no contamination (see Section 2.5.4 for information on controls 
and Section 2.6 for information on agarose gel electrophoresis). The gel images are 
shown in Appendix A. For qPCR, each sample was run in triplicate and quantity 
means were calculated using Ct values along with the slope and Y-intercept from the 
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Primer name Sequence 5’-3’ 
eEF1A2 RT-PCR F GCC ACG ATC AGC ACT GCG 
eEF1A2 RT-PCR R CAA GCG GAC CAT CGA GAA GT 
Actin F TCC ATC ATG AAG TGT GAC GT 
Actin R GAG CAA TGA TCT TGA TCT TCA 
GAPDH F GGA AGG GCT CAT GAC CAC A 
GAPDH R CCG TTC AGC TCT GGG ATG AC 
Table 2.13. Primer sequences for qPCR 
 
Cycles Temperature Time 
1 95ºC 10 minutes 
40 95ºC 30 seconds 
 60ºC 1 minute 
Table 2.14. Cycling program for qPCR 
 
 
2.6. Agarose gel electrophoresis 
2g of agarose (Invitrogen) was added to 100ml 0.5x TBE buffer and microwaved for 
2 minutes to make a 2% w/v gel. Then 6µl SYBR safe (Invitrogen) was added to the 
gel mix and the mix was poured into a tray containing combs to make the wells. 
Once left to set for 30 minutes, the gel was transferred to a tank containing 0.5x TBE 
buffer and the PCR samples were loaded into the wells after addition of 5µl 6x 
purple gel loading dye (NEB). The first well was loaded with either hyperladder I 
(Bioline), low molecular weight marker (NEB) or 100bp DNA ladder (NEB) to 
visualise band sizes. The gel was run at a maximum voltage of 140V until band sizes 
could be accurately determined. All gels were imaged using either the Fujifilm FLA-
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2.7. Protein analysis 
2.7.1. Protein extraction from tissue 
Tissue was weighed and placed in 2ml tubes containing 1.4 and 2.8mm ceramic 
beads (VWR). 10ml protein extraction buffer was aliquoted and 1 Complete Mini 
EDTA-free protease inhibitor tablet was added (Roche). This buffer was then added 
to the tissue at a volume of 10µl/mg and samples were homogenised using a 
Precellys 24 homogeniser. Samples were centrifuged for 10 minutes at 17,000g at a 
temperature of 4ºC in a Heraeus Fresco 17 centrifuge (Thermo Fisher Scientific). 
100µl supernatant was then pipetted into a clean micro-centrifuge tube and mixed 
with 100µl laemmli loading buffer containing 5% v/v beta-mercaptoethanol. Samples 
were then boiled for 5 minutes, placed on ice for 2 minutes and stored at -20ºC until 
use. 
 
2.7.2. SDS polyacrylamide gel electrophoresis 
Gels were made in the laboratory using equipment from Bio-Rad: Mini-Protean Gel 
Casting Stand, glass plates, clamps and combs. The 10% separating gel was prepared 
in a 50ml Falcon tube and 4-5ml was pipetted between the glass plates, overlaid with 
1ml isopropanol (Thermo Fisher Scientific) and left to set for 45 minutes. The 
isopropanol was then poured off and the plates were filled to the top with the 4.3% 
stacking gel mix which had been pre-prepared in a 50ml Falcon tube. Combs were 
inserted between the plates to make wells and the stacking gel was left to set for 30 
minutes. Gels were wrapped in tissue paper, wet using water from the tap, wrapped 
in cling film and stored at 4ºC until use. 
 
Gels were run in a Bio-Rad Protean III tank filled with Western running buffer. 10µl 
Full-Range Rainbow Molecular Weight Marker (Amersham) was loaded into the 
first well and 10µl of each sample was loaded into the other wells. The gel was run at 
100V through the stacking gel and 150V through the separating gel until the samples 
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2.7.3. Membrane transfer 
Following step 2.7.2, protein was transferred to an Immobilon-FL polyvinylidene 
difluoride (PVDF) membrane (Millipore). This was carried out using a Bio-Rad Mini 
Trans-Blot Electrophoretic Transfer Cell in a Bio-Rad Protean III tank containing 
Western transfer buffer for 1 hour at 400mA. 
 
2.7.4. Immunoblotting 
Membranes were blocked for 1 hour in Odyssey Blocking Buffer (Licor Biosciences) 
diluted 1:1 in PBS. Membranes were incubated overnight at 4ºC with primary 
antibodies diluted to an appropriate concentration in Odyssey blocking buffer 1:1 
PBS-T. Antibody dilutions are given in the figure legends for each Western blot. The 
primary antibodies used were rabbit anti-eEF1A2 (50kDa) (Abcam) and mouse anti-
GAPDH (38kDa) (Millipore). Membranes were washed 3 times with PBS-T for 5 
minutes and incubated for 1 hour with secondary antibodies diluted 1:1000 in 
Odyssey blocking buffer 1:1 PBS-T. The secondary antibodies used were donkey 
anti-rabbit for eEF1A2 and donkey anti-mouse for GAPDH (Licor Biosciences). 
Membranes were washed 2 times with PBS-T for 5 minutes and photographed using 
the Licor Odyssey FC imager. 
 
2.7.5. Western blot quantification 
Western blots were quantified using Image Studio Lite Version 4.0 software. Values 
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2.8. Behaviour and motor testing 
2.8.1. General information 
All mice used for behavioural testing were male and were tested from 9 weeks of 
age. Female mice were excluded from testing due to the potential for results to vary 
across different phases of the oestrus cycle. The age groups tested for each mouse 
line are shown in Table 2.15. Mice were habituated to the test room for at least 15 
minutes immediately prior to every test. Following data collection, analysis was 
performed with the experimenter blind to the genotype. Timelines showing the order 
that behavioural tests were carried out for each mouse line are shown in Figure 2.1. 
 
 
Mouse line Young Middle aged Older 
Wasted mixed 
genetic background 




2-5 months N/A N/A 
Eef1a2/D252H 2-4 months N/A N/A 










Figure 2.1. Order of behavioural tests for each mouse line. The Y-maze test was always 
performed before the stranger mouse test to ensure that mice had no prior memory for the Y-
shaped apparatus. For the heterozygous wasted line, a second cohort of mice was used for 
the marble burying, digging and open field tests. For these three tests, five of the mice tested 
at 2-6 months were also tested at 12-18 months. For the Del22.ex3 line, a second cohort of 
mice was used for the Y-maze and hole-board tests. For the D252H line, a second cohort of 
mice was used for the hole-board and novel object recognition (NOR) tests. 
 
2.8.2. Open field 
The open field box was made of white Perspex and measured 50cm x 50cm. The 
light level was set to 100 lux in the centre of the box and the mouse was placed 
inside and allowed to explore for 5 minutes. The box was cleaned with 70% ethanol 
and rinsed with dH2O between mice and at the end of each test day. Data was 
analysed using Any Maze software. Videos were scored for the total distance 
travelled, the total time spent freezing and the total time spent exploring the centre vs 
the outside of the arena. These measurements were taken across the full 5-minute test 
to assess locomotor activity and anxiety. A 30cm square superimposed onto the 































The Y-maze was made of Perspex, with three arms at 120 degrees to each other. The 
Y-maze was filled with fresh bedding and a handful of bedding from each cage of 
test mice. Light levels were set to 100 lux at the end of each arm using the lux meter. 
The test mouse was placed in one arm of the maze facing the wall and habituated to 
two arms for 5 minutes. After a 15-minute or 120-minute inter-trial interval (ITI), the 
gate closing the third arm was removed and the mouse was placed back in the same 
start arm and allowed to explore all 3 arms for 2 minutes. The bedding was mixed 
and gate and maze walls were cleaned with 1% Conficlean between trials. The maze 
was emptied, cleaned with 1% Conficlean and rinsed with dH2O at the end of each 
test day. Videos were scored for the time spent in each arm during the test phase. 
 
2.8.4. Novel object recognition in Y-maze 
This test was carried out in the Y-maze apparatus (Image shown in Figure 4.20). The 
maze was filled with fresh bedding and a handful of bedding from each cage of test 
mice. The start arm was closed using a gate and gates were placed halfway along the 
other two arms. The light level was set to 100 lux in front of each gate using the lux 
meter. Mice were habituated to the maze for 5 minutes in two sessions separated by a 
24-hour delay. 
 
Testing began 24 hours after the second habituation session. In the sample phase, two 
identical objects were placed in front of the gates located halfway along the maze 
arms and the mouse was allowed to explore for 5 minutes. In the choice phase, one 
of the objects from the sample phase was swapped with a completely new, or 
“novel”, object the test mouse had not interacted with before. The test mouse was 
allowed to explore the objects for 2 minutes.  The choice phase took place 5 minutes 
after the sample phase and the position and identity of the novel object was 
counterbalanced between mice. 
 
The bedding was mixed and gate and maze walls were cleaned with 1% Conficlean 
between mice and between phases. The maze was emptied, cleaned with 1% 
Conficlean and rinsed with dH2O at the end of each test day. Videos were scored for 
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the time spent exploring each object during the choice phase. Exploration was 
defined as the mouse being in close proximity to and facing the object. Rearing 
against the objects was counted as exploration but climbing was not. Mice that 
explored for less than 10 seconds in the first minute of the choice phase were 
excluded from analysis. The discrimination ratio (DR) was calculated as the time 
spent exploring the novel object minus the time spent exploring the familiar object 
all divided by the total exploration time (N-F)/(N+F). 
 
2.8.5. Novel object recognition in arena 
The open field box was used for this test. The open field box was made of white 
Perspex and measured 50cm x 50cm. The light level was set to 100 lux in the centre 
of the apparatus using the lux meter. Mice were habituated to the box either once per 
day for 5 minutes on 2 consecutive days or twice per day for 5 minutes on 3 
consecutive days depending on the experiment. 
 
Testing began 24 hours after the final habituation session. In the sample phase, two 
identical objects were placed 5cm from the walls and the mouse was allowed to 
explore for 5 minutes. In the choice phase, one of the objects from the sample phase 
was swapped with a completely new, or “novel”, object the test mouse has not 
interacted with before. The test mouse was allowed to explore the objects for either 2 
minutes or 5 minutes depending on the experiment. The choice phase took place 5 
minutes after the sample phase and the position and identity of the novel object was 
counterbalanced between mice.  
 
The arena was cleaned with 70% ethanol between mice, between phases and at the 
end of each test day. Videos were scored for the time spent exploring each object 
during the choice phase. Exploration was defined as the mouse being in close 
proximity to and facing the object. Rearing against the objects was counted as 
exploration but climbing was not. Mice that explored for less than 25 seconds in the 
choice phase were excluded from analysis. The discrimination ratio (DR) was 
calculated as the time spent exploring the novel object minus the time spent 
exploring the familiar object all divided by the total exploration time (N-F)/(N+F). 




The hole-board arena was made of white Perspex and measured 40cm x 40cm. An 
insert measuring 39.5cm x 39.5cm and containing 16 holes of 1.5cm diameter was 
placed inside the box. The light level was set to 100 lux in the centre of the box and 
the mouse was placed in and allowed to explore for 5 minutes. The box was cleaned 
with 70% ethanol and rinsed with dH2O between mice and at the end of each test 
day. Videos were scored for hole exploration during the full 5-minute test. 
 
2.8.7. Nest building 
Fresh mouse bedding was added to a clean cage and a square of nest material was 
weighed and placed in the centre. The test mouse was placed in one corner of the 
cage facing the wall, the lid was placed on and the mouse was left overnight from 
5pm-9am. The nestlet was removed from the cage and allowed to dry overnight and 
then it was scored according to the scale devised by (Deacon, 2006a, Figure 4.2) and 
weighed to calculate the percentage of shredded nestlet. Between mice, cages were 
cleaned with 70% ethanol and fresh bedding was added. 
 
2.8.8. Marble burying 
Fresh mouse bedding was added to a clean cage at a depth of 5cm and flattened by 
hand to make it level. Then, 20 marbles were placed in the cage in 4 rows of 5. The 
mouse was placed in the cage and left for 30 minutes. Videos were recorded to score 
the total number of marbles buried after the 30-minute test. A marble counted as 
buried if covered 2/3 by bedding. Bedding was mixed but was reused for subsequent 
mice (Deacon, 2006b). Marbles were cleaned with 70% ethanol, rinsed with dH2O 
and dried between mice. 
 
2.8.9. Digging 
Fresh mouse bedding was added to a clean cage and the test mouse was placed in for 
3 minutes in order to observe digging behaviour. Bedding was mixed but was reused 
for subsequent mice (Deacon, 2006b). Videos were scored for digging behaviour 
during the 3-minute test. 
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2.8.10. Stranger mouse social behaviour test 
The stranger mouse test was carried out in the Y-maze apparatus (Images shown in 
Figures 4.5 and 4.6). The maze was filled with fresh bedding and a handful of 
bedding from each cage of test mice. The start arm was closed using a gate and two 
wire mesh gates were placed halfway along the other two arms. Light levels were set 
to 100 lux in front of each gate using the lux meter. The test mouse was habituated to 
the apparatus for 10 minutes. Following this, the mouse was removed briefly and a 
novel male mouse unrelated to the test mouse was placed between the mesh gates at 
one side of the apparatus. The test mouse was placed back in the maze and allowed 
to explore for 10 minutes. Then the test mouse was again removed and another novel 
mouse was placed between the mesh gates at the other side of the apparatus. The test 
mouse was then placed back in and allowed to explore for a further 10 minutes. 
 
The position of novel mouse 1 was counterbalanced between mice. The bedding was 
mixed and gate and maze walls were cleaned with 1% Conficlean between mice and 
between habituation, test 1 and test 2 for a given mouse. The maze was emptied, 
cleaned with 1% Conficlean and rinsed with dH2O at the end of each test day. Videos 
were scored for time spent with the novel mouse vs. the empty mesh gate in test 1 
and time spent with the novel vs. the familiar mouse in test 2. Exploration was 




For three consecutive days prior to the test, ¼ Cadbury’s chocolate button was placed 
in the home cage for 15 minutes to introduce the mouse to the food reward 
(habituation). 12 hours before the test, all food was removed from the home cage to 
stimulate hunger and therefore motivate the mouse to find the chocolate button in the 
testing phase. For testing, the mouse was placed in a clean cage with fresh bedding in 
which the food reward had been buried in one corner. The latency (s) for the mouse 
to find the buried food was measured and the test was stopped if the mouse failed to 
find the food after 15 minutes. The bedding was changed and the cage cleaned with 
70% ethanol between mice. 




2.8.12. Power calculations 
Post-hoc power calculations were performed on behaviour results using online 
software (https://www.stat.ubc.ca/~rollin/stats/ssize/n2.html). Scores for wild-type 
and mutant mice from the literature were used to calculate sample size, taking the 
mean of three values for each where possible. The wild-type standard deviation 
values from my own set of experiments were used in the calculations to obtain 
sample sizes that were based on the variation in my mouse line. Details of each 
parameter in the calculation is shown in Table 2.16. 
 
Parameter Details 
Mu1 Wild-type value from literature (mean 
of 3 independent values) 
Mu2 Mutant value from literature (mean of 
3 independent values) 
Sigma My wild-type standard deviation 
Test type Two sided 
Alpha 0.05 (default) 
Power 0.80 (default) 
Table 2.16. Details of parameters set in sample size power calculations 
 
2.8.13. Grip strength 
All mice used for grip strength testing were male. Limb muscle strength was 
measured using the grip strength meter (Bioseb). Grip strength from all four limbs 
and front limbs only was measured in triplicate with a 1-minute break in between to 
let the mouse rest. This meant that each mouse had six trials: three with all four limbs 
and three with front limbs only. For testing, the mouse was lowered onto the grid 
until it gripped either both front paws or all four paws (depending on the test) and 
pulled from the grid by holding the tail. The maximum force (Newtons (N)) 
generated by the mouse was recorded. Scores were normalised to body weight. 




Chapter 3: Characterisation of mice with the G70S Eef1a2     
  mutation 
 
3.1. Introduction 
3.1.1. The G70S mutation 
Five patients have been identified so far with a mutation in EEF1A2 that changes 
glycine to serine at position 70 on the protein (G70S). This mutation is in exon 3 of 
the gene. These patients all present with epilepsy, intellectual disability and 
hypotonia. In some cases, there is also impaired motor development, autism, severe 
language impairment, abnormalities detected on brain scans and characteristic facial 
features. One of the G70S patients died from respiratory failure at 4 years old. This is 
all described in Section 1.3.2 and in Table 1.2. 
 
3.1.2. Experimental design 
It is important for us to model the human mutations in mice to investigate the 
underlying mechanisms that lead to disease. A mouse model would help us to 
understand whether the mutations result in loss or gain of protein function, an 
essential question that must be answered before we can think about developing 
therapeutic strategies. The work presented in this chapter is from a joint project 
performed by myself, Faith Davies, Fiona McLachlan and Francis Nuñez. 
 
The G70S mutation was chosen to model in mice as it is the most frequently 
occurring mutation in humans. CRISPR/Cas9 was used to introduce the mutation 
because it is quick and easy to prepare the necessary guide RNAs (gRNAs) and 
repair templates, to generate mice with the desired mutation and to breed these mice 
to establish a colony. Due to the somewhat unpredictable nature of the technique and 
the possibility of creating multiple mutations, there is the chance that mice with the 
desired genotype will not be generated. However, this technique is at the forefront of 
molecular biology and is still remarkably quicker than other techniques.  
 
The CRISPR/Cas9 mechanism of action is shown in Figure 3.1A. The gRNA (grey) 
contains a sequence complementary to the DNA region of interest and guides Cas9 




here. Cas9 then introduces a double-stranded break into the DNA at the PAM site 
(red). The cell is able to repair this break in the DNA using one of two mechanisms: 
Non-homologous end joining (NHEJ) or homology directed repair (HDR). NHEJ is 
an error-prone process which can often introduce insertions or deletions into the 
DNA sequence during repair. In this experiment, this would give rise to mice with 
the genotypes Eef1a2+/- and Eef1a2-/-. HDR is the desired repair method. This allows 
the region of interest to take up donor DNA in the form of repair templates. In this 
experiment, this would give rise to mice with the genotypes Eef1a2G70S/+ and 
Eef1a2G70S/G70S. 
 
The gRNAs and repair templates were designed by Cathy Abbott (Figure 3.1B) and 
were cloned into pSpCas9n(BB)-2A-puro plasmids by Jennifer Doig. RNA was 
transcribed by Hemant Bengani and microinjected into single-cell stage mouse 
embryos by staff at the Evans Transgenic Unit, University of Edinburgh. Two repair 
templates were used: one of the repair templates had a G>A base change at the G70S 
site that would change glycine to serine in the protein, creating the G70S mutation, 
whilst the other repair template was wild-type at the G70S site. These two repair 
templates were used to increase the chance of producing heterozygous mice 
(Eef1a2G70S/+). This genotype was predicted to have a high chance of survival and 
ability to breed, while homozygotes (Eef1a2G70S/G70S) might have been expected to 
have too severe a phenotype. 
 
With the human phenotype in mind, it was hypothesised that Eef1a2G70S/+ mice might 
have seizures and behavioural impairments consistent with intellectual disability and 
autism. As for Eef1a2G70S/G70S mice, it was predicted that they may also present with 
seizures but would likely also show more severe phenotypes. For example, we know 
that Eef1a2-null wasted mice exhibit severe muscle wasting and motor neuron 
degeneration, dying by P28 (Shultz et al., 1982, Newbery et al., 2005). Therefore, it 
was possible that Eef1a2G70S/G70S mice might show a similar phenotype and, if more 
severe than null mice, may point towards gain of function as a disease mechanism. 
Conversely, expression of G70S eEF1A2 may have been sufficient to protect against 
neurodegeneration. 







Figure 3.1. Design of CRISPR/Cas9 experiment. A. CRISPR/Cas9 mechanism of action. 
Adapted from (Reis et al., 2014). B. Wild-type and mutant repair template design. Exon 3 is 
shown in bold and underlined. The gRNA target sites are shown in green, the PAM sites in 
yellow and the G70S site in blue. A point mutation in the mutant repair template destroys an 
AciI restriction enzyme site (shown in red). The G>A point mutation at the G70S site in the 
mutant repair template destroys an MnlI restriction enzyme site. 
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I was aware of the possibility that mice would be generated with the genotypes 
Eef1a2+/- and Eef1a2-/- as a product of the CRISPR/Cas9 experiment. The 
expectation was that Eef1a2-/- mice would have a phenotype similar to that of wasted 
mice and would not survive past P28. Therefore, mice were genotyped promptly to 
allow prediction of severe phenotypes early and to provide sufficient time to make 
any necessary decisions regarding the fate of particular mice. 
 
Thirty-five mice were born from two rounds of microinjection. The process involved 
microinjecting gRNA and repair template RNA into the cytoplasm of C57BL/6J 
fertilised oocytes and implanting these into four pseudopregnant females. Once the 
mice were born, Faith Davies and Francis Nuñez performed the PCR genotyping 
from ear notch tissue. Following this, I performed specific restriction enzyme digests 
on the PCR products to detect repair template incorporation prior to sequencing. 
Faith Davies performed the sequencing experiments necessary to confirm the 
genotype of each mouse. Faith Davies and I phenotyped and collected tissue from the 
mice together. After tissue collection, I performed RNA expression analysis and 
Fiona McLachlan performed protein expression analysis on brain tissue. 
 


















• To characterise mice with the Eef1a2/G70S missense mutation with an 
aim to better understand the mechanisms underlying the human 
phenotype. 
1) To identify mice with incorporation of the G70S repair template in advance of 
sequencing using specific restriction enzyme digests. 
2) To determine the effects of the G70S mutation on phenotype and survival. 
3) To perform post-mortem expression analysis using specific restriction enzyme 
digests to determine whether G70S eEF1A2 is expressed at the RNA level and how 



























3.2.1. Restriction enzyme digests were used to detect G70S 
incorporation 
Once Eef1a2 from each mouse ear notch had been amplified by PCR, I digested the 
products using the restriction enzyme AciI (Figure 3.2) to check for incorporation of 
the mutant repair template. This was done in order to predict how many mice had a 
G70S allele prior to sequencing. It was impossible to determine this through PCR 
alone as the G70S change is a point mutation and therefore the PCR product did not 
differ in size from wild-type. These digests were necessary so that we could predict 
mutations quickly and therefore monitor specific mice closely and make informed 
decisions regarding their fate. DNA from two of the mice, #13 and #18, could not be 
successfully amplified and therefore were not included in my digests. 
 
A PAM site mutation engineered into the mutant repair template (GGG>GTG) 
destroyed an AciI restriction enzyme site. This meant that if the mutant repair 
template was incorporated, there would be one less AciI site in the PCR product and 
the cutting pattern would be altered. The wild-type PCR product is shown in Figure 
3.2A. The digest product sizes were predicted using Serial Cloner software and are 
shown in Figure 3.2B. PCR products were digested and run on an agarose gel to 
view band sizes (Figure 3.2C). 
 





Figure 3.2. AciI genotyping digest. A. WT PCR product showing the primers in yellow, the 
G70S site in blue and the AciI recognition site in green. B. Product sizes as predicted by 
Serial Cloner software. If the genotype is +/+ the sizes are 274bp and 213bp. If the genotype 
is G70S/+ the sizes are 487bp, 274bp and 213bp. If the genotype is G70S/G70S the product 
is a single, undigested band of 487bp. C. Agarose gel with AciI digest products run 
alongside a wild-type control to compare band sizes and a no DNA (-DNA) control to check 
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The AciI digest worked well and I was able to identify all three genotypes (+/+, 
G70S/+ and G70S/G70S). There were non-specific bands but these were higher than 
the bands that were specific and therefore the gel was able to be interpreted. 
Importantly, product sizes could be disrupted by the presence of indels and therefore 
it was not always possible to interpret band sizes with complete confidence. A full 
list of the genotype predictions from each mouse based on the digests is shown in 
Figure 3.3A. Figure 3.3B provides a summary, showing how accurate the digests 
were at predicting the genotypes based on the subsequent sequencing (carried out by 
Faith Davies). Note that mouse #12 was excluded from analysis as it could not be 
satisfactorily genotyped. 
 
I analysed how accurate the AciI digest was at predicting G70S incorporation and the 
presence or absence of indels (Figure 3.3B). The digest was able to correctly predict 
the genotype of each allele based on G70S incorporation in 84% of samples. In 
addition, the digest showed a 66% match with the sequencing results when 
predicting the presence or absence of indels. The percentage match with sequencing 
based on predicting the correct genotype at the G70S locus and correctly predicting 
the presence or absence of indels was 59%. The digest predicted the genotypes 
incorrectly for some samples and this was likely due to disruption of restriction 
enzyme sites by the presence of indels. Another reason for inaccuracy was that small 
indels could not be detected on the gel. 
 











Actual mutations based on sequencing
1 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT + 22bp del
Allele 2: G70S
2 Allele 1: WT
Allele 2: WT
Y Allele 1: WT + 20bp del + 6bp sub
Allele 2: WT + 19bp ins
3 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT + large ins
Allele 2: WT + 27bp ins
4 Allele 1: G70S
Allele 2: G70S
N Allele 1: G70S
Allele 2: G70S
5 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT + 43bp del + 1bp sub
Allele 2: G70S + 1bp del
6 Allele 1: WT
Allele 2: WT
Y Allele 1: WT
Allele 2: WT + 24bp del + 1bp sub
7 Allele 1: G70S
Allele 2: G70S
N Allele 1: G70S + 17bp del
Allele 2: same as above or WT or both (mosaic)
8 Allele 1: WT
Allele 2: WT
N Allele 1: WT + 12bp del + 1bp del
Allele 2: same as above or WT or both (mosaic)
9 Allele 1: WT
Allele 2: WT
Y Allele 1: WT
Allele 2: WT + 14bp del
10 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT + 16bp del
Allele 2: G70S
11 Allele 1: G70S
Allele 2: G70S
N Allele 1: G70S + 10bp del
Allele 2: same as above or WT or both (mosaic)
12 Allele 1: WT
Allele 2: WT
Y Unidentified – probable large insertions on both 
alleles
14 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT + 22bp del
Allele 2: G70S + 1bp del
15 Allele 1: WT
Allele 2: WT
N Allele 1: WT
Allele 2: WT
16 Allele 1: WT
Allele 2: G70S
N Allele 1: WT + 125bp ins
Allele 2: WT + 125bp ins
17 Allele 1: WT
Allele 2: G70S
N Allele 1: G70S + 1bp ins
Allele 2: same as above or WT or both (mosaic)
19 Allele 1: WT
Allele 2: WT
Y Allele 1: WT + 25bp del
Allele 2: WT + 40bp del
20 Allele 1: WT
Allele 2: G70S
N Allele 1: WT + 4bp del
Allele 2: G70S
21 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT + 22bp del
Allele 2: G70S + 22bp del
Allele 3: G70S + 1bp del
22 Allele 1: WT
Allele 2: WT
Y Allele 1: WT + 20bp del
Allele 2: WT + 22bp del
23 Allele 1: WT
Allele 2: WT
N Allele 1: WT
Allele 2: WT
24 Allele 1: WT
Allele 2: WT
Y Allele 1: WT + 180bp del
Allele 2: WT + 10bp del
25 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT
Allele 2: WT + 42bp del
26 Allele 1: WT
Allele 2: WT
Y Allele 1: WT + 1bp del + 22bp del
Allele 2: WT + 22bp del
27 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT + 20bp del
Allele 2: WT + 19bp del
Allele 3: G70S + 19bp del
28 Allele 1: WT
Allele 2: WT
N Allele 1: WT
Allele 2: WT + 1bp del
Allele 3: WT + 45bp sub
29 Allele 1: G70S
Allele 2: G70S
N Allele 1: WT + 7bp del + 63bp del
Allele 2: WT + 7bp del + 63bp del
30 Allele 1: WT
Allele 2: WT
N Allele 1: WT + 1bp del
Allele 2: WT + 1bp del
31 Allele 1: WT
Allele 2: G70S
N Allele 1: WT + 7bp ins + 5bp sub
Allele 2: G70S + 1bp del
Allele 3: WT + 4bp del + 14bp sub
Allele 4: WT + 10bp del
Allele 5: G70S + 4bp del + 36bp del
32 Allele 1: WT
Allele 2: WT
N Allele 1: WT
Allele 2: WT + 22bp del
33 Allele 1: WT
Allele 2: G70S
Y Allele 1: WT + 1bp del + 1bp del + 6bp del
Allele 2: G70S
34 Allele 1: WT
Allele 2: WT
Y Allele 1: WT + 22bp del
Allele 2: WT + 22bp del
35 Allele 1: WT
Allele 2: WT
Y Allele 1: WT + 23bp del
Allele 2: WT + 48bp ins






Figure 3.3. The accuracy of genotyping restriction digests based on the sequencing 
results. A. Table showing the predicted mutations based on the results of the AciI digest 
compared with the results from the sequencing. Y = indels were predicted, N = indels were 
not predicted. Del = deletion, ins = insertion, sub = substitution. WT = wild-type for G70S. 
B. Table showing the percentage match of the AciI digests with the sequencing results and 
therefore the percentage of predictions that were accurate and showed the correct genotype. 
The results are summarised for alleles i.e. genotype based on presence or absence of G70S 
(+/+, G70S/+ or G70S/G70S) and for indels i.e. whether or not the digest correctly detected 
the presence of insertions and/or deletions. The “alleles and indels” group shows the 
percentage of digests that correctly predicted the right genotype based on both G70S 




















Alleles only Indels only Alleles and 
indels
Percentage match 84% 66% 59%
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3.2.2. A range of genotypes were obtained from the CRISPR/Cas9 
experiment 
The genotype of each mouse was confirmed by Faith Davies using a combination of 
Sanger sequencing, allele-specific sequencing and TOPO cloning (Table 3.1). Allele-
specific sequencing and TOPO cloning were necessary where mice had indels on 
both alleles or had more than two alleles (mosaicism). All of the mice were 
successfully genotyped apart from mouse #12 and #13 which could not be genotyped 
with any certainty. However, all of the sequencing data that were obtained from 
these two mice pointed towards an Eef1a2-/- mosaic genotype. 
 
 
Table 3.1. Summary of genotypes from the G70S CRISPR/Cas9 experiment. Male mice 
are shown in blue and female mice are shown in orange. Mice with a null allele (-) had an 
indel in exon 3. Mice with a G70S allele had G70S incorporation on one or both alleles with 
no indels. 
 
Unfortunately, none of the mice had the G70S/+ genotype that was required to 
establish a new breeding line. However, one mouse was generated (#4) that had a 
G70S/G70S genotype but the phenotype was too severe for survival. Eight mice had 
G70S incorporation with an indel on the same allele. These alleles have been 
categorised as null or mosaic in Table 3.1. Only the five mice that had G70S allele(s) 
Genotype Number of mice Mouse ID 
number
-/- 17 #2 #3 #5 #7 #11 
#14 #16 #17 #18 
#19 #22 #24 #26 
#29 #30 #34 #35
+/- 5 #6 #9 #25 #32 #8
Mosaic 4 #21 #27 #28 #31
G70S/- 4 #1 #10 #20 #33
Unidentified 2 #12 #13
+/+ 2 #23 #15
G70S/G70S 1 #4
G70S/+ 0 -




containing no indels have been categorised as G70S/G70S or G70S/-. Expression 
analysis was required for each mouse to determine which alleles express RNA and 
protein. 
 
3.2.3. The phenotype of Eef1a2-/- and Eef1a2G70S/-  mice was comparable 
to the phenotype of wasted mice 
The phenotype, fate and age at death for each mouse is shown in Table 3.2. Eighteen 
mice with the genotypes Eef1a2-/-, Eef1a2G70S/-and Eef1a2 mosaic showed a wasted 
phenotype characterised by tremor, ataxia, weight loss and early death by P28 
(Shultz et al., 1982). These mice had to be culled after onset of phenotype as outlined 
on our project license. There was no difference in the timing of onset or severity of 
the wasted phenotype between Eef1a2-/- and Eef1a2G70S/- mice. Two of the mosaic 
mice that showed a wasted phenotype, #27 and #28, survived until P35 and P32 
respectively. This is thought to be due to the assumption that some of the cells would 
have expressed wild-type eEF1A2. 
 
The Eef1a2G70S/G70S mouse #4 was pointed out by the technician, who was blind to 
the genotype, at P18. This mouse had a tremor, was hunched and was visibly smaller 
than its littermates. It was also unable to right itself. It appeared to be displaying a 
wasted-like phenotype earlier than the onset in wasted mice which happens around 
P21. This mouse had to be culled at P18 due to the severity of the phenotype. 
 
Wild-type mouse #15 was runted and had to be culled at P14. Inducing mutations 
using CRISPR/Cas9 can sometimes result in off-target mutations in other parts of the 
genome but no off-target mutations were detected in mouse #15 (the five most 
homologous gRNA sites were checked by Francis Nuñez). Therefore, the runted 
phenotype may have been due to either competition from other littermates in the 
womb/postnatal or a mutation, unrelated to the CRISPR/Cas9 process, located 
elsewhere in the genome. Competition from littermates is likely due to the large litter 
sizes and therefore limited availability of resources. 
 
 





Table 3.2. Summary of phenotype, fate and age of death for each mouse in the G70S 
CRISPR/Cas9 experiment. AGS = audiogenic seizure (described in Section 3.2.4), P = 




Sex Genotype Phenotype Fate Age at 
death
1 M G70S/- Wasted Culled P25
2 M -/- Wasted Culled P22
3 M -/- AGS Died P18
4 M G70S/G70S Wasted Culled P18
5 M -/- AGS Died P18
6 M +/- Wild-type - -
7 M -/- AGS Died P18
8 M +/- AGS Died P18
9 M +/- Wild-type - -
10 F G70S/- Wasted Culled P25
11 F -/- AGS Died P18
12 F Unidentified Wasted Culled P25
13 F Unidentified Wasted Culled P29
14 F -/- AGS Died P18
15 M +/+ Runted Culled P14
16 M -/- Found dead Died P23
17 M -/- Wasted Culled P25
18 M -/- Wasted Culled P25
19 F -/- Found dead Died P23
20 F G70S/- Wasted Culled P23
21 F Mosaic Found dead Died P23
22 M -/- Wasted Culled P23
23 M +/+ Wild-type - -
24 F -/- Wasted Culled P23
25 F +/- Wild-type - -
26 M -/- Wasted,
AGS
Died P23
27 M Mosaic Wasted Culled P35
28 M Mosaic Wasted Culled P32
29 M -/- Wasted, 
AGS
Culled P23
30 F -/- Found dead Died P23
31 F Mosaic Wasted Culled P23
32 F +/- Wild-type - -
33 F G70S/- Wasted Culled P23
34 F -/- Found dead Died P23
35 F -/- Wasted Culled P23




Mice were weighed regularly from P17-P30 (Figure 3.4). Unfortunately, the 
Eef1a2G70S/G70S mouse could not be included in the weight analysis as it was culled at 
P18 due to its severe phenotype. As only one healthy wild-type mouse was generated 
through the CRISPR/Cas9 experiment, another set of age-matched wild-type 
C57BL/6J mice were weighed to add to the dataset. Eef1a2+/+ and Eef1a2+/- mice 
gained weight, as predicted, based on the evidence that heterozygous wasted mice 
are phenotypically normal (Griffiths et al., 2012). Eef1a2-/- and Eef1a2G70S/- mice 




Figure 3.4. Weights of mice born from the G70S CRISPR/Cas9 experiment. Weights 
were measured from P17-P30. Each genotype is represented by a different coloured line. 
The graph shows the mean weight for each genotype on each day with error bars showing 
SEM. At P23 and P25, the weights of Eef1a2-/- and Eef1a2G70S/- mice were significantly lower 
than those of Eef1a2+/+ mice (One-way ANOVA: F = 13.9, DF = 3, 14, p = <0.0001. Tukey’s 
multiple comparison test: at P23 p = <0.0001 for both genotype comparisons. At P25 p = 
<0.0001 for Eef1a2G70S/- vs. Eef1a2+/+ and 0.0017 for Eef1a2-/- vs. Eef1a2+/+.  Weights of 





































3.2.4. Eef1a2-/- mice had seizures in response to environmental sounds 
At P18, a loud sound of 90 decibels (dB) in the room next door was caused by 
collection of liquid nitrogen. This caused six mice to die from seizures (#3, #5, #7, 
#8, #11 and #14). They displayed wild running followed by tonic-clonic seizure and 
did not recover. At P23, the sound of a door banging caused mice #26 and #29 to 
have audiogenic seizures. Mouse #29 recovered but was subsequently culled due to a 
wasted phenotype.  
 
All of the mice that had audiogenic seizures were Eef1a2-/-, apart from mouse #8 
which was Eef1a2+/-. However, the sequencing results from mouse #8 were 
complicated (see Figure 3.3A) and it was later found to have very low expression of 
eEF1A2 in muscle and no expression in brain. The other genotypes that were 
exposed to the sound stimuli were Eef1a2+/-, Eef1a2G70S/-, Eef1a2G70S/G70S and Eef1a2 
mosaic but none of these mice had seizures. It should be noted, however, that the 
group sizes were very small and that these seizures were accidental and were not 
performed under controlled conditions. Therefore, results should be interpreted with 
caution and further study will be required to determine whether missense mutations 
in Eef1a2 increase audiogenic seizure susceptibility in mice. 
 
It is noteworthy that five other mice had sudden unexplained deaths at P23: #16 
(Eef1a2-/-), #19 (Eef1a2-/-), #21 (Eef1a2 mosaic), #30 (Eef1a2-/-) and #34 (Eef1a2-/-). 
Mice #30 and #34 were found dead in their home cage in the morning, having 
seemed healthy when checked the previous afternoon at P22. Mice #16, #19 and #21 
were being moved from the Evans Transgenic Unit to the Biomedical Research 
Facility (BRF) next door for housing purposes but died during transfer. The reasons 
for these sudden deaths could not be resolved and it is entirely possible that the mice 









3.2.5. G70S eEF1A2 was expressed in brain but unable to compensate 
for loss of wild-type protein 
To investigate the effects of the G70S mutation on eEF1A2 function at the mRNA 
and protein level and to gain insight into whether the mutation may lead to loss or 
gain of protein function, expression analysis was performed. After mice were culled, 
brain and muscle tissue was collected. Western blots to examine eEF1A2 protein 
expression in brain are shown overleaf (performed by Fiona McLachlan, Figure 
3.5A) and RT-PCR gels to examine eEF1A2 mRNA expression in brain are shown in 
Figure 3.5B (performed by myself). Following the RT-PCR, I performed restriction 
enzyme digests using AciI and MnlI to determine which alleles were expressing 
RNA and protein. This was an important step to determine whether or not G70S 
eEF1A2 was being expressed. If G70S eEF1A2 was not expressed, this would point 
towards loss of function as a disease mechanism. However, if G70S eEF1A2 was 
















Figure 3.5. eEF1A2 expression in the brains of mice from the G70S CRISPR/Cas9 
experiment. A. Western blots probed with an eEF1A2 antibody and a GAPDH antibody as 
a control. Arrows indicate mice that were subsequently found to express eEF1A2 containing 
the G70S mutation. Experiment by Fiona McLachlan, adapted from Davies et al., 2017. B. 
RT-PCR using cDNA from brain tissue with primers amplifying Eef1a2 and actin as a 
reference gene. The 200bp and 400bp ladder bands are shown (Bioline Hyperladder I). 
Arrows show the positions of the bands for eEF1A2 at 246bp and actin at 152bp. ntc = no 
template control, -RT control = no reverse transcriptase control, +/+ Br = wild-type brain 
positive control, wst/wst Br = wasted brain negative control. Mice #2 and #12 were also 






































































































































































































































































































































































































































































1   2    3   4    5    7   8   10  11 12  13 +/+ -/-
14   15  16  17   18  19  20   21  22  24 +/+  +/-
27 28 29  30 31 33  34 35 +/+ +/-
D indicates allele with internal deletion
R indicates wild-type runt
M indicates mosaic
Indicates	G70S	expression




Based on the Western blot results (Figure 3.5A), mouse #1, #4, #10, #14, #15, #17, 
#20, #21, #27, #28 and #33 were expressing eEF1A2 protein. This Western showed 
whether or not eEF1A2 was expressed in brain tissue from each mouse but did not 
allow us to distinguish between wild-type eEF1A2 and G70S eEF1A2 as there is no 
reason to assume that the presence of the mutation would affect protein size. To 
determine which allele(s) were expressing RNA and protein, I performed RT-PCR 
(Figure 3.5B) and digested the products using the restriction enzymes MnlI and AciI 
(Figure 3.6). 
 
For the RT-PCR, the initial analysis was on samples that had G70S incorporation on 
one or both alleles with no indels (Top gel – mouse #1, #4, #10, #20, #33). Mouse #5 
was initially suspected to have G70S incorporation on one allele with no indels but 
was subsequently found to have a 1bp deletion on the same allele. Therefore, it was, 
in fact, a null (Eef1a2-/-). It can be seen that all of the samples on this gel were 
expressing eEF1A2 (arrows), apart from mouse #5, showing that all of the mice with 
a clean G70S allele were expressing RNA. All of the mice, apart from #5, were also 
shown to express eEF1A2 protein on the Western. Mouse #4 could only be 
expressing RNA and protein containing the G70S mutation as this mouse had the 
mutation on both alleles with no indels. For the other mice, restriction digests were 
required to determine whether or not they were expressing eEF1A2 with the G70S 
mutation. 
 
Subsequent RT-PCR analysis was carried out on samples that had G70S 
incorporation with an indel on the same allele (Bottom gel - #7, #11, #14, #17, #21, 
#27, #31) since these mice could be expressing G70S eEF1A2. Mice #17, #21 and 
#27 were found to express eEF1A2 RNA and protein. Mouse #14 also had a strong 
band indicating RNA expression but it was slightly smaller than the expected size for 
eEF1A2. This mouse showed a slightly smaller band on the Western too indicating 
that it may express a truncated protein. This fits with sequencing data showing that 
mouse #14 had a 21bp in-frame deletion. Mice #7 and #11 did not express eEF1A2 
at the RNA or protein level, however, mouse #31 showed a faint band both in the 
RT-PCR and in the Western. 




The two RT-PCR analyses also provided insight into the nature of the mutations in 
some of the samples that did not express G70S. In the sample from mouse #2, a 
strong band smaller in size than that would be expected for eEF1A2 was observed. 
This was despite the fact that the mutations on both alleles (a 20bp deletion and a 
19bp insertion) were out of frame and were therefore predicted to cause a premature 
stop codon and lead to nonsense-mediated decay of the mRNA product. The band 
observed in the RT-PCR is much stronger than that would be expected if the mRNAs 
were undergoing nonsense-mediated decay. There are a few possible explanations 
for this: there was an error in the sequencing results and one of the mutations is 
actually in frame, the frameshift on one of the alleles may not actually lead to a 
premature stop codon or one of the alleles is resistant to nonsense-mediated decay as 
observed previously with mutations in other genes (Neu-Yilik et al., 2011). This 
mouse was not expressing eEF1A2 at the protein level despite the strong mRNA 
expression, therefore it’s likely that the mRNA was translated but the protein was 
subsequently degraded. Mouse #31 shows two bands in the RT-PCR and one faint 
band in the western indicating expression of eEF1A2 at the RNA and protein level. It 
is curious that this mouse expresses eEF1A2 protein, albeit at a very low level, 
despite the fact that none of the mutations were in frame. The same possibilities 
highlighted for mouse #2 also apply here. Mice #7 and #11 also yielded interesting 
results as the sequencing from these mice was difficult to interpret and it appeared 
that both mice might have a wild-type allele (Figure 3.3A). However, the lack of 
eEF1A2 expression both in the RT-PCR and the western blot indicates that neither 
mouse had a wild-type allele and therefore were not mosaics.  
 
To summarise the expression results in Figure 3.5. it can be seen that mice #1, #4, 
#10, #20, #33, #17, #21 and #27 were expressing high levels of eEF1A2 RNA and 
protein. Mouse #14 was also expressing RNA and protein but the size was slightly 
smaller than that expected for eEF1A2. Note that mouse #28 expressed protein on 
the Western but was not included in the RT-PCR as there was no evidence of G70S 
incorporation in the sequencing. I next performed restriction enzyme digests on the 
RT-PCR products using AciI and MnlI to determine which alleles were expressing 
RNA and protein (Figure 3.6). 






Figure 3.6. eEF1A2 RT-PCR products digested with restriction enzymes. A. RT-PCR 
products showing cut sites for AciI and MnlI. B. MnlI and AciI digests with product sizes 
predicted by Serial Cloner software. MnlI (top) - wild-type band sizes: 112bp, 73bp, 39bp 
and 22bp. G70S band sizes: 112bp, 112bp and 22bp. The purple arrow indicates the sample 
from mouse #20 failed to digest in the predicted way. AciI (bottom) - wild-type band sizes: 
127bp, 90bp, 25bp and 4bp. G70S band sizes: 217bp, 25bp and 4bp. C. Repeated MnlI 
digest on sample #20 and corresponding sequencing trace showing that the cut pattern was 













































































































































































































































































































	 AciI site: destroyed by G à T change
MnlI site: destroyed by G à A change




























The MnlI and AciI digest results are shown in Figure 3.6B. With MnlI, digest of the 
wild-type allele produced bands of 112bp, 73bp, 39bp and 22bp whereas digest of 
the G70S allele produced bands of 112bp, 112bp and 22bp as one of the MnlI sites 
had been destroyed by the G70S change. With AciI, digest of the wild-type allele 
produced bands of 127bp, 90bp, 25bp and 4bp whereas digest of the G70S allele 
produced bands of 217bp, 25bp and 4bp as one AciI site had been destroyed by a 
silent mutation engineered into the repair template. A caveat of the MnlI digest was 
the inability to tell whether G70S RNA was also expressed in mice that expressed 
wild-type RNA due to overlapping bands. Mice #1, #4, #10 and #33 showed only the 
G70S cut pattern in both the MnlI and AciI digest indicating that the only allele that 
was being expressed, at both the mRNA and protein level, contained the G70S 
mutation. 
 
Mouse #20 contained an additional silent C>T point mutation that destroyed the last 
recognition site for MnlI. The sequencing trace showing this mutation is presented in 
Figure 3.6C along with the repeated MnlI digest showing the 22bp difference 
between the undigested sample and the largest digest product. In the AciI digest 
(Figure 3.6B), sample #20 was digested giving a G70S cut pattern only. This shows 
that, as with mouse #1, #4, #10 and #33, this mouse was expressing only eEF1A2 
RNA and protein containing the G70S mutation. 
 
As mentioned, mouse #14 showed a smaller than expected product on both the RT-
PCR and on the Western (Figure 3.5). Therefore, it was thought that this mouse 
could be expressing a truncated protein. From the sequencing results, this mouse had 
a known 21bp deletion one one allele and a 1bp deletion with G70S incorporation on 
the other. The cut pattern on both the MnlI and AciI digests was wild-type but 
specific bands were smaller than the predicted size. This could be observed most 
clearly in the AciI digest where the 127bp band was the correct size but the predicted 
90bp band was smaller than expected and sat around the 75bp marker on the ladder. 
This pattern was consistent with expression of a truncated wild-type protein with a 




21bp deletion. Absence of a G70S cut pattern shows that the other allele was not 
expressing. 
 
Unexpectedly, mouse #17 seemed to be expressing RNA and protein from the G70S 
allele despite this allele containing an 1bp deletion. The MnlI and AciI digests both 
showed a strong G70S cut pattern with a faint wild-type cut pattern suggesting 
expression from both alleles. The sequencing from this mouse was hard to interpret 
but the G70S allele contained a single insertion. However, this did not seem to affect 
expression. 
 
Mice #21 and #27 were mosaics each with at least one wild-type allele containing an 
indel and at least one G70S allele containing an indel. The cut pattern on both the 
MnlI and AciI digests was wild-type with no G70S cut pattern present suggesting 
expression from a wild-type allele only. 
 
Lastly, mice #5, #7 and #31 showed faint bands in both digests that did not fit with 
either a wild-type or a G70S cut pattern. In summary, mice #1, #4, #10, #17, #20 and 
#33 expressed eEF1A2 protein containing the G70S mutation. Table 3.3 provides a 
summary of the Western blotting, RT-PCR and digest results described in Figure 3.5 
and 3.6. 
 





Table 3.3. Summary of Western blot, RT-PCR and digest results showing which alleles 
were expressing eEF1A2 for each mouse of interest. WT = wild-type. 
 
 
Mouse ID Protein 
expression?
Alleles expressing 
mRNA and protein based 
on digest results
Notes
1 (G70S/-) Y G70S
4 (G70S/G70S) Y G70S
5 (-/-) N None Originally 
thought to have 
clean G70S on 
one allele but 
found later to 
have an indel
7 (-/-) N None
10 (G70S/-) Y G70S
14 (-/-) Y WT Truncated 
protein - also 
has a G70S 
mutation on the
other allele but 
there’s an indel
which leads to 
no expression
17 (G70S/-) Y WT, G70S Has a G70S 
mutation with 
an indel on the 
same allele but 
this doesn’t 
seem to affect 
expression
20 (G70S/-) Y G70S





which leads to 
no expression





which leads to 
no expression
31 (mosaic) N None
33 (G70S/-) Y G70S





The aims of this chapter were as follows: 
1) To identify mice with incorporation of the G70S repair template in advance of 
sequencing using specific restriction enzyme digests. 
2) To determine the effects of the G70S mutation on phenotype and survival. 
3) To perform post-mortem expression analysis using specific restriction enzyme 
digests to determine whether G70S eEF1A2 is expressed at the RNA level and how 
expression relates to phenotype and survival. 
 
My first aim was successful in that I was able to clearly identify products that 
represented wild-type and G70S alleles using the AciI digest. However, my genotype 
predictions were not accurate for every sample, likely due to disruption of restriction 
enzyme sites by indels. Despite this, the digest correctly predicted the alleles in 84% 
of samples, indicating a high success rate. 
 
Unfortunately, we did not generate mice of the desired genotype (G70S/+) that were 
required to set up a new breeding line due to the high frequency of indels. A high 
number of indels arose due to inefficient repair template design caused by the 
position of the G70S mutation. Ideally, both PAM sites would have been mutated to 
prevent further cutting after repair template incorporation and this would have 
prevented the build-up of indels. However, the 5’ PAM site was located near a splice 
site and therefore could not be mutated without risking changes to splicing and gene 
expression. Future attempts to generate a G70S mouse model may require the use of 
different methodology. One potential approach is to generate a knock-in mouse by 
introducing the mutation to mouse embryonic stem (ES) cells. These genetically 
modified ES cells can then be microinjected into a mouse blastocyst and the 
blastocyst implanted into the uterus of a female mouse. The resulting offspring can 
then be bred, eventually giving rise to homozygous G70S mice (Babinet and Cohen-
Tannoudji, 2001). 
 
Despite the lack of success in generating this model, valuable data was obtained 
regarding the phenotype and survival of mice with a G70S mutation in Eef1a2. This 




allowed us to better understand the effects of the G70S mutation on eEF1A2 
function. I was able to determine which alleles were expressing RNA and protein for 
all mice tested and successfully identified mice that were expressing G70S eEF1A2. 
This information was essential in order to relate phenotypes to changes in eEF1A2. 
 
We successfully generated four Eef1a2G70S/- mice that had G70S on one allele with 
no indels (#1, #10, #20 and #33). All of these mice showed a phenotype and age of 
survival comparable to that of wasted mice, which are Eef1a2-null, including weight 
loss, tremor and gait abnormalities. In addition, all of these mice were shown to 
express eEF1A2 from the G70S allele in brain and muscle (muscle analysis by Faith 
Davies, not shown). The above evidence suggests that G70S eEF1A2 is functionally 
impaired and unable to compensate for loss of wild-type protein. This points towards 
loss of protein function as a disease mechanism. 
 
However, interestingly, the mouse that had clean G70S incorporation on both alleles 
(#4) showed a more severe phenotype than the four G70S/- mice. This mouse 
showed a wasted phenotype characterised by tremor and weight loss and had to be 
culled at P18 due to the severity. The onset of the phenotype in wasted mice starts at 
P21 (Shultz et al., 1982), therefore the onset of the phenotype in this mouse was 
three days earlier. Although there is only evidence from one mouse, this suggests 
that the G70S mutation may not simply lead to loss of protein function and that a 
gain-of-function mechanism may also be at play. It is possible that this mutation may 
lead to gain of novel protein functions, such as a gain of new binding partners, as 
well as the loss of particular functions. However, it must be noted that the number of 
mice in this experiment was low (4 G70S/- and 1 G70S/G70S) and therefore a 
repeated experiment is necessary to confirm these results. 
 
Unexpectedly, eight Eef1a2-/- mice had audiogenic seizures in response to 
environmental sounds out of the seventeen mice of that genotype that were exposed. 
Therefore, the seizure incidence was 47%. None of the four G70S/- or the one 
G70S/G70S mice exposed to the sound had seizures, however, it must be noted that 
this is a very low number of mice. Therefore, further experiments with a larger 




cohort under controlled conditions would be required to determine whether mice 
with missense mutations in Eef1a2 are susceptible to audiogenic seizures. If these 
experiments confirmed that G70S/- mice are not susceptible to audiogenic seizures, 
this would be in contrast to G70S/+ patients who have epilepsy. This would suggest 
either a species difference or perhaps an interaction between wild-type and mutant 
protein is required to cause seizures. This is entirely possible based on evidence that 
eEF1A is able to act as a dimer (Bunai et al., 2006). The discovery of audiogenic 
seizure susceptibility in Eef1a2-null mice is unexpected considering that seizures 
have never been observed in wasted mice which have been bred since 1972. An 
investigator in our laboratory experienced two incidents in which a wasted mouse 
died during handling (personal communication). However, whether or not these were 
seizures remains unconfirmed. One hypothesis to explain why wasted mice seem to 
be resistant is that their mixed genetic background is somehow protective against 
seizures.  
 
Five of the mice had sudden unexplained deaths at P23. Four of these were Eef1a2-
null and the other a mosaic. These mice did not look severely wasted at P22 and 
were certainly capable of surviving another few days. Therefore, neurodegeneration 
was not a likely cause of death. It is suspected that these mice may have died from 
seizures, however, there is no way to confirm this. Audiogenic seizures were entirely 
possible since three of the mice died while being transferred between facilities, 
meaning that they would have been exposed to novel sounds. An alternative 
hypothesis is that these mice died from sudden unexpected death in epilepsy 
(SUDEP) which can occur in humans with epilepsy. The biological mechanisms 
underlying SUDEP are not clear but it is more common in drug resistant epilepsies 
and in people with high seizure frequency (Donner et al., 2017). 
 
These experiments have been invaluable in allowing us to understand the effects of 
mutations, and in particular the G70S mutation, on eEF1A2 function. Generating a 
mouse line with a missense mutation in Eef1a2 would be beneficial and the next, 
successful, attempt is discussed in Chapter 5. 
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Chapter 4: Investigating the effects of age and genetic  
  background on the behaviour of heterozygous  
  Eef1a2-null mice 
 
4.1. Introduction 
4.1.1. Why study the effects of eEF1A2 mutations on behaviour? 
All of the patients with missense mutations in EEF1A2 have intellectual disability 
and/or developmental delay of varying severity. Eight of the cases outlined in Table 
1.2 have been reported as showing clinical features characteristic of autism. These 
eight cases have the following mutations: G70S (De Ligt et al., 2012), D252H, 
E122K (Nakajima et al., 2014), F98C, R266W (personal communication) and A92T 
(Lopes et al., 2016). The autistic-like phenotypes observed in these individuals 
include repetitive hand twisting, finger sucking, rocking and also self-injury 
behaviours including pulling hair out and hitting oneself (Nakajima et al., 2014). For 
the majority of the cases, autism has not been reported because the intellectual 
disability is too severe for testing. 
 
Based on the above evidence, it is entirely possible that mice with mutations in 
Eef1a2 may show impairments in behavioural tests that are correlates for intellectual 
disability and autism in humans. In addition, it has been shown that eEF1A plays a 
role in the maintenance of LTP, the physiological process underlying the formation 
of new memories. It has been shown that local translation of eEF1A at the synapse is 
important for this process (Tsokas et al., 2005) Therefore, it can be hypothesised that 
changes in eEF1A2 expression and/or function will have a negative effect on 
learning and memory. 
 
4.1.2. Why investigate aging? 
For the aging studies in this chapter, I used heterozygous wasted mice (Eef1a2+/wst). 
These mice are heterozygous null for Eef1a2. I chose this line because they were 
readily available in our laboratory, well studied and phenotypically normal on a 
gross observational level i.e. do not show any of the neurodegenerative phenotypes 
observed in wasted homozygotes (Griffiths et al., 2012). This made them an ideal 
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model to study the effects of eEF1A2 mutations on behaviour as there were predicted 
to be no phenotypes that would affect the ability of the mice to perform the tasks. 
 
Griffiths et al (2012) analysed Eef1a2+/wst mice up to the age of 21 months to detect 
signs of late-onset motor neuron degeneration using grip strength and rotarod tests 
and by analysing spinal cord pathology post-mortem. They found that the mice were 
phenotypically normal and collected tissue post-analysis to measure eEF1A2 
expression levels in brain, spinal cord and muscle. Strikingly, it was observed that 
eEF1A2 expression levels in the brains of male mice at 21 months were much lower 
than the expected 50% of wild-type levels. In some cases, the level of expression was 








Figure 4.1. Western blot showing eEF1A2 expression levels in the brains of 
heterozygous wasted mice at 21 months. Blots probed for eEF1A2 and GAPDH as a 
loading control. Three samples are shown for each group. M = muscle positive control, L = 
liver negative control. The rectangle highlights the Eef1a2+/wst samples that had low 
eEF1A2 expression and their corresponding Eef1a2+/+ controls. Adapted from Griffiths et 
al., 2012. 
 
The data presented in this paper suggests that testing young mice in my behavioural 
assays would provide an eEF1A2 dosage of 50% whilst studying older mice may 
provide the opportunity to test an even lower dose. I hypothesised that older 
Eef1a2+/wst mice might be more impaired in behavioural tests than their younger 
counterparts due to lower eEF1A2 expression levels. 
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4.1.3. Heterozygous-null mice as a model of loss of function 
It is currently unknown whether the human heterozygous missense mutations in 
EEF1A2 result in loss or gain of protein function. As heterozygous wasted mice have 
a deletion on one allele of Eef1a2 resulting in protein expression from only the other 
allele, these mice provide a good model of loss of function. We can use these mice to 
reliably investigate the effects of having ≤50% levels of eEF1A2 on behaviour. 
However, if these mice do not show behavioural deficits this could point towards 
either a mouse-human difference in the levels of eEF1A2 that are necessary for 
normal function or a gain of function mechanism as the cause of disease. If the 
mechanism is found to be gain of function, then a mouse model with one of the 
human missense mutations would be an invaluable tool for future behavioural 
research. 
 
4.1.4. Behavioural testing in mouse models of neurological disease 
Behaviour abnormalities are routinely identified mouse models that have mutations 
in genes associated with intellectual disability and autism in humans. These include, 
but are certainly not limited to, mutations in Fmr1, Tsc1/2, Cntnap2 and Shank2. 
 
Fmr1 knockout mice are hyperactive, which can be shown by increased movement in 
an open field test (Ding, Sethna and Wang, 2014). In terms of autism-like 
phenotypes, they display changes in repetitive behaviours by burying more marbles 
than wild-type mice in the marble burying test and abnormalities in social behaviour 
as they prefer to spend time with an object rather than another mouse in the three-
chamber social test (Dahlhaus and El-Husseini, 2010, Spencer et al., 2011). These 
mice also show evidence of anxiety, as some groups have found that they spend less 
time in the centre of an open field arena and less time in the open arms of an elevated 
plus maze (Restivo et al., 2005, Bilousova et al., 2009). In terms of learning and 
memory, Fmr1 knockout mice show hippocampal working memory deficits in the 
Morris water maze during reversal i.e. when the platform is moved to a new location 
(Baker et al., 2010). They also show deficits in hippocampal-dependent contextual 
fear conditioning and in object recognition (Paradee et al., 1999, Ventura et al., 
2004). It is important to note that conflicting results have been found in some of 
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these tests and the deficits seem to vary depending on genetic background (Spencer 
et al., 2011, Kazdoba et al., 2014). 
 
Mutations in TSC1 and TSC2 cause Tuberous Sclerosis (TSC) in humans, a disorder 
that affects multiple organs including the brain, lung, kidney, heart and skin. Clinical 
features of TSC can include intellectual disability, autism and epilepsy (Caban et al., 
2016). Mice with mutations in Tsc1/2 exhibit impaired social behaviour by avoiding 
spending time with novel mice during direct contact tasks and by building poor nests 
in a group nest building task (Goorden et al., 2007). They also have social 
impairments in the three-chamber test by preferring to spend time with an object 
over another mouse and showing no preference for a novel mouse compared with a 
previously encountered mouse. Similar to Fmr1 knockout mice, these mice display 
changes in repetitive behaviours by burying more marbles than wild-type mice in the 
marble burying test (Reith et al., 2013). Tsc1/2 mice also show learning and memory 
impairments in hippocampal-dependent tasks including the Morris water maze and 
contextual fear conditioning (Goorden et al., 2007, Kirschstein, 2012), a phenotype 
which has also been observed in Fmr1 knockout mice. 
 
The CNTNAP2 gene, which encodes a neurexin-family receptor and cell adhesion 
protein, can be knocked out in mice to produce behavioural deficits (Peñagarikano et 
al., 2011). These mice show increased locomotion in the open field test, similar to 
Fmr1 knockout mice. They also display abnormal social behaviour when allowed 
direct contact with novel mice in the juvenile play test and indirect contact in the 
three-chamber test. Cntnap2 knockout mice also show changes in repetitive 
behaviours including excessive digging and grooming, which are correlates for 
autism in humans. Like Tsc1/2 mutant mice, Cntnap2 mutants building significantly 
poorer nests than wild-type mice in a group nest building task. Interestingly, these 
mice show a hippocampal-dependent working memory deficit in the Morris water 
maze as observed in FmrI and Tsc1/2 mutants (Peñagarikano et al., 2011). 
 
Mutations in mouse Shank genes (Shank1/2/3), which encode synaptic scaffold 
proteins, result in similar behavioural impairments to those described above. For 
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example, mice with Shank2 deletions show reduced sociability and lower preference 
for social novelty in the three-chamber test. These mice also show changes in 
repetitive behaviours, including excessive digging and grooming. In addition, they 
display increased locomotion in the open field test, similar to Fmr1 and Cntnap2 
knockout mice (Schmeisser et al., 2012, Won et al., 2012). 
 
In light of the above studies, the following point is worth noting. In mouse models 
that display hyperactivity coupled with an increase in repetitive behaviours, results 
must be interpreted carefully. This is because the increase in repetitive behaviours 
may in fact be due to the hyperactivity phenotype and therefore not indicative of 
autistic-like behaviour. For example, a significant increase in marble burying 
behaviour in a hyperactive mouse may actually be caused by a high level of 
movement resulting in marbles being buried inadvertently. In addition, repetitive 
body movements regularly co-occur with hyperactivity making it more difficult to 
disentangle the two processes (Kim, Lim and Kaang, 2016). 
 
Based on the above evidence, consistently observed behavioural deficits in mice with 
mutations in genes that cause intellectual disability and autism in humans include 
social impairments, changes in repetitive behaviours, hyperactivity and impaired 
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• To determine the effects of age and genetic background on the behaviour 
of heterozygous Eef1a2-null mice. 
1) To characterise the behavioural phenotype of heterozygous wasted (Eef1a2+/wst) 
mice and to determine whether phenotype is affected by age. 
2) To determine, through protein expression analysis, whether any age-specific effect 
on behaviour found through aim 1 is accompanied by a dosage of eEF1A2 lower 
than 50%. 
3) To characterise the behavioural phenotype of heterozygous mice from a new 
Eef1a2-null mouse line (Del22.ex3) which, in contrast to the mixed background of 
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4.2.1. Investigating the effects of aging on the behaviour of Eef1a2+/wst 
mice 
 
4.2.1.1. The aging cohort 
Mice were bred from heterozygote x heterozygote matings or wild-type x 
heterozygote matings and were housed in male-only cages of mixed genotypes. All 
mice were housed in groups to avoid any confounding effects of single housing on 
behaviour. Female mice were excluded from testing due to the potential for results to 
vary across different phases of the oestrus cycle.  These experiments were not 
completed in a single time frame and multiple cohorts were used throughout the 
course of my project to generate the final dataset. Mice were tested in behavioural 
assays from 9 weeks (2 months) of age. The age of the mice tested ranged from 2 
months to 18 months. For analysis, mice were split into age groups ranging from 2-6 
months, 7-11 months and 12-18 months. These age groups were chosen firstly to 
split the mice tested between 2 months and 11 months into two equal sizes groups. 
Secondly, mice are considered aging after 12 months and therefore all mice tested 
from this age were put into a third group to analyse the effects of aging on behaviour.  
Behavioural testing was performed with assistance from James Innes (summer 
student) and James Vipond (Honours project student). Data for each test are 
presented as mean values in the bar graphs and as individual scores for each mouse 
in the dot plots. The bar graphs allow the means to be observed and compared with 
ease whilst the dot plots show the spread of data and therefore the variability in 
scores within genotypes. Correlations of behaviour score with age are shown in 
Appendix B. 
 
4.2.1.2. Eef1a2+/wst mice showed no evidence of changes in 
repetitive behaviours compared with Eef1a2+/+ mice 
Mice naturally exhibit stereotyped repetitive behaviours such as digging, grooming, 
circling and jumping. However, these behaviours are considered to be abnormal 
when a mouse engages in them for long periods of time or when the frequency of 
these behaviours increases. These persistent behaviours are often identified in mouse 
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models of autism (Silverman et al., 2010). These behaviours are considered to be a 
correlate for autism in humans and can be analysed accordingly. As previously 
mentioned, many mouse models of autism have shown a significant increase in 
repetitive behaviours including Fmr1 knockout mice, Tsc1/2 mutants, Cntnap2 
knockout mice and Shank2 mutants (Peñagarikano et al., 2011, Spencer et al., 2011, 
Reith et al., 2013, Kazdoba, Leach and Crawley, 2016). However, others have shown 
a significant reduction. For example, mice with deletion of Pten in a subset of 
neurons showed a significant decrease in the number of marbles buried and number 
of head dips in the hole-board test compared with their wild-type littermates (Lugo et 
al., 2014). It is noteworthy that mice with other mutations in Pten have shown an 
increase in repetitive behaviours, for example, heterozygous null Pten mice have 
shown a significant increase in repetitive digging behaviour compared with wild-type 
mice (Clipperton-Allen and Page, 2015). 
 
There are several established assays to measure changes in repetitive behaviours in 
mice. Digging behaviour can simply be observed in a clean cage for a defined length 
of time or can be measured using the marble burying assay. These assays aim to 
determine whether mutant mice dig significantly more (or less) than wild-type mice. 
In the marble burying test, this is determined by the number of marbles buried in a 
set period of time (Deacon, 2006b, Angoa-Pérez et al., 2013). The individual nest 
building assay can also be used to investigate repetitive behaviour as mice with 
mutations linked to autism will often shred more nestlet and/or build higher quality 
nests than wild-type mice (Deacon, 2012, Angoa-Pérez et al., 2013). The results of 
this are in contrast to those of group nest building tasks in which mutants often build 
poorer quality nests (Goorden et al., 2007, Peñagarikano et al., 2011). 
 
Firstly, I tested Eef1a2+/+ and Eef1a2+/wst mice in the nest building assay to 
determine whether Eef1a2+/wst mice show changes in repetitive behaviours (Figure 
4.2). Mice were housed individually in clean cages containing a square of nest 
material overnight. Following testing, nest material was weighed to calculate the 
percentage shredded and was scored according to a scale devised by Deacon (2006a) 
(shown in Figure 4.2). There were no statistically significant differences in the 
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percentage of nestlet shredded (Figure 4.2A) or in nest building score (Figure 4.2B) 
between genotypes or age groups. The dot plots in Figure 4.2 show the individual 
data points for each mouse and it can be seen that the results within groups are very 
variable.  
 
For other tests described later in this chapter, a 7-11-month age group was included. 
However, this group was not included in the nest building assay as there were only 3 
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Figure 4.2. Data from Eef1a2+/+ and Eef1a2+/wst mice in the nest building assay. Error 
bars for all graphs show SEM. A. Percentage of nestlet shredded for +/+ and +/wst mice at 
2-6 months and 12-18 months. There was no significant difference between genotypes or age 
groups (Two-way ANOVA). B. Nest score for +/+ and +/wst mice at 2-6 months and 12-18 
months. The scoring criteria used is shown in the images labelled 1-5 (Deacon, 2006a). 
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Further testing was necessary to establish whether or not these mice show changes in 
repetitive behaviours. Therefore, I performed the marble burying test to complement 
the nest building data. Initially, this test was performed with 12 marbles, however, 
wild-type mice buried a high number of marbles (mean = 8) making it difficult to 
observe differences between genotypes (data not shown). Therefore, the test was 
repeated with 20 marbles. Mice were placed in clean cages containing 20 marbles for 
30 minutes and the number of marbles buried was scored. The results are shown in 
Figure 4.3. 
 
There were no significant differences in the number of marbles buried between the 
genotypes for any age group, however, Eef1a2+/wst mice at 12-18 months buried 
significantly fewer marbles than Eef1a2+/wst mice at 2-6 months. This was shown 
using a two-way ANOVA with post-hoc Tukey’s multiple comparisons test. Despite 
the reduction in marble burying behaviour with age, there was no evidence to suggest 
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Figure 4.3. Data from Eef1a2+/+ and Eef1a2+/wst mice in the marble burying assay. 
Number of marbles buried for +/+ and +/wst mice at 2-6 months, 7-11 months and 12-18 
months. A photograph of the apparatus is shown. Error bars for all graphs show SEM. +/wst 
mice at 12-18 months buried significantly fewer marbles than +/wst mice at 2-6 months 
(Two-way ANOVA showed significant effect of age: F = 6.796, DF = 2, 27, p = 0.0041. 
Tukey’s multiple comparisons test p = 0.0187). There were no significant differences 
between any of the other groups. 
 
 
Based on the nest building and marble burying data, it seemed that +/wst mice did 
not show the changes in repetitive behaviours seen in other mouse models of autism. 
To test this hypothesis, I performed a third and final test, the digging assay. Mice 
were placed individually in clean cages containing fresh bedding and digging 
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There was no statistically significant difference in the latency to start digging (Figure 
4.4A), the number of digging bouts (Figure 4.4B) or the total duration of digging 
(Figure 4.4C) between genotypes or age groups. Therefore, Eef1a2+/wst showed no 
evidence of changes in repetitive behaviours in this test. As with the nest building 
assay, the dot plots show that the spread of data within groups is large. 
 
To summarise, Eef1a2+/wst mice did not differ from Eef1a2+/+ mice in the percentage 
of nestlet shredded and quality of nests built in the nest building assay, the number of 
marbles buried in the marble burying assay or the extent of digging in the digging 
assay. These mice showed no evidence of changes in repetitive behaviours compared 
with wild-type mice in any of the three tests performed. 
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Figure 4.4. Data from Eef1a2+/+ and Eef1a2+/wst mice in the digging assay. Error bars for 
all graphs show SEM. A. Latency to start digging for +/+ and +/wst mice at 2-6 months, 7-
11 months and 12-18 months. There was no significant difference between genotypes or age 
groups (Two-way ANOVA). B. Number of digging bouts for +/+ and +/wst mice at 2-6 
months, 7-11 months and 12-18 months. There was no significant difference between 
genotypes or age groups (Two-way ANOVA). C. Total duration of digging for +/+ and +/wst 
mice at 2-6 months, 7-11 months and 12-18 months. There was no significant difference 
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4.2.1.3. Eef1a2+/wst mice showed no preference for social novelty 
For mice, social interactions and social recognition are important for establishing a 
social hierarchy and choosing a mate. The three-chamber test (or stranger mouse 
test) is a well established assay to investigate social behaviour in mice (Crawley, 
2007). In the first stage of this assay, the test mouse is given the choice between 
spending time with another mouse or spending time alone/with an object. This 
allows the experimenter to assess whether mice with specific mutations show 
reduced sociability by avoiding spending time with the other mouse. A second stage 
of this test can also be performed which involves assessing whether a test mouse 
prefers to spend time with the mouse presented in stage one, which is now familiar, 
or with a novel mouse. This allows the experimenter to determine whether mice with 
specific mutations show preference for social novelty by spending more time with 
the novel mouse. Wild-type mice are expected to show preference for social novelty 
in this test (Kaidanovich-Beilin et al., 2011). Both stages of this test are used as 
correlates for autism in humans as mice with mutations in autism-related genes, 
including Fmr1 (Dahlhaus and El-Husseini, 2010), Cntnap2 (Peñagarikano et al., 
2011), Shank2 (Kazdoba, Leach and Crawley, 2016), and Tsc1/2 (Reith et al., 2013) 
have been found to show reduced sociability and/or reduced preference for social 
novelty. 
 
This test is usually performed in a rectangular arena with three chambers. For 
example, in stage one, the chambers contain: the mouse for the test mouse to interact 
with (left), an empty “decision making chamber” (middle) and a chamber which is 
empty or contains an object (right). In stage two, the chamber on the right is taken up 
by the novel mouse (Kaidanovich-Beilin et al., 2011). I used an adapted version of 
this apparatus to assess the social behaviour of Eef1a2+/wst mice. Rather than a 
rectangular arena, a Y-shaped maze was used. The setup is shown in Figure 4.5A and 
4.6A.  
 
The results of stage 1, where the test mouse was given the choice between spending 
time alone or with a mouse, is shown in Figure 4.5. Figure 4.5A shows an image of 
the Y-shaped apparatus containing the stranger mouse in the left arm between wire 
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mesh gates, empty wire mesh gates with no mouse in between in the right arm 
(“cage’) and the test mouse in the middle.  
 
Figure 4.5B shows the data for the time spent exploring the mouse vs the empty cage 
for Eef1a2+/+ and Eef1a2+/wst mice in each age group. For all age groups, both 
Eef1a2+/+ and Eef1a2+/wst mice spent significantly more time exploring the mouse 
than the empty cage. This was shown using a two-way ANOVA with Holm-Sidak’s 
multiple comparisons test. The total exploration time did not differ between 
genotypes at any age, shown using a two-way ANOVA (data not shown). Therefore, 
there is no evidence that Eef1a2+/wst mice show the reduced sociability that is 
observed in other mouse models of autism. 
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Figure 4.5. Data from Eef1a2+/+ and Eef1a2+/wst mice in the stranger mouse test stage 1. 
Error bars for all graphs show SEM. A. Image of the Y-shaped apparatus. B. Time spent 
exploring the mouse vs the empty cage for +/+ and +/wst mice at 2-6 months, 7-11 months 
and 12-18 months. Asterisks on the bar graph show statistically significant differences (Two-
way ANOVA showed significant effect of stimulus (mouse vs cage): F = 53.39, DF = 1, 92, p 
= <0.0001. Holm Sidak’s multiple comparisons test: from left to right, p = 0.0255, 0.0137, 
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The results of stage 2, whether the test mouse was provided the option of spending 
time with a familiar mouse vs a novel mouse, are shown in Figure 4.6. Figure 4.6A 
shows an image of the Y-shaped apparatus containing the familiar mouse in the left 
arm between wire mesh gates, the novel mouse in the right arm between wire mesh 
gates and the test mouse in the middle. 
 
Figure 4.6B shows the data for the time spent exploring the familiar mouse vs the 
novel mouse for Eef1a2+/+ and Eef1a2+/wst mice in each age group. Eef1a2+/+ mice in 
each age group spent significantly more time exploring the novel mouse compared 
with the familiar mouse, shown by a two-way ANOVA with Holm-Sidak’s multiple 
comparisons test. Interestingly, Eef1a2+/wst mice showed no preference for the novel 
mouse at any age indicating that they show a lack of preference for social novelty 
which is not age-specific. The total exploration time did not differ between 
genotypes at any age, shown using a two-way ANOVA (data not shown). This social 
impairment has been observed in other mouse models with mutations in autism-
related genes including mice with mutations in Tsc1/2 and Shank2 (Reith et al., 
2013, Kazdoba, Leach and Crawley, 2016). 
 
To ensure that the social novelty impairment found in Eef1a2+/wst mice was not due 
to olfactory deficits, I performed the buried food test (Reith et al., 2013). This test 
involved burying a small piece of food under fresh bedding in a clean cage and 
measuring the time taken for the test mouse to find the food. The mean latency to 
find the food was not significantly different between genotypes (unpaired t-test) and 
both genotypes located the food after a mean of approximately one minute (Figure 
4.6C). Therefore, the apparent lack of preference for the novel mouse observed in 
Eef1a2+/wst mice is not likely to be due to olfactory deficits. In summary, the 
impairment appears to be due to a reduced preference for social novelty rather than 
an inability to distinguish between the mice through olfaction. 
 
For both stages of this test, it is important to note that the number of mice tested for 
the ‘Eef1a2+/+ 7-11mo’ age group is low (N = 4). These were the only mice available 
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at this age at the time of testing as it was particularly important to test littermates due 
to the mixed genetic background of the wasted line. Due to the low N, results from 
this group should be interpreted with caution. However, as there are groups both 
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Figure 4.6. Data from Eef1a2+/+ and Eef1a2+/wst mice in the stranger mouse test stage 2. 
Error bars for all graphs show SEM. A. Image of the Y-shaped apparatus. B. Time spent 
exploring the familiar mouse vs the novel mouse for +/+ and +/wst mice at 2-6 months, 7-11 
months and 12-18 months. Asterisks on the bar graph show statistically significant 
differences. Two-way ANOVA showed significant effect of stimulus (familiar vs novel 
mouse): F = 36.92, DF = 1, 88, p = <0.0001. Holm Sidak’s multiple comparisons test: from 
left to right, p = 0.0107, 0.0136, <0.0001. C. Olfactory buried food test results for +/+ and 
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4.2.1.4. Locomotor activity of Eef1a2+/wst mice decreased with age 
The open field test is routinely used to assess locomotor and anxiety phenotypes in 
mice. This test also provides useful baseline data to interpret other behavioural tests 
that involve locomotion, including the marble burying test. The test involves placing 
a mouse in an opaque, square arena, usually measuring 50cm x 50cm, and recording 
exploration in the arena for a set period of time. Locomotor activity is commonly 
used as an indicator of hyperactivity in mouse models, with a significant increase in 
movement compared with wild-type mice indicating hyperactivity. A defined square 
area is set as the centre of the apparatus and the time spent in the centre vs the 
outside is routinely used to assess anxiety. Anxious mutant mice will spend 
significantly less time in the centre than their wild-type counterparts. Freezing can 
also be used as a measure of anxiety with more time spent freezing indicating higher 
anxiety (Seibenhener and Wooten, 2015). As outlined in section 4.1.4, particular 
mouse models with mutations in genes that cause autism in humans have shown 
hyperactivity and anxiety in the open field test including Fmr1 knockout mice 
(Restivo et al., 2005, Ding, Sethna and Wang, 2014). 
 
I performed the open field test to determine whether Eef1a2+/wst mice show any 
locomotor and/or anxiety phenotypes. In terms of motor analysis, it is important to 
note that Eef1a2+/wst mice have previously been tested on the rotarod and were shown 
to have a normal performance up to the age of 21 months (Griffiths et al., 2012). 
Mice were allowed to explore the 50cm x 50cm open field arena for 5 minutes. The 
total distance travelled was measured to determine whether these mice are 
hyperactive. The time spent freezing, the time spent in the outside zone and the time 
spent in the centre zone were used to assess the presence of anxiety phenotypes. 
 
Figure 4.7A shows the data for the total distance travelled for Eef1a2+/+ and 
Eef1a2+/wst mice in each age group. Eef1a2+/wst mice in the 12-18-month group 
travelled a significantly smaller distance than those in the 2-6-month group. This was 
shown using a two-way ANOVA with Tukey’s multiple comparisons test. 
Hyperactive mice have been shown to travel significantly larger distances than wild-
type mice in the open field (Peñagarikano et al., 2011, Ding, Sethna and Wang, 
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2014, Kazdoba, Leach and Crawley, 2016). However, this was not the case here for 
any age group. Therefore, +/wst mice do not appear hyperactive compared with wild-
type mice. 
 
Figure 4.7B shows the data for the total time spent freezing for Eef1a2+/+ and 
Eef1a2+/wst mice in each age group. Eef1a2+/wst mice in the 12-18-month group spent 
significantly more time freezing than Eef1a2+/wst mice in the 2-6-month group. This 
was shown using a two-way ANOVA with Tukey’s multiple comparisons test. 
However, there was no difference in the time spent freezing between the genotypes 
at any given age. Based on the data in Figure 4.7A and B, it appears that Eef1a2+/wst 
mice show decreased locomotion as they age. 
 
Figure 4.7C shows the data for the time spent in the outside and centre zones of the 
open field box for Eef1a2+/+ and Eef1a2+/wst mice in each age group. Eef1a2+/+ mice 
at 2-6 months, Eef1a2+/wst mice at 2-6 months, Eef1a2+/wst mice at 7-11 months and 
Eef1a2+/+ mice at 12-18 months spent significantly more time in the outside zone 
than in the centre zone (Two-way ANOVA with Tukey’s multiple comparisons test). 
Therefore, generally, Eef1a2+/+ and Eef1a2+/wst mice both preferred to spend time in 
the outside zone. There were no significant differences in the time spent in either 
zone between genotypes. Therefore, there was no indication of increased anxiety of 
Eef1a2+/wst mice compared with Eef1a2+/+ mice based on the results of this analysis. 
It should be noted that one Eef1a2+/+ mouse in the 12-18-month group and one 
Eef1a2+/wst mouse in the 12-18-month were excluded from analysis of this parameter 
as they did not move at all during the whole test and, as a result, spent the whole time 
in the centre zone. The dot plots show that there is a large spread of data for some 
groups (for wild-type mice at 2-6 months, for example). 
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Figure 4.7. Data from Eef1a2+/+ and Eef1a2+/wst mice in the open field test. Error bars for 
all graphs show SEM. A. Total distance travelled for +/+ and +/wst mice at 2-6 months, 7-
11 months and 12-18 months. Asterisks on the bar graph show statistically significant 
differences. Two-way ANOVA showed significant effect of age: F = 10.3, DF = 2, 27, p = 
0.0005. Tukey’s multiple comparisons test: p = 0.0061. B. Total time spent freezing for +/+ 
and +/wst mice at 2-6 months, 7-11 months and 12-18 months. Asterisks on the bar graph 
show statistically significant differences. Two-way ANOVA showed significant effect of age: 
F = 5.54, DF = 2, 27, p = 0.0096. Tukey’s multiple comparisons test p = 0.00277. C. Time 
spent in outside and centre zone for +/+ and +/wst mice at 2-6 months, 7-11 months and 12-
18 months. The numbers of mice are the same as for A and B, apart from for the 12-18-
month group where n = 4 for each genotype. Asterisks on the bar graph show statistically 
significant differences. Two-way ANOVA showed significant effect of zone: F = 59.58, DF = 
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4.2.1.5. Eef1a2+/wst mice showed normal spatial memory in a short 
ITI Y-maze test 
The Y-maze is routinely used to assess spatial memory in mice, a process that is 
dependent on hippocampal function (Sharma, Rakoczy and Brown-Borg, 2010b). 
Mice with mutations in genes linked to intellectual disability and autism, including 
Fmr1 (Paradee et al., 1999, Baker et al., 2010), Tsc1/2 (Goorden et al., 2007, 
Kirschstein, 2012) and Cntnap2 (Peñagarikano et al., 2011) have been found to show 
impairments in hippocampal-dependent memory tasks including the Morris water 
maze and contextual fear conditioning. There is minimal data on performance in the 
Y-maze but deficits in Fmr1 knockout mice have been observed (Bilousova et al., 
2009). The Y-maze has also been used to assess spatial memory in mouse models 
with mutations in genes related to learning and memory (Freudenberg et al., 2016). 
 
I used the Y-maze in an attempt to assess spatial memory of Eef1a2+/wst mice. The Y-
maze test consisted of two phases. In the first phase, one of the three arms was closed 
with a gate and the test mouse was allowed to explore the other two arms for 5 
minutes (Figure 4.8A). These are commonly referred to as the ‘start’ and ‘other’ arm, 
the start arm being the arm that the mouse is placed in to begin the test. To assess 
spatial memory, the mouse was removed from the maze for a short ITI of 15 
minutes. After 15 minutes, the second phase was begun. In this phase, the gate 
closing the third (‘novel’) arm was opened and the mouse was allowed to explore all 
three arms for 2 minutes. As mice show an innate preference for novelty, wild-type 
mice are expected to spend significantly more time exploring the novel arm than the 
two familiar arms. 
 
Figure 4.8B shows the results of the Y-maze test. The bar graph shows the mean 
time spent in the familiar vs novel arms and the dot plot shows the individual scores 
for each mouse. Mice at 12-18 months were not included in this test as there were 
not enough mice of this age at the time of testing. Both Eef1a2+/+ and Eef1a2+/wst 
mice at 2-6 months and 7-11 months showed a significant preference for exploring 
the novel arm compared with the familiar arms. This was shown using a two-way 
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ANOVA with Tukey’s multiple comparisons test. Therefore, +/wst mice appeared to 
show preference for novelty and therefore normal spatial memory in the Y-maze 
after 15 minutes. 
 
The implementation of this test with a longer ITI to further assess spatial memory is 










Chapter 4: Investigating the effects of age and genetic  




Figure 4.8. Data from Eef1a2+/+ and Eef1a2+/wst mice in the Y-maze test. A. Image of the 
Y-maze. This maze was also used for the stranger mouse test (Section 4.2.1.3) and the novel 
object recognition test (Section 4.2.2.7). B. Mean time spent exploring Y-maze arms for +/+ 
and +/wst mice at 2-6 months and 7-11 months. Familiar = mean of ‘start’ and ‘other’ arm. 
Asterisks on the bar graph show statistically significant differences. Two-way ANOVA 
showed significant effect of arm (familiar vs novel): F = 149.8, DF = 1, 124, p = <0.0001. 
Tukey’s multiple comparisons test: from left to right p = <0.0001, <0.0001, 0.0006, 
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4.2.1.6. Variation in data was due to mixed genetic background of 
wasted line 
After testing a small group of mice for some of the above behavioural tests, I 
performed post-hoc power calculations to determine the recommended number of 
mice for testing. The results of this analysis are shown in Figure 4.9. I used data from 
a set of young mice at 2-6 months (set 1) and an older set at 12 months (set 2). Power 
calculations were performed with an online calculator using standard deviations from 
my mice to take the variation in my mouse line into consideration. From Figure 
4.9A, it can be seen that for some of the tests, power analysis recommended testing a 
very large, unfeasible number of mice. Examples of this are the stranger mouse test 1 
and 2, with recommendations of 27 and 43 mice respectively and the marble burying 
test with a recommendation of 27 and 60 mice. From the behaviour results in this 
chapter, it can be seen that there is a large amount of variation within groups for 
some of the tests. It is noteworthy that I attempted to perform a power calculation on 
data from the digging assay, however, a value of 1 along with an error was received. 
This appeared to be due to the fact that the mean values from the literature (mu1 and 
mu2) used for the calculation were very different from the mean values I obtained in 
my experiment. Therefore, my standard deviation used as the value for sigma did not 
make sense with the data. I could not find other suitable values. 
 
To determine whether the variability I observed might be due to the mixed genetic 
background of the wasted line, I performed a Y-maze exploration test on six wild-
type mice from the wasted line (mixed background) and six wild-type mice on a pure 
C57BL/6J genetic background. This test involved a simple measurement of 
preference for the novel arm by allowing mice to explore two arms and subsequently 
three arms with a short 15-minute ITI (see Section 4.2.1.5). The results of this test 
are shown in Figure 4.9B. Both groups of mice spent significantly more time 
exploring the novel arm than the familiar arms. It can be seen that the standard 
deviations for mice on the mixed genetic background were higher than those for the 
C57BL/6 mice, especially for novel arm exploration (19 for mixed vs. 3 for 
C57BL/6) indicating higher variation in the mixed line. Therefore, it seems likely 
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that the high variability within certain groups in my analyses and the 
recommendation of testing large numbers of mice through the power calculations is 





Figure 4.9. Tables showing evidence for high variability in data from the wasted line. 
A. Results of post-hoc power calculations showing the recommended number of mice that 
should be tested. Set 1 = 2-6 month old mice, set 2 = 12 month old mice. B. Results of Y-
maze analysis of wild-type mice from the wasted line (mixed) and wild-type mice on a pure 
C57BL/6 background. Familiar = mean of ‘start’ and ‘other’ arm, novel = novel arm. In the 
table, individual scores are shown for each mouse with the mean shown below. The standard 
deviation shows the spread of the data and has been used as an indicator of variability. In 
the graph, error bars show SD and asterisks represent statistically significant differences. 
Two-way ANOVA showed significant effect of arm (familiar vs novel): F = 130.6, DF = 1, 
20, p = <0.0001. Tukey’s multiple comparison’s test: mixed p = <0.0001, C57BL/6 p = 
<0.0001. 
 








Nest building 7 9
Marble burying 27 60
Digging 1 1
Mixed C57BL/6
Familiar Novel Familiar Novel
17 86 25.5 68
23.5 69 29 62
24 66 28.5 63
15.5 116 31 66
24.5 66 31 58
21.5 77 28 63
Mean 21 80 28.83 63.33
Standard 
Deviation
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4.2.1.7. eEF1A2 protein expression levels in the brains of aging 
Eef1a2+/wst mice showed high levels of variability 
After behavioural testing, I aimed to determine whether aging Eef1a2+/wst mice 
expressed eEF1A2 in the brain at levels lower than 50% of wild-type (Aim 2). 
Griffiths et al (2012) showed that eEF1A2 expression in the brain declines with age 
in Eef1a2+/wst mice but used a small number of animals. Eef1a2+/wst mice at 21 
months expressed, in some cases, eEF1A2 at 7.5% of wild-type. Therefore, I wanted 
to determine whether age-specific effects on behaviour in the marble burying and 
open field tests were due to lower expression levels of eEF1A2 in aging mice, 
specifically in the animals in which I had carried out my behavioural analysis. I 
decided to analyse cortex and hippocampus as key brain regions important for 
behaviour in mice. 
 
When a subset of the aging mice from the behaviour cohort reached 15-18 months, 
they were culled and brain tissue was dissected. Hippocampus and cortex were 
dissected with assistance from Dr Matthieu Vermeren. Protein was extracted from 
the samples and run on Western blots with an eEF1A2-specific antibody. Figure 
4.10A shows the results for the cortex and Figure 4.10B shows the results for the 
hippocampus. Western blots show bands for eEF1A2 in red and the loading control, 
GAPDH, in green (arrows). The expression values for each mouse are shown in the 
graphs beneath the blots. 
 
From the graphs, it can be seen that the expression levels were very variable within 
genotypes, especially in the cortex. This seems unlikely to represent an accurate 
measure of expression as, for several Eef1a2+/+ mice, expression appeared to be 
lower than for Eef1a2+/wst mice. In addition, comparing the individual expression 
values for each mouse between cortex and hippocampus showed no correlation 
further suggesting that these values are not accurate. One reason for variable results 
could be the use of small amounts of tissue extract, especially for the hippocampus, 
in combination with the Licor method for Western blotting. Fluorescent detection 
methods are less sensitive than chemiluminescent methods, which can lead to 
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inaccurate quantification when using small amount of tissue. However, the Licor 
method was selected because the accuracy of quantification is improved by the 
ability to probe for the loading control simultaneously (Kurien and Scofield, 2006). 
To summarise, I was unable to quantify eEF1A2 protein expression in aging mice. 
 
The mice used for behavioural analysis had been genotyped prior to the start of my 
project. Therefore, I extracted DNA from tissue and repeated the genotyping on these 





Figure 4.10. eEF1A2 protein expression in cortex and hippocampus of aging mice. 
Blots were imaged using the Licor Odyssey FC with eEF1A2 in red (concentration = 
1:1000) and GAPDH in green (concentration = 1:2000) and quantified using Image Studio 
Lite version 4.0. Br = wild-type brain positive control, M = wild-type muscle positive 
control, Li = wild-type liver negative control. A. eEF1A2 expression in cortex. B. eEF1A2 
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4.2.2. Characterising the behavioural phenotype of a new Eef1a2-null 
mouse line on a C57BL/6J genetic background 
 
4.2.2.1. Establishing the line 
Due to the high variability in behavioural data as a result of the mixed genetic 
background of the wasted line, I decided to establish a new line. It was hypothesised 
that a line bred on a pure genetic background would reduce variation based on the 
results of the Y-maze test shown in Figure 4.9. 
 
Heterozygous null mouse #9 from the G70S CRISPR/Cas9 experiment described in 
Chapter 3 was used to establish the new line (Table 3.2). The breeding process is 
shown in Figure 4.11A. Figure 4.11B shows part of the genotyping results from a 
litter which shows bands for a heterozygous, wild-type and homozygous mouse from 
left to right. Founder #9 contained a 22bp deletion on one allele of Eef1a2 and this 
22bp size difference between mutant and wild-type Eef1a2 was used to identify the 
genotypes. Therefore, the genotyping results from heterozygous mice show two 
bands which are 22bp different in size. The wild-type product is 208bp and the 
mutant product is 186bp.  As this line has a 22bp deletion in exon 3 of Eef1a2, it was 
named ‘Del22.ex3’. 
 
Figure 4.11C shows the weights of the first litter that contained wild-type, 
heterozygous and homozygous mice (F2 generation). Weight data was collected 
between P19 and P26. It is well established that homozygous wasted mice, which are 
complete nulls for Eef1a2, progressively lose weight from around P21 and do not 
survive past P28 (Shultz et al., 1982). Therefore, homozygous mice from this line 
were predicted to show the same phenotype. The heterozygous mice and the one 
wild-type mouse from the Del22.ex3 litter gained weight from P19-P26 and were 
phenotypically normal as expected. As predicted, the one homozygous mouse from 
this litter was unable to gain weight at the same rate as wild-type and heterozygous 
mice. This was apparent by P24 and the mouse had started to lose weight by P26. 
This mouse had to be culled at P26 due to low weight, a characteristic tremor and 
unsteady gait, phenotypes which are characteristic of homozygous wasted mice 
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(Shultz et al., 1982). Unfortunately, as there was only one homozygous mouse in the 
litter, statistical analysis could not be performed. It is important to note that the 
whole litter was very small at P19 (5.0-5.5g) but this was not the case for subsequent 
litters. 
 
I collected brain and skeletal muscle from the wild-type and homozygous mouse at 
P26. Protein was extracted from the tissue and ran on a Western blot with antibodies 
specific to eEF1A2 and GAPDH as a loading control. This was performed in order to 
confirm that there was no eEF1A2 expression in the homozygous mouse and that the 
mutation resulted in complete loss of expression. The results are shown in Figure 
4.11D with eEF1A2 in red and GAPDH in green (arrows). There were no eEF1A2-
specific bands in brain or muscle from the homozygous (-/-) mouse indicating that 
eEF1A2 was not expressed. Therefore, using founder #9 to establish a new Eef1a2-
null line was successful. 
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Figure 4.11. Establishing the new Del22.ex3 Eef1a2-null mouse line. +/+ = wild-type, 
+/- = heterozygote, -/- = homozygote A. The breeding process. #9 = heterozygous null 
mouse from the G70S CRISPR/Cas9 experiment. B. Genotyping PCR ran on a 2% agarose 
gel with Low Molecular Weight DNA Ladder (NEB) (left). +/+ product = 208bp, -/- product 
= 186bp. C. Weights of F2 generation from P19-P26. D. eEF1A2 protein expression in +/+ 
and -/- mice from F2 generation. Blots were imaged using the Licor Odyssey FC with 
eEF1A2 in red (concentration = 1:1000) and GAPDH in green (concentration = 1:2000) 
and quantified using Image Studio Lite version 4.0. +/+ liver control = wild-type liver 
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4.2.2.2. The Del22.ex3 behaviour cohort 
Wild-type (Eef1a2+/+) and heterozygous (Eef1a2+/-) mice from the Del22.ex3 line 
were used to repeat the behavioural tests performed on heterozygous wasted mice. I 
hypothesised that the variation in results observed with the wasted line would be 
lower in the Del22.ex3 line and, therefore, testing a lower number of mice would be 
required to provide robust, reliable behavioural data.  
 
Mice were bred from wild-type x heterozygote matings and were housed in male 
only cages of mixed genotypes. Mice were housed in groups to avoid any 
confounding effects of single housing on behaviour. Female mice were excluded 
from testing due to the potential for results to vary across different phases of the 
oestrus cycle. Mice were tested in behavioural assays from 9 weeks (2 months) of 
age. The age of the mice tested ranged only from 2 months to 5 months as there was 
insufficient time to age mice. This age group provided a comparison for the wasted 
heterozygous mice tested at 2-6 months. As with the wasted line, data are presented 
as mean values in the bar graphs and as individual scores for each mouse in the dot 
plots. The bar graphs allow the means to be observed and compared with ease whilst 
the dot plots show the spread of data and therefore the variability in scores within 
genotypes. Testing was performed with assistance from Charlie Cumber (Honours 
project student). 
 
4.2.2.3. Eef1a2+/- mice showed changes in repetitive behaviours in 
the nest building and marble burying assays 
I performed the nest building assay to determine whether Eef1a2+/- mice showed 
changes in repetitive behaviours. This test was performed in the same way as 
described for the wasted line (Section 4.2.1.2). The results are shown in Figure 4.12.  
 
Figure 4.12A shows the percentage of nestlet shredded for Eef1a2+/+ and Eef1a2+/- 
mice. Eef1a2+/- mice shredded significantly less nestlet than Eef1a2+/+ mice, shown 
using an unpaired t-test. Therefore, Eef1a2+/- mice were found to show alterations in 
repetitive behaviours. Figure 4.12B shows the nest building score for Eef1a2+/+ and 
Eef1a2+/- mice. In contrast to the results for the percentage of nestlet shredded, there 
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was no significant difference in nest building score between Eef1a2+/+ and Eef1a2+/- 
mice (Mann-Whitney test). The results of this test are in contrast to those observed 
for heterozygous wasted mice where there was no significant difference in either 
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Figure 4.12. Data from Eef1a2+/+ and Eef1a2+/- mice in the nest building assay. Error 
bars for all graphs show SEM. A. Percentage of nestlet shredded. The asterisk on the bar 
graph shows a statistically significant difference, unpaired t-test, t = 2.46, DF = 27, p = 
0.0207. B. Nest score. The scoring criteria used is shown in the images labelled 1-5 
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To further explore the effects of Eef1a2 deletions on repetitive behaviours, Eef1a2+/- 
mice were tested in the marble burying assay. This assay measured the number of 
marbles, out of 20, buried in 30 minutes as performed on the wasted line (Section 
4.2.1.2). The results of this test are shown in Figure 4.13. 
 
The data in Figure 4.13 shows that Eef1a2+/- mice buried significantly fewer marbles 
than Eef1a2+/+ mice. A similar result was found for Eef1a2+/wst mice in that they 
buried significantly fewer marbles as they aged. However, there was no difference in 
marble burying scores between genotypes for the wasted line. The marble burying 
data for the Del22.ex3 line reveals alterations in repetitive digging behaviour. This 
complements the nest building data which showed that Eef1a2+/- mice shredded 
significantly less nestlet than Eef1a2+/+ mice, also indicating changes in repetitive 
behaviour. Curiously, these changes in repetitive behaviours were in the opposite 
direction from what was expected when considering that most mouse models of 
autism show an increase in these behaviours (see Section 4.1.4). In addition, some of 
the patients with missense mutations in EEF1A2 show an increase in repetitive 
behaviours, as described in Section 4.1.1. 
 
Chapter 4: Investigating the effects of age and genetic  





Figure 4.13. Data from Eef1a2+/+ and Eef1a2+/- mice in the marble burying assay. A 
picture of the apparatus is shown. The graphs show the number of marbles buried for each 
genotype. Error bars for all graphs show SEM. The asterisk on the bar graph shows a 
statistically significant difference, unpaired t-test, t = 2.16, DF = 26, p = 0.0399. 
 
 
Based on the nest building and marble burying results, it appears that Eef1a2+/- mice 
show a reduction in repetitive behaviours compared with wild-type mice. I 
performed the digging assay as a further test to analyse repetitive digging behaviour. 
This test involved observing digging behaviour for 3 minutes as described in Section 
4.2.1.2. The results of this test are shown in Figure 4.14. 
 
There was no significant difference in the latency to start digging (Figure 4.14A), the 
number of digging bouts (Figure 4.14B) or the total duration of digging (Figure 
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digging behaviour for Del22.ex3 Eef1a2+/- mice. The same result was observed for 
the wasted line (Section 4.2.1.2). 
 
Interestingly, both Eef1a2+/+ and Eef1a2+/- mice from the Del22.ex3 line engaged in 
very low levels of digging behaviour compared to mice from the wasted line. Mice 
from the Del22.ex3 line took longer to begin digging, shown by a higher mean 
latency to start digging than the wasted line. Del22.ex3 mice also had a substantially 
lower mean number of digging bouts and mean duration of digging than mice from 
the wasted line (Figure 4.4, Figure 4.14). 
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Figure 4.14. Data from Eef1a2+/+ and Eef1a2+/- mice in the digging assay. Error bars for 
all graphs show SEM.  A. Latency to start digging. There was no significant difference 
between genotypes (unpaired t-test). B. Number of digging bouts. There was no significant 
difference between genotypes (unpaired t-test). C. Total duration of digging. There was no 
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I performed another test for repetitive behaviours on the Del22.ex3 line which had 
not been tested on the wasted line as the apparatus had not been available earlier. 
This was the hole-board test. This test involves placing the mouse in a 40cm x 40cm 
box containing 16 holes and allowing the mouse to explore for a set period of time 
(Figure 4.15). Changes in repetitive behaviours are indicated by an increase (or 
decrease) in hole exploration (‘head dips’) compared with wild-type mice. An image 
of the apparatus is shown in Figure 4.15A. 
 
Mice with mutations in genes related to autism have shown changes in repetitive 
behaviours in the hole-board test and, curiously, this has been observed in both 
directions. Specifically, mice with deletion of Pten, a component of the mTOR 
pathway, show a significantly reduced hole-poke frequency compared with wild-type 
mice (Lugo et al., 2014). Conversely, mice with deletion of Shank2 specifically in 
Purkinje cells show an increase in hole-poke frequency compared with wild-type 
mice (Ha et al., 2016). 
 
In my experiment, mice were allowed to explore the hole-board arena for 5 minutes. 
The results of this test are shown in Figure 4.15B-D. The latency to the first head dip 
(Figure 4.15B), the total number of head dips (Figure 4.15C) and the total number of 
holes explored were measured (Figure 4.15D). There were no significant differences 
in any of these three parameters between Eef1a2+/+ and Eef1a2+/- mice (unpaired t-
tests). Therefore, there were no identifiable differences in repetitive behaviours 
between Eef1a2+/+ and Eef1a2+/- mice in this test. 
 
To summarise, Eef1a2+/- mice showed a significant decrease in repetitive behaviours 
compared with wild-type mice in the nest building and marble burying assays but not 
in the digging or hole-board tests. These results are in contrast to those for the wasted 
line for which there were no differences between genotypes. 
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Figure 4.15. Data from Eef1a2+/+ and Eef1a2+/- mice in the hole-board test. Error bars 
for all graphs show SEM. A. An image of the apparatus. B. Latency to first head dip. There 
was no significant difference between genotypes (unpaired t-test). C. Total number of head 
dips. There was no significant difference between genotypes (unpaired t-test). D. Total 
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4.2.2.4. Eef1a2+/- mice showed normal sociability and preference 
for social novelty 
Eef1a2+/+ and Eef1a2+/- mice were tested in the stranger mouse assay to investigate 
sociability and preference for social novelty as performed on the wasted line (Section 
4.2.1.3). Test 1 measured whether the test mouse preferred to spend time alone or 
with another mouse to assess sociability. The results of this test are shown in Figure 
4.16.  
 
Figure 4.16 shows the results for the time spent exploring the mouse vs the empty 
cage. Both Eef1a2+/+ and Eef1a2+/- mice spent significantly more time exploring the 
mouse than the empty cage, shown using a two-way ANOVA with Holm-Sidak’s 
multiple comparisons test. The total exploration time did not differ between 
genotypes, shown using an unpaired t-test (data not shown). These results suggest 
that Eef1a2+/- mice have normal sociability, in agreement with results from 
Eef1a2+/wst mice. However, other tests of social behaviour should be considered in 
the future. 
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Figure 4.16. Data from Eef1a2+/+ and Eef1a2+/- mice in the stranger mouse test stage 1. 
Time spent exploring the mouse vs the empty cage. Error bars for all graphs show SEM. 
Asterisks on the bar graph show statistically significant differences. Two-way ANOVA 
showed significant effect of stimulus (mouse vs cage): F = 192, DF = 1, 52, p = <0.0001. 
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Following this, I performed a second stranger mouse test to determine whether 
Eef1a2+/- mice showed preference for social novelty. This was carried out as 
described for the wasted line in Section 4.2.1.3. The results of this test are shown in 
Figure 4.17. 
 
Figure 4.17 shows the results for the time spent exploring the familiar mouse vs the 
novel mouse. Both Eef1a2+/+ and Eef1a2+/- mice spent significantly more time 
exploring the novel mouse compared with the familiar mouse, shown using a two-
way ANOVA with Holm-Sidak’s multiple comparisons test. The total exploration 
time did not differ between genotypes, shown using an unpaired t-test (data not 
shown). Therefore, Eef1a2+/- mice were phenotypically normal in this test and 
showed a preference for social novelty. Interestingly, this is in contrast to the 









Chapter 4: Investigating the effects of age and genetic  





Figure 4.17. Data from Eef1a2+/+ and Eef1a2+/- mice in the stranger mouse test stage 2. 
Time spent exploring the familiar mouse vs the novel mouse. Error bars for all graphs show 
SEM.  Asterisks on the bar graph show statistically significant differences. Two-way ANOVA 
showed significant effect of stimulus (familiar vs novel mouse): F = 21.51, DF = 1, 50, p = 
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4.2.2.5. Eef1a2+/- mice showed no hyperactivity or anxiety 
phenotypes in the open field test 
To detect locomotor and/or anxiety phenotypes in Eef1a2+/- mice, I performed the 
open field test. This was carried out using the same method described for the wasted 
line in Section 4.2.1.4. The results of this test are shown in Figure 4.18. 
 
The total distance travelled was measured to investigate locomotion (Figure 4.18A), 
whereas the total time spent freezing (Figure 4.18B) and time spent in each zone 
(Figure 4.18C) were measured to investigate anxiety. There were no significant 
differences in the total distance travelled (unpaired t-test), freezing time (unpaired t-
test) or time spent in each zone (two-way ANOVA) between genotypes. Therefore, 
Eef1a2+/- mice did not show any locomotor or anxiety phenotypes in this test. The 
same result was found when testing Eef1a2+/wst mice in that there were no significant 
differences between genotypes. However, locomotor activity decreased in Eef1a2+/wst 
mice with age. 
 
Eef1a2+/+ and Eef1a2+/- mice spent significantly more time in the outside zone 
compared with the centre zone (Figure 4.18C). Therefore, Eef1a2+/+ and Eef1a2+/- 
mice both preferred to spend time in the outside zone. The same result was observed 
in some but not all of the age groups for the wasted line. 
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Figure 4.18. Data from Eef1a2+/+ and Eef1a2+/- mice in the open field test. Error bars for 
all graphs show SEM. A. Total distance travelled. There was no significant difference 
between genotypes (unpaired t-test). B. Total time spent freezing. There was no significant 
difference between genotypes (unpaired t-test). C. Time spent in outside and centre zone. 
Asterisks on the bar graph show statistically significant differences. Two-way ANOVA 
showed significant effect of zone: F = 821.1, DF = 1, 54, p = <0.0001. Tukey’s multiple 
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4.2.2.6. Eef1a2+/- mice showed normal spatial memory in a short-ITI 
Y-maze test 
I tested Eef1a2+/+ and Eef1a2+/- mice in the Y-maze to assess spatial memory as 
performed on the wasted line (Section 4.2.1.5). The results of this test are shown in 
Figure 4.19. 
 
Figure 4.19 shows the data for arm exploration. Both Eef1a2+/+ and Eef1a2+/- mice 
spent significantly more time exploring the novel arm compared with the familiar 
arms indicating normal spatial memory in this particular test after a 15 minute ITI. 
This was shown using a two-way ANOVA with Tukey’s multiple comparisons test. 
Previously tested Eef1a2+/wst mice also showed normal spatial memory in this test. 
 
As mentioned, the implementation of this test with a longer ITI to further assess 
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Figure 4.19. Data from Eef1a2+/+ and Eef1a2+/- mice in the Y-maze test. The bar graph 
shows the mean time spent exploring the Y-maze arms. Familiar = mean of ‘start’ and 
‘other’ arm. Error bars for all graphs show SEM. Asterisks on the bar graph show 
statistically significant differences. Two-way ANOVA showed significant effect of arm 
(familiar vs novel): F = 57.53, DF = 1, 28, p = <0.0001. Tukey’s multiple comparisons test: 
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4.2.2.7. Requirement for optimisation of the novel object 
recognition test 
Mice with mutations in genes related to autism and intellectual disability have been 
identified as having impairments in object recognition tasks, including Fmr1 
knockout mice, Shank3 mutant mice and Shank1 knockout mice (Bhattacharya et al., 
2012, Yang et al., 2012, Kazdoba et al., 2014, Sungur et al., 2017). Therefore, I 
performed the novel object recognition test to assess whether Eef1a2+/- mice show an 
impairment in recognition memory. 
 
The novel object recognition test takes advantage of the innate behaviour of mice to 
show a preference for novelty and, specifically, explore new objects. In the first 
phase, the mouse is presented with two identical objects and allowed to explore these 
for a defined period of time. The mouse is then moved to a holding cage for a set 
period of time, referred to as the inter-trial interval (ITI). Following this, the second 
phase begins in which the mouse is allowed to explore one of the objects from phase 
one and a completely new, or novel, object. Wild-type mice are expected to show a 
preference to explore the novel object compared with the familiar object. Mice with 
recognition memory impairments will show no preference for either object (Grayson 
et al., 2015). 
 
I tested Del22.ex3 mice with a short 5 minute ITI. Figure 4.20A shows an image of 
the apparatus, which was the same Y-shaped maze used in the stranger mouse tests 
and in the Y-maze test. Figure 4.20B shows the results presented as the mean 
discrimination ratio (DR) for each genotype (see Section 2.8.4 for discrimination 
ratio calculation). A score of 1 indicates 100% preference for the novel object, a 
score of -1 indicates 100% preference for familiar object and a score of 0 indicates 
no preference for either object. There was no significant difference in DR between 
genotypes (unpaired t-test). However, as a DR of greater than 0 indicates preference 
for the novel object, the preference of both Eef1a2+/+ and Eef1a2+/- mice was low 
(mean = 0.16 and 0.14 respectively). Discrimination ratios for this test are normally 
approximately 0.5-0.6 for wild-type mice (Lise et al., 2012, Mazumder et al., 2016). 
Chapter 4: Investigating the effects of age and genetic  
background on the behaviour of heterozygous Eef1a2-null mice 
	
134 
The dot plot shows that the majority of the mice for each genotype did prefer to 
investigate the novel object, indicated by scores greater than 1. 
 
I then analysed the first minute only to investigate object exploration during the time 
when exploration is highest. The results are presented in Figure 4.20C as the mean 
exploration time for each object rather than DR. Interestingly, wild-type mice spent 
significantly more time exploring the novel object compared with the familiar object 
whereas heterozygous mice did not (two-way ANOVA with Tukey’s multiple 
comparisons test). This might suggest that Eef1a2+/+ mice show learning in this test 
whilst Eef1a2+/- mice do not, however, the test should be optimised such that a DR of 
0.5-0.6 is achieved to further investigate this. When the full two-minute test was 
analysed in the same way, neither genotype showed a significant preference for the 
novel object (data not shown). There was also no significant difference between 
genotypes in the total exploration time (data not shown). Therefore, results were not 
confounded by lower overall exploration of either genotype. 
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Figure 4.20. Data from Eef1a2+/+ and Eef1a2+/- mice in the novel object recognition test. 
Error bars for all graphs show SEM. A. Image of apparatus used for novel object 
recognition. One arm was closed and the other two arms split in half using gates. The 
objects used were a bulb (right arm) and a Lego® figure (left arm). B. Discrimination 
ratios. There was no significant difference between genotypes (unpaired t-test). C. 
Exploration during first minute of test. The asterisk on the bar graph shows a statistically 
significant difference. Two-way ANOVA showed significant effect of object (familiar vs 
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4.2.2.8. No difference in body weight or grip strength between 
Eef1a2+/+ and Eef1a2+/- mice 
Following behavioural testing, Eef1a2+/+ and Eef1a2+/- mice were weighed and grip 
strength tested to establish whether there were any differences in muscle function 
between genotypes. Wasted homozygous mice show a significant reduction in 
weight compared to their wild-type littermates by P23 (Newbery et al., 2005) and 
perform significantly worse than their wild-type littermates in the grip strength test 
by P20. In contrast, wasted heterozygotes show no significant differences compared 
with wild-type mice in either of these measurements at all ages tested (Griffiths et 
al., 2012). It was therefore predicted that Del22.ex3 heterozygotes would also be 
phenotypically normal but it was important to analyse this directly on the 
experimental cohort under test. 
 
I measured weight and grip strength at 5 months of age. The grip strength test 
involved measurement of all four limbs and front limbs only, in triplicate. Grip 
strength measurements were normalised to body weight (Newtons/grams). The 
results of the weight and grip strength analyses are shown in Figure 4.21. There were 
no significant differences in weight or grip strength between genotypes. This 
indicates that Del22.ex3 heterozygotes gain weight normally and do not show any 
evidence of changes in muscle function compared with wild-type mice. This is in 
agreement with the phenotypes observed in wasted heterozygotes (Griffiths et al., 
2012). 
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Figure 4.21. Body weight and limb grip strength data from Eef1a2+/+ and Eef1a2+/- mice 
at 5 months. Error bars for all graphs show SEM. A. Body weight. There was no significant 
difference between genotypes (unpaired t-test). B. Front (fore) limb grip strength (Newtons) 
normalised to body weight (grams). There was no significant difference between genotypes 
(unpaired t-test). C. All four limb grip strength (Newtons) normalised to body weight 























































































































Grip strength of all four limbs
C
N = 8 N = 8
N = 8 N = 8
N = 8
N = 8
Chapter 4: Investigating the effects of age and genetic  
background on the behaviour of heterozygous Eef1a2-null mice 
	
138 
4.2.2.9. Variation lower in behavioural data from the Del22.ex3 line 
  compared with the wasted line 
To compare the level of variation in data from each test between the two lines, I 
calculated the coefficient of variation (CV). This is the ratio of the standard deviation 
to the mean and is commonly used to compare the variation in data from two 
separate experiments. The formula used to calculate the CV is shown in the legend of 
Table 4.1. The CV is expressed as a percentage and a higher CV indicates more 
variability in the data.  
 
Table 4.1 shows the CV values for the Del22.ex3 line and the wasted line for each 
behavioural test. For the wasted line, the 2-6 month old cohort was used for analysis. 
CV values were calculated using the data from wild-type mice and therefore show 
the resulting variation from testing mice on a mixed genetic background vs a pure 
C57BL/6 genetic background. The lower CV values are shown in Table 4.1 in green 
and it can be seen that the CV is lower for the Del22.ex3 line in all tests apart from 
the digging assay. The variation in the data for the number of digging bouts and the 
total duration of digging is higher in the Del22.ex3 line than in the wasted line. 
 
The evidence presented in Table 4.1 suggests that the variation in the Del22.ex3 line 
is generally lower than the variation in the wasted line and this is likely due to the 
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 Del22.ex3 line Wasted line 
Nest building (% 
shredded) 
26% 47% 
Marble burying 23% 29% 
Y-maze 20% 34% 
Stranger mouse test 1 15% 33% 
Stranger mouse test 2 25% 31% 
Latency to start digging 41% 65% 
Number of digging bouts 76% 36% 
Total digging duration 121% 55% 
Total distance travelled 
in open field 
24% 63% 
Total time spent freezing 
in open field 
77% 117% 
Time spent in centre of 
open field 
47% 99% 
Mean 45% 55% 
 
Table 4.1. Comparing variation in results from the wasted line and the Del22.ex3 line. 
The coefficient of variation for each behavioural test on each mouse line is shown. CV = 
(SD/mean)*100. Values highlighted in green indicate the line which showed the lowest 
variation for a given test. The mean CV for each line is given in the final row. There was no 
significant difference in the mean CV between genotypes (unpaired t-test, t = 0.78, DF = 20, 
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The aims of this chapter were as follows: 
1) To characterise the behavioural phenotype of heterozygous wasted mice and to 
determine whether phenotype is affected by age. 
2) To determine, through protein expression analysis, whether any age-specific effect 
on behaviour found through aim 1 is accompanied by a dosage of eEF1A2 lower 
than 50%. 
3) To characterise the behavioural phenotype of heterozygous mice from a new 
Eef1a2-null mouse line (Del22.ex3) which, in contrast to the mixed background of 
wasted mice, is on an inbred C57BL/6J genetic background. 
 
I performed seven behavioural tests on Eef1a2+/+ and Eef1a2+/wst mice which 
assayed repetitive behaviours, sociability, preference for novelty, locomotor activity 
and anxiety. In terms of aging, I studied mice up to the age of 18 months and found 
age-specific changes in behaviour in the marble burying and open field tests.  
 
There were no changes in the repetitive behaviours of Eef1a2+/wst mice compared 
with Eef1a2+/+ mice in any of the three assays used (nest building, marble burying 
and digging). However, in the marble burying test, Eef1a2+/wst mice buried 
significantly fewer marbles as they aged. Similarly, Eef1a2+/wst mice also travelled a 
significantly shorter distance and spent more time freezing in the open field test as 
they aged, despite a lack of significant differences in this test between genotypes. In 
the marble burying and open field tests, there was no change in the behaviour of 
Eef1a2+/+ mice with age, this effect was specific to Eef1a2+/wst mice. The reduction 
in marble burying behaviour and locomotor activity observed here in aging 
Eef1a2+/wst mice may be suggestive of a motor impairment despite the fact that 
Eef1a2+/wst mice show no motor coordination impairments in the rotarod test at 21 
months of age (Griffiths et al., 2012). It is possible that motor coordination may be 
intact while general locomotor activity is impaired. In addition, the rotarod test 
forces activity whereas the open field test allows activity to be optional. Therefore, 
certain motor impairments which are detectable in the open field test may be 
undetectable in the rotarod test. Furthermore, pain has never been studied in this 
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mouse line. It is possible that Eef1a2+/wst mice may have reduced motivation for 
movement due to unidentified muscular pain, however, this is unlikely as pain 
models have been shown to be impaired in the rotarod test (Ruan et al., 2013). 
Another possibility is that Eef1a2+/wst mice have a reduced motivation for activity as 
they age generally and this may be further tested using an in-cage running wheel 
which would allow measurement of voluntary activity (Brooks and Dunnett, 2009). 
In addition, patients with EEF1A2 mutations present with motor abnormalities (see 
Table 1.2). 
 
It is curious that Eef1a2+/wst mice do not show reduced nestlet shredding or digging 
behaviour in the digging test with age, as an age-specific motor impairment or 
motivation change might be expected to reduce these behaviours too. Digging 
behaviour does appear to decline with age in Eef1a2+/wst mice but this was not 
statistically significant. It is also possible that, rather than the impairments discussed 
above, Eef1a2+/wst mice simply show a reduction in repetitive digging behaviour with 
age. However, if this was the case, a significant reduction should have been observed 
in the digging assay as well as the marble burying assay.  
 
The observation that aging Eef1a2+/wst mice showed reduced locomotor activity and 
increased freezing time in the open field test makes it somewhat difficult to 
disentangle the results. Specifically, this could be due to a motor impairment or 
reduced motivation as discussed above or it could be due to anxiety. For example, 
apparent increased freezing could simply represent reduced locomotor activity due to 
a motor impairment. Or reduced locomotor activity could simply represent increased 
freezing due to anxiety. No anxiety phenotype was observed when comparing the 
time spent in the outside of the open field box vs the centre and the ‘n’ for the 12-18-
month group was low resulting in highly variable data and difficulty in drawing 
conclusions. Further studies of anxiety would be beneficial, such as the elevated plus 
maze which measures the preference of mice to spend time in open vs closed arms, 
with more time in the closed arms indicating higher anxiety (Moy et al., 2007). 
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In the stranger mouse test, Eef1a2+/wst mice showed normal sociability but reduced 
preference for social novelty. This was apparent at all ages tested and therefore was 
not an age-specific impairment. Many mouse models with mutations in autism 
related genes show impairments in both sociability and social novelty (Won et al., 
2012, Reith et al., 2013), however, impairments in social novelty only have also been 
observed (Wagnon et al., 2015). This reveals that an autism-like phenotype in 
Eef1a2+/wst mice in that they prefer not to spend time with mice with which they are 
unfamiliar. No specific social impairments have been reported in patients with 
EEF1A2 mutations, largely due to the fact that most of the patients are non-verbal 
(Table 1.2). However, this would be an interesting avenue for future investigation 
upon identification of any new milder cases, if possible. 
 
Ideally, a larger number of mice would have been used for each behavioural test on 
the wasted line given the results of the power calculations. However, time limitations 
and the desire to move on to testing the Del22.ex3 line meant that this was not 
achieved. In addition, it would have been difficult and time consuming to breed a 
large cohort of mice at 12-18 months for the aging study; unfortunately, for some 
tests, there were only 5 mice available per genotype. It was decided that it would be 
more beneficial to move on to the new line due to the possibility of lower variation 
and more robust behavioural results. This was a positive decision as the result of 
comparing the coefficients of variation between the mouse lines showed that the 
variation was generally lower in the Del22.ex3 line than in the wasted line. 
 
The second aim of this chapter was to determine whether the age-specific effects on 
behaviour, namely in the marble burying and open field tests, were due to a lower 
dosage of eEF1A2 in the brains of aging mice. However, I was unable to achieve this 
aim due to variable Western blot results which was likely due to the use of small 
amounts of tissue in combination with the Licor detection method. In hindsight, 
whole brain may have been a better choice for analysis. However, previous work has 
shown that eEF1A2 expression levels in heterozygous mice are significantly lower 
than wild-type levels for all age groups that were tested in this study (Griffiths et al., 
2012). 
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There was a high level of variation in behavioural data from the wasted line which 
seemed to be due to the mixed genetic background. To overcome this, I bred a new 
Eef1a2-null mouse line on a C57BL/6J genetic background. My third aim was to 
characterise the behavioural phenotype of this line and compare this to the behaviour 
of mice from the wasted line to determine whether genetic background had any 
influence on the results. Ideally, I would have also analysed the effects of age on 
behaviour, however, there was insufficient time to age mice. Therefore, mice were 
tested at 2-5 months and provided a direct comparison for the cohort of heterozygous 
wasted mice that were tested at 2-6 months. 
 
In the repetitive behaviour analysis, I found that Eef1a2+/- mice showed a significant 
reduction in repetitive behaviours compared with wild-type mice in the nest building 
and marble burying assays. This reduction was not observed in the digging or hole-
board tests. However, the number of digging bouts and the total time spent digging 
were very low for both genotypes which would make it incredibly difficult to 
observe any significant differences. Unlike with the wasted line, the reduction in 
these behaviours cannot be linked to decreased locomotion as there was no 
significant difference between genotypes in the total distance travelled in the open 
field test. Commonly, mouse models with mutations in autism-related genes show an 
increase in repetitive behaviours compared with wild-type mice (Peñagarikano et al., 
2011, Reith et al., 2013, Kazdoba et al., 2014, Kazdoba, Leach and Crawley, 2016). 
However, in some models, a reduction in repetitive behaviours has been observed. 
For example, mice with deletion of Pten have shown a significant reduction in the 
number of marbles buried and number of head dips in the hole-board test compared 
with wild-type mice (Lugo et al., 2014). However, this is the opposite phenotype 
from that which is observed in patients with EEF1A2 mutations who show an 
increased repetition of behaviours such as hand twisting and finger sucking 
(Nakajima et al., 2014). Therefore, the implications of this change in repetitive 
behaviours of Eef1a2+/- mice are unclear. 
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There were no other behavioural changes in Eef1a2+/- mice compared with Eef1a2+/+ 
mice. The novel object recognition test was attempted to investigate recognition 
memory, however, this was largely unsuccessful due to the observation that wild-
type mice showed a very low preference for the novel object. This made it difficult to 
conclude any differences between genotypes. One possible reason for this may be 
that the objects selected were not particularly interesting to the mice. Therefore, 
using the same ITI with more carefully selected objects may be beneficial. Ideas for 
objects were given by a paper published in Nature whereby a Lego® tower and a 
flask filled with sand were used (Leger et al., 2013). However, similar objects did 
not work well in my study. Alternatively, choosing to perform this test in the Y-maze 
may have affected object exploration as mice are required to make two decisions: the 
first regarding which arm to enter and the second regarding whether or not to explore 
the object. A further attempt at this test with different objects performed in the open 
field box rather than the Y-maze is described in Chapter 5. The open field box was 
chosen as this apparatus is commonly used to perform the novel object recognition 
test (Antunes and Biala., 2012, Leger et al., 2013). 
 
An important part of this chapter involved comparing behaviour results between the 
wasted line and the Del22.ex3 line. The behaviour results for both lines are 
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Reduced locomotion Y N 
Hyperactivity N N 
Anxiety Y? N 




Spatial memory N N 
 
Table 4.2. Comparison of behaviour results from both mouse lines. Y = heterozygous 
mice showed a behavioural change. N = heterozygous mice did not show a behavioural 
change. The wasted line was on a mixed genetic background comprised predominantly of 
C57BL/6J, C3H/HeH and HRS/J whereas the Del22.ex3 line was on a pure C57BL/6J 
genetic background. 
 
There were several differences in the results from the behavioural tests between the 
two mouse lines. Firstly, Eef1a2+/- mice from the Del22.ex3 line showed a 
significant reduction in repetitive behaviours compared with Eef1a2+/+ mice, 
whereas this difference was not observed in the wasted line. Secondly, Eef1a2+/wst 
mice showed reduced locomotion and increased freezing time in the open field test 
with age. This effect may have also been observed in the Del22.ex3 line had there 
been sufficient time to investigate aging. Therefore, this cannot be considered a 
difference between lines as mice above the age of 5 months were not tested for the 
Del22.ex3 line. As mentioned, it is unclear whether these result in the open field test 
for Eef1a2+/wst mice indicated a locomotor/motivation deficit or anxiety. Therefore, 
both of these are declared in Table 4.2.  
 
Interestingly, Eef1a2+/wst mice showed a lack of preference for social novelty 
whereas Eef1a2+/- mice showed normal preference for social novelty. This behaviour 
difference between the two lines may have been due to the change in genetic 
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background, however, other reasons are also possible. For example, the mice that 
were used as stranger mice for the wasted line came from the same lineage. 
Therefore, it may have been more difficult for the test mice to distinguish between 
the familiar mouse and the novel mouse. Following testing of the wasted line, I 
became aware that that this test is generally carried out with stranger mice that are 
unrelated to one another (Emma Wood, personal communication). Therefore, I used 
unrelated stranger mice to test the Del22.ex3 line. In summary, the difference in the 
results of this test between the two lines may be due to the change in protocol, rather 
than the change in genetic background. 
 
However, as mentioned, there was also a difference in repetitive behaviour results 
between the lines. Therefore, it is likely that the genetic background is having an 
influence on behaviour. This is certainly not uncommon as genetic background has 
been shown to have an effect on behaviour in many different studies. In a 
comparison between C57BL/6J and 129/SvJ mice, the 129/SvJ strain were shown to 
be more anxious in the open field test and the elevated plus maze (Homanics, 
Quinlan and Firestone, 1998). Different sub-strains can also show differences in 
behaviour. C57BL/6J, C57BL/6N and C57BL/6C mice have shown significant 
differences in several behavioural tests including the open field test, elevated plus 
maze and a radial arm maze which was used to assess spatial working memory. The 
differences observed in the open field test included differences in the total distance 
travelled and the time spent in the centre indicating variation in both locomotor 
activity and anxiety (Matsuo et al., 2010). The behaviour of Fmr1 knockout mice has 
also been shown to be affected by genetic background. In a study comparing Fmr1 
knockout mice on a FVB and C57BL/6 genetic background, KO mice on the BL/6 
background showed more aggression in a direct social interaction task. KO mice on 
the FVB background showed higher locomotor activity, whereas, KO mice on the 
BL/6 background spent more time engaging in repetitive grooming behaviour 
(Pietropaolo et al., 2011). In another study comparing Fmr1 KO mice on six genetic 
backgrounds, strain-specific differences were observed in several behaviours 
including open field locomotion and anxiety, repetitive digging behaviour and social 
novelty preference. The types of social behaviours displayed in a direct social 
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interaction test also differed between strains (Spencer et al., 2011). Other genetic 
mouse models have also shown variation in behaviour on different genetic 
backgrounds. One such study compared the anxiety-related behaviours of serotonin 
transporter (5-HTT) null mice bred on a C57BL/6 or a 129S6 genetic background. In 
the light/dark exploration and elevated plus-maze tests, they found that only KO 
mice on the BL/6 background showed increased anxiety and reduced locomotor 
activity (Holmes et al., 2003). Therefore, it is entirely possible that the behavioural 
differences I observed between the wasted line and the Del22.ex3 line could be 
explained by the difference in genetic background. 
 
Female mice were excluded from behavioural testing due to potential variability in 
results caused by different phases of the oestrus cycle. Previous studies have shown 
that the behavioural performance of female mice differs significantly across different 
phases of the oestrus cycle (Meziane et al., 2007, Kästner et al., 2017). Meziane et al 
(2007) showed that this varies between different background strains, with the 
performance of BALB/cByJ mice showing oestrus-stage dependent variation in more 
behavioural tests than C57BL/6J mice. Despite this, it may have been worthwhile to 
test females in my behavioural assays and compare performance with males. If there 
had been no difference in performance, scores may have been combined and this 
would have provided an effective means by which to increase the number of mice 
tested. It is worth considering testing females in the future as EEF1A2 mutations 
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The aim of this chapter was to determine the effects of aging on the behaviour of 
heterozygous Eef1a2-null mice and to determine how behaviour changes with 
genetic background. I managed to identify age-related behavioural changes in two of 
my behavioural tests, however, perhaps it would have been beneficial to test a larger 
number of mice. Despite this, moving on to test the Del22.ex3 line was a wise 
decision as I obtained more robust behavioural results due to the lower variation in 
data from this line. The behavioural results from the two lines did differ which 
implies that the change in genetic background had an influence. The evidence 
presented here suggests that heterozygous Eef1a2-null mice display social 
impairments and changes in repetitive behaviours as seen in other autism models. 
These mouse models provide a valuable tool to study the effects of loss of protein 
function, however, future research would benefit from a mouse model with one of 
the human missense mutations. This is explored in Chapter 5. 
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Chapter 5: Behavioural characterisation of mice with the  
  D252H Eef1a2 mutation 
 
5.1. Introduction 
5.1.1. The D252H mutation 
Two patients have been identified so far with a mutation in EEF1A2 that changes 
aspartic acid to histidine at position 252 on the protein (D252H). This mutation is in 
exon 5 of the gene. Based on the clinical evidence available so far, these patients 
both present with global developmental delay and microcephaly. One of these is a 
12-year old female who has generalised tonic-clonic seizures that started at 8 years 
old, hypotonia, autism, characteristic facial features and atrophy of the cerebrum. In 
addition, she is unable to walk and is non-verbal (Nakajima et al., 2014). There is no 
further information available regarding the other case, who is also female and was 
identified through the DDD study. This is all described in Section 1.3.2 and in Table 
1.2. 
 
5.1.2. Generation of the D252H mouse line 
Generating a mouse line with one of the eEF1A2 missense mutations would provide 
invaluable insight into the underlying disease mechanisms. This mouse line would 
greatly benefit research into whether these mutations lead to loss or gain of protein 
function. 
 
Following the previously unsuccessful attempt to generate a mouse line with the 
G70S mutation (Chapter 3), another CRISPR/Cas9 experiment was undertaken to 
generate a mouse line with the D252H mutation. This mutation was chosen because 
there is more than one human case and the position of the mutation allowed efficient 
design of repair templates, being far away from exon/intron boundaries. In addition, 
the D252H mutation causes autism and global developmental delay, making this a 
relevant and interesting mutation for the study of behaviour. 
 
The reasons for the selection of the CRISPR/Cas9 method to introduce the mutation 
are described in Section 3.1.2. The gRNAs and repair templates were designed and 
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cloned into pSpCas9n(BB)-2A-puro plasmids by Faith Davies. RNA was transcribed 
by Hemant Bengani and microinjected into single-cell stage mouse embryos by staff 
at the Evans Transgenic Unit, University of Edinburgh. Unlike with the G70S 
experiment, I was not involved in the genotyping or monitoring of the mice once 
they had been born. This was performed by Faith Davies. 
 
5.1.3. Importance of comparing behaviour results between the D252H 
line and the null lines 
In Chapter 4, I studied the effects of loss of eEF1A2 function on mouse behaviour. 
However, it is essential to compare the results with an Eef1a2-missense model due to 
the possibility that human EEF1A2 mutations may lead to gain of protein function. 
Therefore, the behaviour of D252H heterozygous mice may provide a more accurate 
correlate for the intellectual disability and autistic phenotypes observed in humans. 
Nevertheless, it is interesting and informative to determine the ways in which 
behaviour changes with different Eef1a2 mutations in mice. This allows us to better 
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• To investigate the effects of the Eef1a2/D252H missense mutation on 
mouse behaviour 
1) To establish a new breeding line of mice with the D252H mutation. 
2) To characterise the behavioural phenotype of heterozygous Eef1a2/D252H mice 
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5.2.1. Establishing the line 
Two founders heterozygous for the D252H mutation were born from the 
CRISPR/Cas9 experiment (mouse #15 and #16, both male). The phenotypes of these 
two mice were apparently normal at a gross observational level. I bred both of these 
mice separately with C57BL/6J female mice to establish two new breeding lines. As 
the D252H change is a point mutation, genotyping solely by PCR was not an option. 
Therefore, exon 5 of Eef1a2 was amplified by PCR and products were digested using 
the restriction enzyme Hin1II. The D252H allele had one more Hin1II restriction 
site, therefore, the presence of a D252H allele resulted in a different cut pattern from 
wild-type upon digest. A genotyping example, which also shows the cut pattern for 
homozygous mice, is shown in Figure 5.1A. Digest of the wild-type allele produced 
bands of 300bp and 112bp. Digest of the D252H allele produced bands of 202bp, 
128bp and 112bp. 
 
Wild-type and heterozygous mice from the first litter from each founder mating were 
weighed between P20 and P31. The results of this are shown in Figure 5.1B. Wild-
type mice are shown in blue and heterozygous D252H mice are shown in orange. 
The weights of both litters were comparable and therefore they have been plotted 
together. Due to the low number of mice for the Eef1a2D252H/+ group, statistical 
analysis could not be performed. However, it is clear that Eef1a2D252H/+ mice gained 
weight between P19 and P30 and this weight gain appeared to be comparable to 
Eef1a2+/+ mice. These results are in contrast to the weight analyses described later in 
this chapter, likely due to the small number of mice tested here. 
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Figure 5.1. Establishing the new Eef1a2/D252H mouse line. A. PCR products digested 
with Hin1II restriction enzyme and ran on a 2% agarose gel with 100bp DNA ladder (NEB) 




5.2.2. The D252H behaviour cohort 
The offspring from the two founder breeding pairs along with the offspring from two 
other wild-type x heterozygote breeding pairs were used for behavioural testing. 
Therefore, the genotypes used for behavioural testing were Eef1a2+/+ and 
Eef1a2+/D252H. Mice were housed in male only cages of mixed genotypes. All 
animals were housed in groups to avoid any confounding effects of single housing on 
behaviour. Female mice were excluded from testing due to the potential for results to 
vary across different phases of the oestrus cycle. Mice were tested in behavioural 
assays from 9 weeks (2 months) of age. The age of the mice tested ranged from 2-4 
months. Consistent with Chapter 4, data are presented as mean values in the bar 
graphs and as individual scores for each mouse in the dot plots. The bar graphs allow 
the means to be observed and compared with ease whilst the dot plots show the 
spread of data and therefore the variability in scores within genotypes. The 
background information for each behavioural test has been described in Chapter 4 
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stated. Testing was performed with assistance from Charlie Cumber (Honours 
project student). 
 
5.2.3. Eef1a2+/D252H mice showed no evidence of changes in repetitive 
behaviours compared with Eef1a2+/+ mice 
I tested mice in the nest building assay to detect differences in repetitive behaviours 
between genotypes. The results are shown in Figure 5.2. There was no statistically 
significant difference in the percentage of nestlet shredded (Figure 5.2A) or in nest 
building score (Figure 5.2B) between genotypes, shown using an unpaired t-test for 
the percentage and a Mann-Whitney test for the score. Therefore, Eef1a2+/D252H mice 
showed no changes in repetitive behaviour in this test. 
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Figure 5.2. Data from Eef1a2+/+ and Eef1a2D252H/+ mice in the nest building assay. Error 
bars for all graphs show SEM. A. Percentage of nestlet shredded. There was no significant 
difference between genotypes (unpaired t-test). B. Nest score. The scoring criteria used is 
shown in the images labelled 1-5 (Deacon, 2006a). There was no significant difference 
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To further investigate the effects of the D252H mutation on repetitive behaviours, I 
assessed the performance of mice in the marble burying assay. The results are shown 
in Figure 5.3. There was no significant difference in the number of marbles buried 
between genotypes (unpaired t-test). Although it initially appeared that heterozygous 
mice buried more marbles, the difference was not statistically significant and the dot 
plot shows that the data for each genotype was quite variable. Therefore, 





Figure 5.3. Data from Eef1a2+/+ and Eef1a2D252H/+ mice in the marble burying assay. The 
graphs show the number of marbles buried for each genotype. Error bars for all graphs 
show SEM. There was no significant difference between genotypes (unpaired t-test). 
 
 
Following the marble burying test, I performed the digging assay to assess repetitive 
digging behaviour in Eef1a2+/D252H mice further. The results are shown in Figure 5.4. 
Statistical analysis using unpaired t-tests showed that there were no significant 
differences in the latency to start digging (Figure 5.4A), the number of digging bouts 
(Figure 5.4B) or the total digging duration (Figure 5.4C) between genotypes. 
Therefore, Eef1a2+/D252H mice showed no alterations in repetitive digging behaviour. 
 
Both genotypes engaged in very low levels of digging, shown by the high latency to 
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addition, the dot plots show that the data for each genotype for all three parameters 




Figure 5.4. Data from Eef1a2+/+ and Eef1a2D252H/+ mice in the digging assay. Error bars 
for all graphs show SEM. A. Latency to start digging. There was no significant difference 
between genotypes (unpaired t-test). B. Number of digging bouts. There was no significant 
difference between genotypes (unpaired t-test). C. Total duration of digging. There was no 
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As a final test to assess changes in repetitive behaviours, I performed the hole-board 
test. The results are shown in Figure 5.5. There were no significant differences in the 
latency to the first head dip (Figure 5.5A), the total number of head dips (Figure 
5.5B) or the total number of holes explored (Figure 5.5C) between genotypes. These 
were determined using unpaired t-tests. The dot plots show that there was a large 
spread of data for each genotype for all three parameters, although for the total 
number of head dips the spread of the wild-type data was lower than that for D252H. 
 
Taken together, the results from these four tests suggest that there are no differences 
in repetitive behaviours between Eef1a2+/+ and Eef1a2+/D252H mice. 
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Figure 5.5. Data from Eef1a2+/+ and Eef1a2D252H/+ mice in the hole-board test. Error bars 
for all graphs show SEM. A. Latency to first head dip. There was no significant difference 
between genotypes (unpaired t-test). B. Total number of head dips. There was no significant 
difference between genotypes (unpaired t-test). C. Total number of holes explored. There 
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5.2.4. Eef1a2+/D252H mice showed normal sociability and preference for 
social novelty 
I performed the stranger mouse social behaviour test to assess sociability and 
preference for social novelty in Eef1a2+/D252H mice. The results of test 1, which was 
used to assess sociability, are presented in Figure 5.6. As with the Del22.ex3 line 
(Chapter 4), the stranger mice used were unrelated to one another. 
 
Data are presented as the time spent exploring the mouse vs the empty cage. Both 
genotypes spent a significantly larger amount of time exploring the mouse compared 
with the empty cage, indicating normal sociability. This was shown by a two-way 
ANOVA with Holm-Sidak’s multiple comparisons test. There was no significant 
difference in the total exploration time between genotypes, shown using an unpaired 
t-test (data not shown). 
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Figure 5.6. Data from Eef1a2+/+ and Eef1a2+/D252H mice in the stranger mouse test stage 
1. Error bars for all graphs show SEM. Time spent exploring the mouse vs the empty cage. 
Asterisks on the bar graph show statistically significant differences. Two-way ANOVA 
showed significant effect of stimulus (mouse vs cage): F = 116.6, DF = 1, 38, p = <0.0001. 
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I tested Eef1a2+/+ and Eef1a2+/D252H mice in part 2 of the stranger mouse test to 
assess preference for social novelty. The results for the time spent exploring the 
novel vs familiar mouse are shown in Figure 5.7.  
 
Both genotypes spent a significantly larger amount of time exploring the novel 
mouse compared with the familiar mouse, as shown by a two-way ANOVA with 
Holm-Sidak’s multiple comparisons test. In addition, there was no significant 
difference in the total exploration time between genotypes, shown using an unpaired 
t-test (data not shown). Therefore, Eef1a2+/D252H mice appear to show normal 
preference for social novelty.  
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Figure 5.7. Data from Eef1a2+/+ and Eef1a2+D252H- mice in the stranger mouse test stage 
2. Error bars for all graphs show SEM. Time spent exploring the familiar mouse vs the novel 
mouse. Asterisks on the bar graph show statistically significant differences. Two-way 
ANOVA showed significant effect of stimulus (familiar vs novel mouse): F = 33.66, DF = 1, 
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5.2.5. Eef1a2+/D252H mice showed no hyperactivity or anxiety phenotypes 
in the open field test 
I assessed the performance of Eef1a2+/+ and Eef1a2+/D252H mice in the open field test 
to investigate locomotor activity and anxiety. The results are shown in Figure 5.8. 
There were no significant differences in the total distance travelled (Figure 5.8A), the 
total time spent freezing (Figure 5.8B) or the time spent in each zone (Figure 5.8C) 
between genotypes. This was shown using unpaired t-tests for total distance travelled 
and freezing time and a two-way ANOVA with Tukey’s multiple comparisons test 
for the time spent in each zone. These results indicate that Eef1a2+/D252H mice do not 
show any locomotor or anxiety phenotypes in the open field test. The scores for the 
total time spent freezing for wild-type mice were quite variable in that two of the 
mice spent a much higher length of time freezing (25-30s) than the rest of the mice. 
This resulted in a large SEM error bar on the bar graph and a large difference in 
mean scores between genotypes, although not significant (+/+ = 9.4, +/D252H = 
5.2). 
 
Both genotypes spent a significantly larger amount of time exploring the outside of 
the arena compared with the centre (two-way ANOVA with Tukey’s multiple 
comparisons test). Therefore, both Eef1a2+/+ and Eef1a2+/D252H mice preferred to 
spend time in the outside zone. 
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Figure 5.8. Data from Eef1a2+/+ and Eef1a2+/D252H mice in the open field test. Error bars 
for all graphs show SEM. A. Total distance travelled. There was no significant difference 
between genotypes (unpaired t-test). B. Total time spent freezing. There was no significant 
difference between genotypes (unpaired t-test). C. Time spent in outside and centre zone. 
Asterisks on the bar graph show statistically significant differences. Two-way ANOVA 
showed significant effect of zone: F = 311.4, DF = 1, 38, p = <0.0001. Tukey’s multiple 
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5.2.6. Eef1a2+/D252H mice showed normal spatial memory in the Y-maze 
I tested Eef1a2+/+ and Eef1a2+/D252H mice in the Y-maze to test spatial memory, a 
form of memory which is dependent on the hippocampus. Initial testing was 
performed by following the 15-minute ITI protocol described in Chapter 4. 
Following this, a different cohort of mice was tested with a longer ITI to assess 
whether memory for the novel arm was intact after a longer delay. The protocol for 
this second test was exactly the same except that an ITI of 120 minutes was used. 
Spatial memory was considered normal when mice were able to remember the 
familiar arms, indicated by higher exploration of the novel arm. The results of both 
tests are shown in Figure 5.9. 
 
Figure 5.9A shows the results for the 15-minute ITI test. Both genotypes spent 
significantly more time exploring the novel arm compared with the familiar arms, 
shown using a two-way ANOVA with Tukey’s multiple comparisons test. This 
indicates that both Eef1a2+/+ and Eef1a2+/D252H mice show a preference for novelty 
and normal spatial memory after a short ITI in the Y-maze. 
 
Figure 5.9B shows the results for the 120 minute ITI test. Again, both genotypes 
spent significantly more time exploring the novel arm compared with the familiar 
arms, shown using a two-way ANOVA with Tukey’s multiple comparisons test. This 
suggests that Eef1a2+/D252H mice also have normal spatial memory after a long ITI, 
however, other tests of spatial memory should be considered. This is examined in the 
discussion. 
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Figure 5.9. Data from Eef1a2+/+ and Eef1a2+/D252H mice in the Y-maze test. Error bars for 
all graphs show SEM. Familiar = mean of ‘start’ and ‘other’ arm. A. 15 minute ITI.. Data 
presented as mean time spent exploring Y-maze arms in the bar graph. Asterisks on the bar 
graph show statistically significant differences. Two-way ANOVA showed significant effect 
of arm (familiar vs novel): F = 66.98, DF = 1,40, p = <0.0001. Tukey’s multiple 
comparisons test: from left to right p = <0.0001, 0.0008. B. 120 minute ITI. Data presented 
as mean time spent exploring Y-maze arms in the bar graph. Asterisks on the bar graph 
show statistically significant differences. Two-way ANOVA showed significant effect of arm 
(familiar vs novel): F = 23.47, DF = 1, 32, p = <0.0001. Tukey’s multiple comparisons test: 
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5.2.7. Optimisation of the novel object recognition test was 
unsuccessful 
Following the results of the novel object recognition tests described in Chapter 4 
(Section 4.2.2.7) there was a requirement for optimisation. I repeated the test with 
new sets of objects in the open field box rather than in the Y-maze. The open field 
box was chosen to perform the novel object recognition test as this apparatus is 
commonly used for this assay (Antunes and Biala, 2012, Leger et al., 2013). The use 
of this apparatus removed the requirement for mice to select both an arm and an 
object to explore and ensured that both objects were visible to the mice at all times. 
 
The first attempt at this test involved habituating the mice to the empty open field 
box for 5 minutes on the 2 days preceding the test. This was followed by a sample 
phase lasting 5 minutes, a 5-minute ITI and a choice phase lasting 2 minutes. 
However, the total exploration time for each mouse was very low and the mice were 
deemed to be very anxious due to the high level of freezing behaviour (data not 
shown). It was suspected that mice may have been anxious due to the habituation 
being too short, therefore, the test was repeated with a longer habituation. Mice were 
habituated to the empty open field box for two 5 minute sessions on the 3 days 
preceding the test as performed by Leger et al., 2013. The results are shown in 
Figure 5.10A. Coloured pet toys were used as objects as performed by (Deshmukh 
and Knierim, 2011). The exploration of the familiar object and novel object and the 
total exploration time in the choice phase is shown for each mouse. The highest total 
exploration time was 16 seconds which is very low despite the longer habituation. 
Due to this, it was suspected that the 2-minute choice phase may have been too short. 
Therefore, the test was repeated with a 5-minute choice phase (Figure 5.10B). A 
tower and a rocket made from Lego® were used as objects. There was a large 
improvement in the choice phase exploration time, with a mean of 66 seconds for 
wild-type and 73 seconds for +/D252H. However, wild-type mice did not show a 
preference for the novel object, shown by a mean DR below 0. The sample phase 
exploration time was then analysed to ensure that this was sufficient to allow mice to 
recognise the novel object. The exploration in the sample phase was low, with a 
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mean of 48 for wild-type and 33 for +/D252H. Therefore, the ability of the mice to 
recognise a new object was likely impaired by inadequate learning in the sample 
phase. In the next attempt, the test was repeated in exactly the same way as in Figure 
5.10B but with different objects (Figure 5.10C). In this attempt, Disney® figurines 
were used as objects. Again, the choice phase exploration time was higher than that 
of the 2-minute trial (A), with a mean of 37 seconds for wild-type and 48 seconds for 
+/D252H. However, this was lower than that of the previous trial (B). The 
exploration in the sample phase was also lower  than the previous trial with a mean 
of 19 for wild-type and 22 for +/D252H. Therefore, the objects appeared to be less 
interesting to the mice. Unfortunately, as with the previous trial, wild-type mice did 
not show a preference for the novel object as the mean discrimination ratio was again 
below 0. As with attempt B, this points towards insufficient learning in the sample 
phase as a possible explanation for lack of preference for the novel object. 
 
At this point, there was insufficient time to continue optimising this test. A summary 
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Familiar Novel Total Familiar Novel Total
4 12 16 6 1 7
9 5 14 8 8 16
4 6 10 3 3 6
4 6 10 2 4 6
4 8 12 6 6 12
12 4 16 5 4 9
2 7 9 3 7 10
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Figure 5.10. Steps taken to optimise the novel object recognition test in the open field 
box. Error bars for all graphs show SEM. A. Table showing the results of attempt 2. Each 
row represents scores from an individual mouse. Mice highlighted in red had a total 
exploration time of less than 10 seconds. N = 8 +/+, 9 +/D252H. B. Attempt 3. There was 
no significant difference in the DR, sample phase exploration time or choice phase 
exploration time between genotypes (unpaired t-tests). C. Attempt 4. There was no 
significant difference in the DR, sample phase exploration time or choice phase exploration 




ITI length Trial length Habituation length Problems
Attempt 1 (not 
shown)
5 minutes 2 minutes 1 x 5 min for 2 days No/little exploration, 
mice anxious
Attempt 2 (A) 5 minutes 2 minutes 2 x 5 min for 3 days Low exploration
Attempt 3 (B) 5 minutes 5 minutes 2 x 5 min for 3 days Wild-type show no 
preference for novel 
object
Attempt 4 (C) 5 minutes 5 minutes 2 x 5 min for 3 days Wild-type show no 
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5.2.8. Body weight of Eef1a2+/D252H mice significantly lower than that of 
Eef1a2+/+ mice 
Eef1a2+/D252H and Eef1a2+/+ mice were weighed and grip strength tested at 4 months 
of age. This was performed to determine whether Eef1a2+/D252H mice are able to gain 
weight normally and in order to assess muscle strength. This is important due to the 
fact that homozygous Eef1a2-null mice have a well studied skeletal muscle atrophy 
phenotype, characterised by weight loss and reduced performance in the grip strength 
test (Newbery et al., 2005, Griffiths et al., 2012). The effects of the heterozygous 
D252H mutation on skeletal muscle function are unknown, however, the skeletal 
muscle function of heterozygous null mice is completely normal (Griffiths et al., 
2012) (Section 4.2.2.8). Comparing weight profiles and skeletal muscle function 
between mouse lines will help us to determine whether the missense mutations result 
in loss or gain of protein function. 
 
The result of the weight analysis is shown in Figure 5.11A. The weight of 
Eef1a2+/D252H mice was significantly lower than that of Eef1a2+/+ mice, shown using 
an unpaired t-test. However, the difference in weight was very small, with a mean of 
29.9 for wild-type and 27.9 for heterozygote resulting in a difference of 2g. The 
results of the grip strength tests are shown in Figure 5.11B and C. These were 
performed as described for the Del22.ex3 line (Section 4.2.2.8). There were no 
significant differences in the grip strength of front limbs (B) or all four limbs (C) 
between genotypes (unpaired t-tests). Therefore, adult Eef1a2+/D252H mice have 
normal muscle strength but weigh less than wild-type mice. 
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Figure 5.11. Body weight and limb grip strength data from Eef1a2+/+ and Eef1a2+/D252H 
mice at 4 months. Error bars for all graphs show SEM.  A. Body weight. Asterisks on the 
bar graph show a statistically significant difference. Unpaired t-test: t = 3.91, DF = 35, p = 
0.0004. B. Front (fore) limb grip strength (Newtons) normalised to body weight (grams). 
There was no significant difference between genotypes (unpaired t-test). C. All four limb 
grip strength (Newtons) normalised to body weight (grams). There was no significant 
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5.2.9. Eef1a2D252H/D252H mice showed evidence suggestive of excessive 
grooming behaviour 
A repetitive behaviour which is commonly reported to be excessive in autism models 
is self-grooming (Silverman et al., 2010). Mice with mutations in genes including 
Cntnap2, Shank2/3 and Fmr1 have been shown to engage in high levels of grooming 
behaviour compared with wild-type mice (Pietropaolo et al., 2011, Peñagaricano et 
al., 2011, Kazdoba, Leach and Crawley, 2016). A common phenotype which is 
indicative of increased grooming in mice is the loss of fur.  
 
On collection of tissue from three homozygous D252H mice (Eef1a2D252H/D252H) for 
expression analysis at P24, I observed loss of fur on the neck. An example is shown 
in the image in Figure 5.12A with a wild-type mouse for comparison. Tissue was 
also collected from heterozygous D252H mice at 4 months of age post-behaviour. 
Images were taken of these mice as a comparison for the homozygotes. An example 
is shown in the image in Figure 5.12B with a wild-type mouse for comparison. There 
was no evidence of fur loss for Eef1a2+/D252H mice at 4 months of age. This data 
highlights the possibility that Eef1a2D252H/D252H mice may be engaging in excessive 
grooming behaviour, however, this must be assessed by observing and analysing 
various grooming parameters and comparing this with wild-type mice. In addition, it 
would be interesting to observe whether there is a difference in grooming behaviour 
between Eef1a2+/D252H and Eef1a2D252H/D252H mice as the images suggest that this is 
possible. 
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Figure 5.12. Images of mice from the D252H line showing evidence of fur loss. A. A 
homozygous mouse at P24 (left) and an age-matched wild-type mouse (right). B. A 
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5.2.10. Protein and RNA expression analysis showed that the 
D252H eEF1A2 protein is unstable 
As a mouse line with a D252H mutation in Eef1a2 has never before been made or 
characterised, it was unknown whether D252H eEF1A2 is expressed and how the 
expression levels compare to wild-type mice. It is important to determine whether 
D252H eEF1A2 protein is expressed to better understand whether the mutation leads 
to loss or gain of protein function. If the protein is not expressed, this indicates that 
the disease phenotype is as a result of loss of protein function. However, If the 
protein is expressed, both loss and gain of function remain possible. It was 
hypothesised that D252H eEF1A2 would be expressed at the protein level as this was 
found to be the case for G70S eEF1A2 (Section 3.2.5). It is important to determine 
the level of expression to assess the stability of the protein. For example, 
homozygous and/or heterozygous D252H mice may express eEF1A2 at the same 
level as wild-type mice, or the level may be significantly lower. This may be either 
due to a lower level of synthesis of the mutant protein or due to degradation if the 
protein is unstable. 
 
I analysed eEF1A2 expression in the brains of wild-type, heterozygous and 
homozygous littermates at P24 and in wild-type and heterozygous littermates from 
my behaviour cohort at 4 months. These are the mice mentioned in Section 5.2.9. 
Brain tissue was collected from the mice and RNA and protein were extracted. 
Protein lysates were run on a Western blot with antibodies specific to eEF1A2 and 
GAPDH as a loading control. Note that prior to running the qPCR for RNA 
expression analysis, samples were amplified by RT-PCR and run on an agarose gel 
with appropriate controls (see Section 2.5.4) to ensure that there was no 
contamination. An image of the gel is shown in Appendix A. 
 
The Western blot for the mice at P24 is shown in Figure 5.13A with eEF1A2 shown 
in red and GAPDH in green. Three samples per genotype were used for analysis. The 
presence of eEF1A2-specific bands in the Eef1a2D252H/D252H samples showed that 
D252H eEF1A2 was being expressed. The quantification results are shown in the bar 
graph below the blot, showing that eEF1A2 expression was significantly lower in the 
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brains of Eef1a2D252H/D252H mice compared with Eef1a2+/+ mice. This was shown 
using a one-way ANOVA with Tukey’s multiple comparisons test. To check whether 
the lower levels were reflected at the transcriptional level, RNA expression was 
quantified by qPCR. The results of this analysis are shown in the second bar graph in 
Figure 5.13A. There was no significant difference in RNA expression between 
genotypes (one-way ANOVA). These results suggest that the levels of eEF1A2 
expression are equal in the brains of Eef1a2+/+ and Eef1a2D252H/D252H mice at the 
RNA level and that the lower protein level seen is the result of decreased stability of 
the D252H protein. 
 
As mentioned, expression was also analysed in twelve randomly selected mice from 
the behaviour cohort (six per genotype). The results are shown in Figure 5.13B with 
eEF1A2 shown in red and GAPDH in green on the Western blot. The quantified 
protein expression shown in the bar graph indicates that eEF1A2 expression was 
significantly lower in the brains of Eef1a2+/D252H mice compared with Eef1a2+/+ 
mice (unpaired t-test). Subsequently, RNA expression was quantified by qPCR to 
assess eEF1A2 transcription. The results are shown in the second bar graph in Figure 
5.13B. There was no significant difference in RNA expression levels between 
Eef1a2+/D252H and Eef1a2+/+ mice (unpaired t-test). As with the homozygotes at P24, 
these results suggest that in the brains of heterozygous mice from the behaviour 
cohort, eEF1A2 protein is unstable. In contrast, a significant reduction in eEF1A2 
protein expression was not observed for Eef1a2+/D252H mice at P24 (A), however, 
analysing a greater number of mice would be beneficial here. 
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Figure 5.13. eEF1A2 RNA and protein expression in the brains of D252H mice. Blots 
were imaged using the Licor Odyssey FC with eEF1A2 in red (concentration = 1:1000) and 
GAPDH in green (concentration = 1:2000) and quantified using Image Studio Lite version 
4.0. +/+ Br = wild-type brain positive control, wst/wst Br = wasted brain negative control, 
+/+ Li = wild-type liver negative control. A. RNA and protein expression in mice at P24. 
The asterisk on the top bar graph shows a statistically significant difference. One-way 
ANOVA F = 6.18, DF = 2, 6, p = 0.0349. Tukey’s multiple comparisons test, p = 0.0293. B. 
RNA and protein expression in mice at 4 months post-behaviour. The asterisk on the top bar 






































































































































































































Mean eEF1A2 mRNA expression
Chapter 5: Behavioural characterisation of mice with the  




The aims of this chapter were as follows: 
1) To establish a new breeding line of mice with the D252H mutation. 
2) To characterise the behavioural phenotype of Eef1a2D252H/+ mice and compare this 
with the phenotype of heterozygous null mice. 
 
I successfully established two new breeding lines of Eef1a2/D252H mice using the 
two Eef1a2D252H/+ founders from the CRISPR/Cas9 experiment. These two founders 
were phenotypically normal at a gross observational level and were able to breed 
normally, making it easy to establish the lines. The Eef1a2/D252H mice will provide 
an invaluable opportunity to study the effects of eEF1A2 missense mutations on both 
protein function at the cellular and tissue level and phenotype at the whole organism 
level. Comparing the phenotypes of null mice and D252H mice will provide insight 
into whether the missense mutations lead to loss or gain of protein function. 
 
I used a mixture of mice bred from both founders for my behavioural experiments. 
This was necessary as this set of experiments was performed at the end of my project 
and therefore it was vital to breed a large enough number of mice in a short space of 
time. The presence or absence of off-target mutations has not been assessed in these 
lines and therefore it is possible that one or both may have other mutations that could 
confound results. In the future, both lines should be analysed for off-target effects 
and phenotypically compared but this was not in the scope of my project. Ideally, it 
would have been useful to compare behaviour results of mice bred from each 
founder, however, there were not enough mice to perform this analysis. It is, 
however, worth noting that off-target mutations are unlikely to be on the same 
chromosome as Eef1a2 and therefore would segregate away from the D252H 
mutation. 
 
In contrast to the situation observed in humans, the behaviour of mice that were 
heterozygous for the D252H missense mutation was normal. These mice showed no 
evidence of changes in repetitive behaviours, normal sociability and preference for 
social novelty, no hyperactivity, no increase in anxiety and no evidence of 
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hippocampal memory deficits. These are the results of the tests that were 
implemented, however, there are other tests that have not been considered. These are 
discussed throughout this section. 
 
It is interesting that mice with heterozygous null mutations in Eef1a2 showed 
changes in behaviour (Chapter 4) while mice with a D252H missense mutation did 
not. The normal behaviour phenotype of Eef1a2+/D252H mice is inconsistent with the 
autism and intellectual disability phenotypes observed in patients with D252H 
EEF1A2 mutations. This indicates that Eef1a2 missense mutations are better 
tolerated in mice than in humans and points to a mouse-human difference in 
pathology. My behaviour results suggest that, in mice, Eef1a2 missense mutations 
are tolerated better than Eef1a2 null mutations. 
 
Further analysis of hippocampal spatial memory was of interest because mice with 
mutations in genes known to cause autism and intellectual disability in humans have 
shown hippocampal memory deficits. For example, mice with mutations in Fmr1, 
Tsc1/2 and Cntnap2 show impairments in the Morris water maze with Fmr1 and 
Tsc1/2 mutants also showing deficits in contextual fear conditioning tests (Goorden 
et al., 2007, Peñagaricano et al., 2011, Kirschstein, 2012, Kazdoba et al., 2014). The 
results of the Y-maze test provided insight into the hippocampal memory of 
Eef1a2+/D252H mice, however, further testing is required to determine whether 
hippocampal memory is completely normal. In line with the mouse models described 
above, it would be beneficial to test Eef1a2+/D252H mice in the Morris water maze and 
in hippocampal-dependent contextual fear conditioning tests to determine whether 
there are similar phenotypes. This is an interesting avenue for future investigation. 
 
Unfortunately, I was unable to resolve the problems associated with the novel object 
recognition test due to lack of sufficient time. The trials described in this chapter 
were performed with a very short ITI of 5 minutes to ensure that wild-type mice 
were able to remember the familiar objects. Despite this, wild-type mice showed no 
preference for the novel object in any of the attempts. An increase in habituation and 
choice phase length did not improve the results, nor did any change of objects. 
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Perhaps a longer sample phase would have been necessary to improve familiarisation 
with the objects and increase exploration of the novel object in the choice phase as 
exploration in the sample phase was very low. In addition, the use of a smaller arena 
might have encouraged mice to explore the objects. Furthermore, the possibility that 
there was an unforeseen stressor in the test room affecting performance cannot be 
ruled out. This might have included sub-optimal temperature and/or lighting, 
environmental noise or odours. 
 
As alluded to in section 4.3, it may have been worthwhile to test females as well as 
males in the behavioural assays. If there had been no difference in performance 
between males and females, scores may have been combined. This would have 
increased the number of mice tested, making results more robust. 
 
I observed loss of fur on the neck of three homozygous D252H mice at P24 but not 
any of the six heterozygous D252H mice at 4 months whilst collecting tissue. This 
suggests that Eef1a2D252H/D252H mice might engage in excessive grooming behaviour 
although other causes, such as fighting, must not be overlooked. To assess grooming, 
behaviour should be observed and scored. Assessment should be carried out by 
spraying mice with a fine mist to induce the behaviour, placing in a cage and 
recording for a set period of time. Different types of grooming can be scored, 
including nose/face grooming, head and neck washing, body grooming and 
tail/genital grooming which can involve a combination of scratching and licking. 
Measurements such as the latency to start grooming, the total duration of grooming, 
the number of grooming bouts and the pattern of grooming should be taken and 
compared with wild-type mice (Kalueff et al., 2007). Age matched Eef1a2D252H/D252H 
and Eef1a2+/D252H mice at around P24 should also be compared to assess any 
differences between homozygotes and heterozygotes. It would also be interesting to 
assess older heterozygotes, at 4 months and above, to determine whether there are 
any changes in grooming behaviour with age. 
 
I found that male Eef1a2+/D252H mice weighed significantly less than male Eef1a2+/+ 
mice, with a small but robust difference of 2g at 4 months of age. In addition, recent 
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data from our laboratory showed that mixed male and female Eef1a2+/D252H mice 
weighed significantly less than their Eef1a2+/+ littermates between P14 and P24 
(unpublished data). One possible reason for reduced weight may be due to a 
potentially altered metabolism in Eef1a2+/D252H mice. In a study of mice null for the 
Kcnma1 BK potassium channel, male KO mice weighed significantly less than their 
wild-type littermates between 7 and 18 weeks postnatal. Measurement of body 
composition by quantitative magnetic resonance revealed that KO mice had a higher 
fat and water composition that their wild-type littermates, indicating differences in 
metabolism (Halm et al., 2017). Other possibilities include a reduced appetite of 
Eef1a2+/D252H mice or heightened stress levels which may be the cause of a reduced 
appetite or could result in weight loss. It is possible that reduced weight could occur 
as a result of altered function of the hypothalamic-pituitary-adrenal (HPA) axis and 
therefore it would be interesting to study the role of eEF1A2 in the hypothalamus. As 
a next step, it will be important to monitor weight gain weekly, ideally up to 18 
weeks as performed by Halm et al., 2017, to determine whether this weight 
difference is present continuously throughout postnatal development in both male 
and female mice. 
 
eEF1A2 protein expression was significantly lower in the brains of Eef1a2D252H/D252H 
mice at P24 and Eef1a2+/D252H mice at 4 months compared with their wild-type 
littermates. As there was no difference in expression at the RNA level, this suggests 
that the D252H protein is unstable and is susceptible to degradation as a result. At 
P24, there was no significant difference in eEF1A2 expression between Eef1a2+/+ 
and Eef1a2+/D252H mice, although expression in Eef1a2+/D252H mice was slightly 
lower. As it is known than eEF1A2 can homodimerise, this introduces the possibility 
that wild-type eEF1A2 is able to stabilise mutant eEF1A2 in the heterozygote (Bunai 
et al., 2006). Since there is no wild-type eEF1A2 protein in Eef1a2D252H/D252H brain, 
the protein is unable to be stabilised resulting in degradation and significantly lower 
expression levels. However, as mentioned, expression in the brains of Eef1a2+/D252H 
mice was significantly lower than Eef1a2+/+ mice at 4 months in the behaviour 
cohort. This result argues against the hypothesis that wild-type eEF1A2 stabilises 
mutant eEF1A2 in heterozygous mice. There were two main differences between the 
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Eef1a2+/D252H mice at P24 and at 4 months: age and the fact that the 4-month cohort 
had been through behavioural testing. Either of these may have affected protein 
expression but the specific reason for the difference in expression at P24 and 4 
months is currently unclear. 
 
These experiments have provided insight into the effects of missense mutations on 
eEF1A2 function, with a particular focus on behaviour. Future experimentation on 
this mouse line will be hugely beneficial in improving our knowledge of human 
disease.
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Chapter 6: Discussion 
 
6.1. Project summary 
The experiments conducted in my PhD project were based on the recent discovery of 
twenty de novo heterozygous missense mutations in EEF1A2 in over forty patients 
with intellectual disability, epilepsy and in some cases autism. The main aim of my 
project was to phenotype mouse models with different mutations in Eef1a2, with a 
particular focus on behaviour. These behavioural analyses were intended to provide a 
correlate for the intellectual disability and autism observed in patients and to address 
the question of whether the mutations operate through a gain or loss of function 
mechanism. For my behavioural experiments, I characterised heterozygous null mice 
by studying the effects of age and genetic background on behaviour. I compared the 
behaviour of these null lines to heterozygous mice from a new line, generated by 
CRISPR/Cas9, with a D252H missense mutation in Eef1a2. I also, separately, 
characterised mice with a G70S missense mutation in Eef1a2 that were generated 
using CRISPR/Cas9 technology. Although we were unable to generate a G70S 
breeding line, the founder mice provided a wealth of information on the effects of the 
G70S mutation on eEF1A2 function. In this discussion, I will examine the aims of 
my project by chapter with a focus on the wider context of my work, its limitations 
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6.2. Chapter 3 aim: To characterise mice with the Eef1a2/G70S 
missense mutation with an aim to better understand the 
mechanisms underlying the human phenotype 
The restriction enzyme digest protocol I developed provided an accurate prediction 
of genotype prior to sequencing, with a success rate of 84%. This allowed early 
prediction of mice that had G70S incorporation and/or large indels, providing an 
indication of mice that should be particularly closely monitored in terms of 
phenotype. The utilisation of specific restriction enzyme digests to predict genotype 
is widely used in studies such as this and has proven to be valuable here (Singh, 
Schimenti and Bolcun-Filas, 2015).  
 
Using RT-PCR and specific restriction enzyme digests in combination with Fiona 
McLachlan’s western blot results, I was able to show that six mice expressed G70S 
eEF1A2. Five of these mice were Eef1a2G70S/- and the other Eef1a2G70S/G70S. The 
phenotype and survival of the Eef1a2G70S/- mice was comparable to that of Eef1a2-
null wasted mice, showing that G70S eEF1A2, although expressed, was unable to 
compensate for loss of wild-type protein. This result pointed towards loss of function 
as a mechanism for human disease, however, the one Eef1a2G70S/G70S mouse had a 
more severe phenotype. This suggested that the G70S protein might also gain some 
toxic functions that contribute to the disease phenotype. It is vital that missense 
mutations in eEF1A2 are studied further to determine whether loss of function, gain 
of function, or both, are at play. It is unfortunate that only one G70S homozygote 
was generated and conclusions regarding gain of function most certainly cannot be 
based on this mouse alone. Therefore, it will be necessary to correlate phenotype and 
protein expression in a larger cohort of mice and the D252H line will be ideal for this 
analysis. However, it is worth bearing in mind that all of the mutations might not 
operate through the same mechanism as suggested by the different phenotypic 
manifestations in the patients. 
 
Audiogenic seizures were observed in eight Eef1a2-/- mice, however, unfortunately, 
these were not under controlled conditions. In addition, although four mice with a 
G70S allele were exposed to the same sound stimulus, none of them had seizures. 
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However, it is true that the G70S mice were in lower cages and therefore were 
arguably more sheltered from the sound. Due to the low number of G70S mice 
exposed, it was not possible to determine whether mice of this genotype are 
susceptible to audiogenic seizures as a larger cohort would be required. It will be 
important to determine whether mice with missense mutations in Eef1a2 are 
susceptible to audiogenic seizures under controlled conditions. This could be 
performed using D252H heterozygotes as a correlate for the genotypes of the 
patients. Audiogenic seizure activity could be closely monitored and scored by 
exposing mice to sound of around 120dB in a Perspex box (Ross and Coleman, 
2000). Wireless telemetry could also be used to record EEG signals in awake 
behaving mice (Zayachikivsky, Lehmkuhle and Dudek, 2015). Finally, mice could 
be monitored in-cage using video recording to detect spontaneous seizures. 
 
My aims to predict genotypes prior to sequencing and to determine whether mice 
carrying a G70S allele expressed G70S eEF1A2 were largely successful and the 
G70S CRISPR/Cas9 experiment has improved understanding of the effects of 
missense mutations on eEF1A2 function. In addition, this study showed for the first 
time that mice with mutations in Eef1a2 are susceptible to seizures. 
 
6.3. Chapter 4 aim: To determine the effects of age and genetic 
background on the behaviour of heterozygous Eef1a2-null mice 
In my behavioural analysis of heterozygous Eef1a2-null mice, I found that 
heterozygous wasted mice showed reduced marble burying behaviour, decreased 
locomotor activity and an increased freezing response with age. These results pointed 
towards three main possibilities: a motor impairment, reduced motivation for 
movement or increased anxiety. In addition, a robust lack of preference for social 
novelty was identified at all ages tested, a behaviour which has been identified in 
other autism models (Wagnon et al., 2014). The behaviour of heterozygous Eef1a2-
null mice from the Del22.ex3 line was different from that of heterozygous wasted 
mice suggesting that the change in genetic background may have had an influence on 
behaviour. Del22.ex3 Eef1a2+/- mice showed a reduction in repetitive behaviours 
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compared with wild-type mice and normal preference for social novelty. In addition, 
there was lower variation in results from the Del22.ex3 line, thought to be due to the 
pure C57BL/6 genetic background in contrast to the mixed genetic background of the 
wasted line. To summarise, I showed for the first time that heterozygous null 
mutations in Eef1a2 result in changes in behaviour. 
 
For future experimentation, it would be more beneficial to study the Del22.ex3 line 
than the wasted line due to the lower variability of results. Therefore, robust 
behaviour results could be obtained by testing a much lower number of mice. Ideally, 
power calculations should be performed either prior to testing or post-hoc after 
testing a small cohort of mice to determine the number of mice that should be tested.  
 
It would be interesting to repeat the stranger mouse test on the Del22.ex3 line using 
stranger mice from the same lineage as performed on the wasted line. This would 
reveal whether the lack of impairment in this task in the Del22.ex3 line was due to 
the change in protocol or the difference in genetic background. Since I identified a 
social impairment in heterozygous null mice, it would also be interesting to 
determine whether mice of this genotype show any other social behaviour deficits, 
particularly in behaviours that have shown to be affected by other autism-related 
mutations. For example, Cntnap2 knockout mice show abnormal social behaviour in 
the juvenile play test. This test involves allowing direct interaction between the test 
mouse and an unfamiliar mouse in a cage for 10 minutes and measuring the time 
spent interacting (Peñagaricano et al., 2011). Communication deficits could also be 
studied by measuring ultrasonic vocalisations (USVs) (Wöhr and Scattoni., 2013). 
 
As there was insufficient time to age mice from the Del22.ex3 line, investigating the 
effects of age on the behaviour of these mice would be an interesting avenue for 
future investigation. It would be particularly beneficial to determine whether 
heterozygous mice from this line show the same age-related behavioural changes as 
heterozygous mice from the wasted line. Subsequent western blotting could be 
performed on whole brain tissue to determine eEF1A2 expression levels. 
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Unfortunately, I was unable to optimise the novel object recognition test which 
meant that learning and memory was not studied as extensively as desired. It would 
be valuable to study further the role of eEF1A2 in learning and memory as eEF1A2 
has been shown to be important for the maintenance of LTP at hippocampal synapses 
(Tsokas et al., 2005). Firstly, it would be interesting to repeat the Y-maze test with a 
longer ITI of 120 minutes as performed on the D252H line to study hippocampal 
spatial memory. Another hippocampal memory test which would be beneficial and 
easy to implement is the contextual fear conditioning test (Curzon, Rustay and 
Browman, 2009). Other types of memory should also be studied as behaviours 
related to brain areas other than the hippocampus may be affected by deletion of 
Eef1a2. For example, Fmr1 knockout mice show impairments in reversal learning in 
a water based Y-maze test when the escape platform is moved to the other arm 
(Bhattacharya et al., 2012). This task involves functions of the prefrontal cortex and 
is used as a correlate for the behavioural inflexibility that is observed in humans with 
autism (Santos, Kanellopoulos and Bagni, 2014).  
 
As mentioned, my work shows behavioural changes in mice with mutations in 
Eef1a2 for the first time. The results from Chapter 4 show that presumed 50% levels 
of eEF1A2 in the brain are not sufficient to elicit normal behavioural responses. 
However, interestingly, apart from the observed changes in behaviour, these mice are 
phenotypically normal (Griffiths et al., 2012, Chapter 4). The observation that 
heterozygous Eef1a2-null mice show similar behavioural deficits to other mouse 
models of autism suggests that eEF1A2 interacts with common pathways, including 
the ERK1/2 and mTOR pathways, and there is evidence to suggest that this is the 
case (Tsokas et al., 2005, Bluem et al., 2007, Khwanraj et al., 2016). It has also been 
shown that eEF1A2 is a target of FMRP, the product of the gene which is mutated in 
Fragile X syndrome (Darnell et al., 2011). However, various lines of evidence, both 
through the G70S CRISPR/Cas9 experiment and testing of the D252H mouse line 
(see Chapter 5 aim) suggest that the human missense mutations may lead to gain of 
protein function. If this appears to be the case after further investigation, further 
behavioural testing of the D252H line will be more valuable than continuing with the 
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Del22.ex3 line. Despite this, the new Eef1a2-null Del22.ex3 line generated in my 
project will be useful for future investigation of eEF1A2 function. 
 
6.4. Chapter 5 aim: To investigate the effects of the Eef1a2/D252H 
missense mutation on mouse behaviour 
The results of my behavioural analysis on Eef1a2+/D252H mice showed that the mice 
were phenotypically normal, in contrast to the results of heterozygous null mice, 
suggesting that, in terms of behaviour, the missense mutation is better-tolerated. 
Weight data revealed that Eef1a2+/D252H mice weighed significantly less than 
Eef1a2+/+ littermates at 4 months, complementing results gathered between P14 and 
P24. Finally, expression analysis results showed that D252H eEF1A2 protein is 
expressed in brain but appears to undergo degradation due to instability. 
 
Other recent data from our laboratory, collected by Laura Kaminioti-Dumont, 
indicates that there may be a gain of function of the D252H protein (unpublished 
data). Due to the well-characterised neurodegenerative phenotype of homozygous 
wasted mice (Newbery et al., 2005), homozygous D252H mice and homozygous null 
mice from the Del22.ex3 line were tested for signs of neuromuscular degeneration. 
Mice were given a daily phenotypic score based on gait, kyphosis, hindlimb clasping 
and balance with a higher score indicating a more severe disease phenotype (Guyenet 
et al., 2012). The scores for Eef1a2D252H/D252H mice were significantly higher than the 
scores for Eef1a2-/- mice from P18-P24. Between P15 and P24, Eef1a2D252H/D252H 
mice weighed significantly less than Eef1a2-/- mice. These results show that the 
D252H protein has a more severe effect on particular phenotypes than complete 
absence of eEF1A2. This builds upon data generated through the G70S 
CRISPR/Cas9 experiment showing the missense protein was insufficient to protect 
against neurodegeneration and that the homozygous missense mutant had a more 
severe phenotype than homozygous null mutants. However, it is important to bear in 
mind that these mutations may work through different mechanisms. 
 
None of the behavioural tests I performed on Eef1a2+/D252H mice revealed any 
evidence for phenotypic abnormalities; however, this does not mean that these mice 
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do not show changes in behaviour. It would be very interesting to perform the 
behavioural tests of social behaviour and learning and memory suggested in Section 
6.3 on this line. In addition, there was evidence to suggest that Eef1a2D252H/D252H 
mice engage in repetitive grooming behaviour and this could be followed up as 
described in Chapter 5. Despite repeated attempts to optimise the novel object 
recognition protocol on both this line and the Del22.ex3 line, the problems could not 
be resolved. If possible, it would be beneficial to resolve these problems in the future 
as mice with mutations in autism-related genes have shown impairments in this test, 
including Fmr1 knockout mice and Shank3 mutant mice (Bhattacharya et al., 2012, 
Yang et al., 2012).  
 
The observation that Eef1a2+/D252H mice show reduced weight compared with their 
Eef1a2+/+ littermates is interesting and the reason for this is currently unknown. One 
possible way to determine whether this could be due to increased stress is by 
measuring corticosterone metabolites and other stress hormones in blood and/or fecal 
samples (Touma, Palme and Sachser, 2004). Mouse behaviour and general 
phenotype could also be observed to determine whether Eef1a2+/D252H mice show 
increased stress responses. This may involve simple observations of coat condition, 
respiration, motor posture, movement, alertness, feeding, changes in urine/feces and 
vocalisations. Behavioural tasks such as the elevated plus maze and the light-dark 
choice test could also be used as measurements of stress and anxiety (Takao and 
Miyakawa, 2006). However, it is also possible that Eef1a2+/D252H mice have either 
fewer cells or cells of reduced size compared with Eef1a2+/+ mice and that this may 
be the reason for the difference in weight. Finally, as mentioned in the discussion for 
this chapter, differences in body composition may underlie the difference in weight 
and this would be another interesting avenue for future investigation. 
 
Due to the expression results suggesting that the D252H protein is unstable, drugs 
that act to stabilise proteins could, possibly, be used therapeutically. However, this is 
not likely to be beneficial for patients with EEF1A2 mutations as results from mice 
suggest that missense mutations in Eef1a2 lead to gain of toxic functions. Further 
research into the effects of these mutations on eEF1A2 function is necessary, 
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however, targeting eEF1A2 using small molecule drugs may be a more efficient 
strategy as this has been shown to work well in diseases caused by gain of function 
mutations (Chen and Altman, 2017). Boosting wild-type levels of eEF1A2 using 
gene therapy is also an option, however, the effectiveness of this approach whilst the 
toxic protein remains is unknown. In addition, eEF1A2 is an oncogene which is 
overexpressed in many tumour types (Anand et al., 2002, Lee and Surh, 2009), 
therefore, boosting wild-type levels should be treated with caution. Gene silencing is 
another potential treatment option. This approach uses single stranded DNA or RNA 
molecules which are complementary to and bind the mutant mRNA, reducing its 
translation into protein. This approach has been extensively studied as a potential 
treatment option for patients with Huntington’s disease with success in rodent 
models and human clinical trials currently ongoing (Godinho et al., 2015). However, 
it is currently unknown whether 50% levels of eEF1A2 are compatible with normal 




In my project, I have successfully shown behavioural changes in mice with 
heterozygous mutations in Eef1a2 and shown a difference in phenotype between null 
and missense mutants which suggests that Eef1a2-null mutations are less well-
tolerated than missense mutations in mice. The number of human cases with 
missense mutations in EEF1A2 is increasing and, based on results from the DDD 
study, there are predicted to be 5-6 new cases in the UK each year, with a birth 
incidence of approximately 1/100,000 (personal communication). This increase in 
the number of cases has not occurred because of a rise in mutation frequency but 
because of the development and widespread use of new sequencing methods. 
Therefore, genetic causes of developmental disorders are being identified more 
quickly in a substantially larger number of undiagnosed individuals. 
 
It is important to determine the effects of missense mutations on eEF1A2 function 
and phenotype using multiple different model systems with the aim to test 
therapeutics in the future. Cell models are a valuable tool which can be used to study 
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every human EEF1A2 mutation by simple and effective mutagenesis and transfection 
of plasmids. However, studies in cell lines are confounded by co-expression of 
eEF1A1. Zebrafish models are also being explored, with the hope of screening small 
molecules for therapy. Mouse models provide a correlate for human physiology and 
are extremely useful to study the effects of these mutations on phenotype at a whole 
organism level. Future studies using the D252H mouse model generated in our 
laboratory will increase understanding of the human phenotype. An interesting 
avenue for future investigation of D252H mice would be proteomic analysis of brain 
tissue by mass spectrometry to identify pathways that are involved in disease 
pathogenesis. Changes to interactions of eEF1A2 with synaptic proteins and ion 
channel subunits would be interesting to follow up. In the future, a mouse model 
with another of the human missense mutations, perhaps one identified in patient(s) 
with different clinical features from the D252H patients, would be a valuable 
comparator. This would provide insight into the ways in which different missense 
mutations in EEF1A2 lead to differences in pathology. Together, these strategies will 








Appendix A – qPCR on D252H mouse brain: controls, melting 
curves and standard curves 
 
A1. Agarose gel showing lack of contamination in controls 
Prior to the qPCR experiments presented in Section 5.2.10, cDNA samples were 
amplified using RT-PCR and run on a 2% agarose gel to ensure that there was no 
contamination using the protocol shown in Section 2.5.5. The gel images are shown 




Figure A1.1. cDNA samples run on a 2% agarose gel. ntc = no template control, -RT = 
no reverse transcriptase cDNA synthesis control, -RNA = no RNA cDNA synthesis control 
(see Section 2.5.4). 
 
 
A2. Melting curves and standard curves 
Serial dilutions of cDNA were used to produce standard curves following the 

























1:256, 1:1024, 1:4096 and 1:16384. Melting curves (Figure A2.1) and standard 
curves (Figure A2.2) were generated using SDS software. 
 
 
Figure A2.1. qPCR melting curves for eEF1A2 and the reference genes GAPDH and 
Actin. These were generated in order to ensure primer specificity. A single peak indicates 




































Figure A2.2. qPCR standard curves for eEF1A2 and the reference genes GAPDH and 
















Appendix B – Correlating behaviour score with age for mice 
in the wasted line 
 
Behaviour scores were correlated with age to confirm whether scores increased or 
declined as mice aged. Correlation plots are shown in Figure B1. A summary table of 
the statistical results for these analyses is also shown (Table B1). 
 
The results of these correlation analysis are largely in agreement with the results of 
the aging studies presented in Chapter 4. Firstly, there is a significant negative 
correlation of marble burying score with age for Eef1a2+/wst mice (Figure B1. C, 
Table B1) which complements the result in Figure 4.3 showing that Eef1a2+/wst mice 
bury significantly fewer marbles at 12-18 months compared with 2-6 months. 
Similarly, there is a significant negative correlation of the total distance travelled in 
the open field arena with age for Eef1a2+/wst mice (Figure B1. G, Table B1) which is 
in agreement with the result in Figure 4.7A showing that Eef1a2+/wst mice cover a 
significantly shorter distance at 12-18 months compare with at 2-6 months. In 
addition, the significant positive correlation for Eef1a2+/wst mice for time spent 
freezing in the open field test (Figure B1. H, Table B1) complements data shown in 
Figure 4.7B whereby Eef1a2+/wst mice spend a significantly larger amount of time 
freezing at 12-18 months compared with 2-6 months. 
 
However, some of the correlations are significant despite the lack of significant 
differences in the age group analyses shown in Chapter 4. There were two significant 
correlations for Eef1a2+/wst mice in the digging assay: a significant negative 
correlation for the number of digging bouts (Figure B1. D, Table B1) and a 
significant positive correlation for the latency to start digging (Figure B1. E, Table 
B1). In Chapter 4, there was no significant difference in the number of digging bouts 
of the latency to start digging between Eef1a2+/wst age groups (Figure 4.4 A and B). 
The lack of significance in the data presented in Chapter 4 compared with the 
significant correlations shown here is thought to be due to the standard error values 
associated with the Chapter 4 results. Standard error has no influence on correlation 




variable. In the correlation analyses, a significant positive correlation was found for 
Eef1a2+/wst mice for the time spent in the centre of the open field arena (Figure B1. I, 
Table B1). Again, the reason for obtaining a significant result from this analysis but 
not from the analysis in Chapter 4 (Figure 4.7C) is thought to be due to the standard 
error values in the Chapter 4 analyses. It can be seen from the correlation plot that 
the variability in scores from the mice at 16 months is very large which explains why 
significance was not achieved when comparing age groups in Chapter 4. This result 
makes sense when considering that Eef1a2+/wst mice cover a significantly smaller 
distance and spend significantly more time freezing in the open field test as they age. 
The data suggests that 12-18 month old Eef1a2+/wst mice spent more time freezing in 
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Figure B1. Correlation of age with behaviour score for each test performed on the 
wasted line. A and B. Nest building assay. C. Marble burying test. D, E and F. Digging 
assay. G, H and I. Open field test. J and K. Stranger mouse test. L. Y-maze test. Results 
from wild-type analyses are shown with purple data points (left) and results from Eef1a2+/wst 
analyses are shown with red data points (right). 
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 R R squared P value Significant? 
Nest building - % nestlet shredded -0.30 0.09 0.2727 N 
Nest building - % nestlet shredded 0.07 0.00 0.7573 N 
Nest building - score -0.13 0.02 0.6565 N 
Nest building - score -0.02 0.00 0.9329 N 
Marble burying -0.26 0.07 0.3136 N 
Marble burying -0.66 0.43 0.0058 Y 
Digging – number of bouts -0.16 0.03 0.5379 N 
Digging – number of bouts -0.61 0.37 0.0120 Y 
Digging - latency 0.34 0.12 0.1812 N 
Digging - latency 0.55 0.30 0.0283 Y 
Digging - duration -0.11 0.01 0.6629 N 
Digging - duration -0.40 0.16 0.1298 N 
Stranger mouse test 1 0.17 0.03 0.4707 N 
Stranger mouse test 1 -0.13 0.02 0.5107 N 
Stranger mouse test 2 -0.07 0.00 0.7621 N 
Stranger mouse test 2 -0.02 0.00 0.9308 N 
Y-maze -0.05 0.00 0.8397 N 
Y-maze 0.27 0.07 0.1224 N 
Open field – distance travelled -0.43 0.18 0.0875 N 
Open field – distance travelled -0.80 0.64 0.0002 Y 
Open field – time spent freezing 0.28 0.08 0.2772 N 
Open field – time spent freezing 0.77 0.59 0.0005 Y 
Open field – time in centre -0.27 0.07 0.3160 N 
Open field – time in centre 0.56 0.32 0.0286 Y 
 
Table B1. Statistical analysis of correlations shown in Figure B1. Pearson’s correlations 
were performed on the data. As with Figure B1, results from wild-type analyses are shown in 
purple and results from Eef1a2+/wst analyses are shown in red. Statistically significant results 
are highlighted in yellow. Note: an ‘R’ of 1 indicates a perfect positive correlation whilst 









Appendix C - Confirming the genotypes of mice from the 
wasted line behaviour cohort 
 
The genotypes of the mice that were culled for tissue were confirmed by PCR using 
the protocol shown in Section 2.4.3. DNA was extracted from tissue using the 




Figure C1. PCR products from the wasted behavioural cohort run on a 2% agarose 
gel. +/+ = wild-type, +/wst = wasted heterozygote, wst/wst = wasted homozygote tissue 
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